Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),0.8348686709970132,2.5983198795455973,0.0,0.0,0.0,14/30,3.60%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GABRB1;GRIN2B;GRIA3;GRIN3A;GRID1;GRIA2;GRIK4;GRIA1
prerank,ligand-gated channel activity (GO:0022834),0.8348708826205037,2.578827784542458,0.0,0.0,0.0,14/29,3.60%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GABRB1;GRIN2B;GRIA3;GRIN3A;GRID1;GRIA2;GRIK4;GRIA1
prerank,transmitter-gated ion channel activity (GO:0022824),0.8303978967475041,2.5683641943431734,0.0,0.0,0.0,17/29,8.86%,GRID2;GRIA4;GRIK5;GRIK2;GABRB3;GRIK1;GABRB1;GABRG3;GABRA2;GRID1;GRIA2;GRIK4;GABRA3;GABRA5;GABRB2;GABRG2;GLRA2
prerank,glutamate receptor activity (GO:0008066),0.8953870071766902,2.544928202358669,0.0,0.0,0.0,13/19,3.60%,GRM7;GRID2;GRIA4;GRIK5;GRIK2;GRM5;GRIK1;GRM8;GRM1;GRID1;GRIA2;GRIK4;GRIA1
prerank,potassium channel activity (GO:0005267),0.6194025592210534,2.450746838513218,0.0,0.0,0.0,34/89,15.79%,KCND2;GRIK5;GRIK2;KCNB2;GRIK1;KCNQ3;KCNN2;KCNQ5;KCNC2;KCNK10;KCND3;KCNT2;KCNMB3;KCNMB2;KCNH7;KCNH5;KCNH1;GRIK4;KCNK2;HCN2;KCNA1;KCNH4;KCNF1;HCN1;TMEM175;KCNG1;KCNMA1;KCNV1;KCNH8;KCNA2;KCNS3;TMEM38A;GRIK3;KCNK12
prerank,voltage-gated cation channel activity (GO:0022843),0.6056240610858555,2.4374980455819886,0.0,0.0,0.0,34/97,13.91%,KCND2;KCNB2;GRIN2A;CACNA2D3;KCNQ3;CACNA1C;CACNA1E;KCNQ5;GRIN2B;KCNC2;CACNA2D1;KCND3;GRIN3A;KCNH7;KCNH5;CACNB2;KCNH1;NCS1;CACHD1;TMC1;HCN2;KCNA1;CACNG4;CACNG2;KCNH4;RYR1;KCNF1;HCN1;KCNG1;KCNMA1;KCNV1;KCNH8;KCNA2;KCNS3
prerank,voltage-gated potassium channel activity (GO:0005249),0.6212391508052006,2.418526406476506,0.0,0.0,0.0,30/80,13.91%,KCND2;KCNB2;KCNQ3;KCNN2;KCNQ5;KCNC2;KCND3;KCNT2;KCNH7;KCNH5;KCNH1;KCNJ3;KCNJ10;KCNJ6;KCNK2;KCNJ9;HCN2;KCNIP2;KCNA1;KCNH4;KCNJ16;KCNF1;HCN1;KCNG1;KCNMA1;KCNJ12;KCNV1;KCNH8;KCNA2;KCNS3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.7811917897909749,2.393716920499677,0.0,0.0,0.0,12/28,7.67%,GRID2;GRIK5;GRIK2;GRIK1;GABRG3;GABRA2;GRID1;GRIK4;GABRA3;GABRA5;GABRG2;CHRNA5
prerank,ionotropic glutamate receptor activity (GO:0004970),0.8662017628286751,2.377494994006331,0.0,0.0,0.0,11/17,3.60%,GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;GRIN2B;GRIA3;GRIN3A;GRIA2;GRIK4;GRIA1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.844872385636316,2.3737511031428498,0.0,0.0,0.0,11/19,7.52%,GRID2;GRIK5;GRIK2;GRIK1;GABRG3;GABRA2;GRID1;GRIK4;GABRA3;GABRA5;GABRG2
prerank,ion channel activity (GO:0005216),0.6003710759786574,2.3255952724594353,0.0,0.0,0.0,22/80,8.42%,GRID2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;UNC80;TRPM3;GABRB1;GRIN2B;GRIA3;GRIN3A;NALCN;TRPC1;GRID1;GRIA2;GRIK4;GRIA1;TMC1;CHRNA5;PKD1L3;TRPM1
prerank,ligand-gated cation channel activity (GO:0099094),0.6023434656007631,2.2784544118875107,0.0,0.0,0.0,19/75,7.72%,ASIC2;GRIA4;GRIK5;GRIK2;GRIN2A;GRIK1;KCNN2;GRIN2B;GRIA3;GRIN3A;GRIA2;GRIK4;GRIA1;KCNJ3;KCNJ10;KCNJ6;KCNJ9;CHRNA5;KCNJ16
prerank,neuropeptide receptor activity (GO:0008188),0.6939885184647419,2.157454694019277,0.0,0.00039990631378191186,0.005,12/29,15.71%,SORCS1;HCRTR2;SORCS3;GPR37;NPY2R;NTSR1;GPR143;NPSR1;GALR1;NPY1R;TACR3;OPRM1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.804427190535292,2.1299776333701006,0.0,0.0007426831541664078,0.011,8/15,3.81%,HS3ST6;HS3ST5;HS6ST3;HS3ST4;HS6ST2;NDST4;NDST3;HS3ST1
prerank,ligand-gated anion channel activity (GO:0099095),0.783980828062577,2.124209786902503,0.0,0.0007509351892127012,0.012,10/17,8.86%,GABRB3;GABRB1;GABRG3;GLRA1;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GLRA2
prerank,sodium channel activity (GO:0005272),0.6391944777753296,2.119516140963658,0.0,0.000758155719878208,0.013,12/37,10.58%,ASIC2;GRIK5;GRIK2;GRIK1;SCN2A;SCN1A;GRIK4;SCN3A;SCN9A;HCN2;SLC4A11;HCN1
prerank,GABA receptor activity (GO:0016917),0.7349331537254248,2.101448236637772,0.0,0.0009684005833738454,0.018,10/21,8.53%,GABRB3;GABRB1;GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABBR1;GPR156
prerank,GABA-A receptor activity (GO:0004890),0.7462782863506715,2.0542457658059243,0.0,0.001877337973031753,0.035,8/18,7.52%,GABRB3;GABRB1;GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.827074085907606,2.0310483368463337,0.0,0.0022801675785810763,0.044,8/12,7.52%,GABRB3;GABRB1;GABRG3;GABRA2;GABRA3;GABRA5;GABRB2;GABRG2
prerank,phosphatidylinositol binding (GO:0035091),-0.5301920843602395,-2.0153561257561368,0.0,0.017521213998141837,0.015,38/91,20.61%,DENND1A;SNX10;PITPNC1;SNX2;SNX9;PITPNA;ITPR1;SNX27;SNX8;MTM1;FES;SNX24;WDFY3;PITPNM1;SNX5;ANKFY1;FCHO2;ESYT1;PICALM;HIP1;EEA1;ESYT2;MYO1E;SESTD1;SNX13;NCF1;AIDA;CCDC88A;ITPR3;RNF34;SNX16;APPL2;WDFY1;SNX1;SNX4;DENND1B;APPL1;MPPE1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.7398164801779249,-1.9546242515426229,0.0,0.026829358934654688,0.04,6/17,5.07%,ABCA1;ABCG1;PLTP;PITPNC1;PITPNA;PITPNM1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.669237420027806,1.9486458607060702,0.0024630541871921183,0.008664636798608091,0.166,6/21,14.82%,GRM5;GRM1;GRIA1;CHRNA5;CHRNA7;CHRFAM7A
prerank,acetylcholine receptor activity (GO:0015464),0.6683922980044003,1.9459202720005968,0.002506265664160401,0.008375815571987822,0.167,6/22,14.82%,CHRM2;CHRM3;HRH3;CHRNA5;CHRNA7;CHRFAM7A
prerank,voltage-gated calcium channel activity (GO:0005245),0.5822147341957487,1.9280914389172787,0.0,0.010318794732887817,0.206,14/37,15.71%,CACNA2D3;CACNA1C;CACNA1E;CACNA2D1;CACNB2;NCS1;CACHD1;TMC1;CACNG4;CACNG2;RYR1;TMC2;CACNA1G;OPRM1
prerank,outward rectifier potassium channel activity (GO:0015271),0.7959213366667435,1.900975932681259,0.0,0.013373678536982054,0.269,5/11,6.77%,KCND2;KCND3;KCNT2;KCNK2;KCNIP2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.6117182573215972,-1.899616429365923,0.0,0.04964343966140188,0.112,17/35,20.13%,LYN;FGR;SYK;PEAK1;FES;ABL2;TEC;PTK2B;PKDCC;LCK;DYRK1A;ITK;FRK;TXK;ZAP70;HCK;SLA
prerank,cyclic nucleotide binding (GO:0030551),0.6508329992877206,1.8947407410487407,0.0,0.01371900826446281,0.284,8/21,10.71%,PDE4B;PDE10A;KCNH1;PDE4D;PDE11A;POPDC2;HCN1;RAPGEF4
prerank,cholesterol transfer activity (GO:0120020),-0.7218932932071015,-1.8684851638873239,0.001669449081803005,0.0615980179622174,0.179,6/16,11.01%,ABCA1;ABCG1;PLTP;GRAMD1B;STARD5;NPC2
prerank,sterol transfer activity (GO:0120015),-0.7068217935187541,-1.8590886409321938,0.0034129692832764505,0.05497280891917002,0.196,6/17,11.01%,ABCA1;ABCG1;PLTP;GRAMD1B;STARD5;NPC2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.7311689722895341,-1.8573060096311262,0.0016420361247947454,0.047270775265820165,0.202,7/14,12.51%,CYBB;CYBA;KMO;NCF1;NCF4;MICAL1;NCF2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.6285492088104087,1.8293105075194125,0.004739336492890996,0.029113179643323186,0.527,7/23,3.86%,PDE4B;PDE10A;PDE1A;PDE1C;PDE4D;PDE11A;PDE9A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.643819805539843,1.8288412894908155,0.002380952380952381,0.028160069595476296,0.529,7/21,3.86%,PDE4B;PDE10A;PDE1A;PDE1C;PDE4D;PDE11A;PDE9A
prerank,neuropeptide binding (GO:0042923),0.6538841761937483,1.8282934299635114,0.009779951100244499,0.02730965153931661,0.532,8/18,23.27%,GPR37;OPRD1;GPR149;OPRK1;OPRL1;OPRM1;SORL1;MC4R
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.7196894832529964,1.8161419000670247,0.004629629629629629,0.02967638103523271,0.578,7/13,8.86%,GABRG3;GLRA1;GABRA2;GABRA3;GABRA5;GABRG2;GLRA2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.7871314729908819,-1.812473448399426,0.0017064846416382253,0.07524735654559131,0.339,5/10,12.51%,CYBB;CYBA;NCF1;NCF4;NCF2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5640275454289396,1.8100998890361724,0.004901960784313725,0.03047561908475949,0.598,14/32,21.68%,KCNB2;KCNQ3;KCNQ5;KCNC2;KCNH1;KCNA1;KCNG1;KCNA2;KCNS3;KCNE4;KCNA6;KCNQ2;KCNG3;KCNA5
prerank,calcium channel activity (GO:0005262),0.4613697027539841,1.8003014236219463,0.0,0.032174684645498046,0.626,19/84,9.78%,CACNA2D3;CACNA1C;CACNA1E;TRPC5;RYR2;CACNA2D1;SLC24A4;SLC24A2;TRPC1;CACNB2;NCS1;SLC24A3;CACHD1;TMC1;CACNG4;CACNG2;PKD1L3;TRPM1;RYR1
prerank,phosphotyrosine residue binding (GO:0001784),-0.5633895520540272,-1.7898056893166718,0.001736111111111111,0.09143883555280272,0.437,19/37,18.46%,BCAR3;FGR;GRB2;SYK;PLCG2;VAV1;ABL2;SH3BP2;STAP1;VAV2;PTPN6;LCK;CRK;SAMSN1;RASA1;CRKL;ZAP70;HCK;PTPN11
prerank,androgen receptor binding (GO:0050681),-0.6004342311735494,-1.7879892321372393,0.0,0.08346911668559237,0.445,12/25,23.95%,FOXP1;PRKCB;KDM3A;PRMT2;DDX5;TGFB1I1;TRIM68;NSD1;ARID5A;KDM1A;ZBTB7A;PRPF6
prerank,histone methyltransferase activity (GO:0042054),-0.5630467089369898,-1.7810930020211475,0.0,0.08300675131619697,0.483,14/32,16.35%,NSD3;PRMT2;SMYD2;SMYD3;EZH2;KMT5B;EED;PRMT1;KMT2C;SMYD1;SETDB1;DOT1L;PRMT6;KMT5A
prerank,chemorepellent activity (GO:0045499),0.5988014844345615,1.7790320803222375,0.0,0.0382082532377331,0.701,7/25,3.44%,NRG3;NRG1;SEMA6D;EPHA7;SEMA6A;SEMA3E;SEMA5A
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.5402983961420609,-1.7702993478043272,0.0017452006980802793,0.0860132323545145,0.526,21/42,18.46%,BCAR3;FGR;GRB2;SYK;PLCG2;VAV1;ABL2;SH3BP2;STAP1;YWHAE;VAV2;PTPN6;PIN1;LCK;CRK;SAMSN1;RASA1;CRKL;ZAP70;HCK;PTPN11
prerank,calcium ion binding (GO:0005509),0.37752617450555376,1.768513020098654,0.0,0.04145487168334058,0.741,90/323,14.58%,KCNIP4;NRXN1;ADGRL3;ASTN2;CDH18;SPOCK1;CDH8;RYR3;RYR2;CDH10;SYT1;EML1;CDH2;SLIT3;SLIT2;CDH20;CDH11;PCLO;KCNIP1;SYT10;ENPP2;NCS1;CDH13;TUBB4A;PAM;TESC;MMP12;SYT2;CDH12;PITPNM3;CDH22;SCUBE1;SLIT1;CDH19;CDH7;PDCD6;SPARCL1;SLC25A23;CASQ2;DCHS1;PRNP;SYT5;PLA2G4E;ENPP3;KCNIP2;GLCE;ADGRV1;CDH6;PCDHB6;CALR3;LETM1;CCDC47;SYT11;SYT12;CETN3;CDH17;PLA2G10;CRP;RYR1;PCDHA4;MMP13;DSC3;DSC2;CABCOCO1;DNER;CDHR3;SMOC2;GSN;TTN;CDH9;CDK5R1;CAPN3;AMY1C;AMY1B;AMY1A;DYSF;NDUFAB1;RET;CALM1;F9;CALM3;SYT7;CALM2;MICU3;CDH1;NOL3;CDH5;CLEC3B;ATP2A1;MCTP2
prerank,calcium-activated potassium channel activity (GO:0015269),0.7126545924641808,1.7605163761341407,0.010964912280701754,0.04332318399304045,0.77,3/11,2.07%,KCNN2;KCNMB3;KCNMB2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5524181183732717,-1.7589817897956264,0.001694915254237288,0.09226014245896562,0.586,8/34,5.65%,IQGAP2;IQGAP1;GAB2;OGT;DAPP1;KIF16B;ARAP1;MYO1G
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.7498941558159039,1.7563682165545853,0.0024154589371980675,0.04383286851060563,0.786,5/10,7.52%,GABRG3;GABRA2;GABRA3;GABRA5;GABRG2
prerank,GTPase regulator activity (GO:0030695),-0.41233846681105357,-1.7530901039766003,0.0,0.09249179312480645,0.615,69/212,16.66%,IQGAP2;ARHGAP15;IQGAP1;NRP1;VAV3;ABR;ARHGAP10;ARHGAP25;ASAP1;STARD8;ARHGAP22;MYO9B;JUN;ARHGAP30;ARHGAP24;ARHGAP19;ARHGAP17;IPO5;SIPA1;TBC1D15;SGSM2;RGS1;HTR2B;TBC1D2B;TBC1D9;RIN2;ARFGEF1;ARAP1;RAB3GAP1;RGS3;TBC1D5;ARHGAP18;TBC1D1;SIPA1L2;RIC8B;WASL;TBC1D22A;PREB;ARRB1;EIF5;SIPA1L3;TBC1D16;GPS1;ALS2;SIRPA;TBC1D22B;RGS11;SH3BP1;TBC1D8B;ITGB1BP1;TBC1D8;NCKAP1L;CDC42EP2;ADAP1;TBC1D17;FLCN;CCDC88A;RGS12;TBC1D10B;RACGAP1;RGS14;RASA1;RP2;RALGAPA2;TBC1D30;ACAP2;ARHGAP31;TBC1D7;BNIP2
prerank,GTPase activator activity (GO:0005096),-0.39235238364575703,-1.75082504777779,0.0,0.08854470645489537,0.629,95/313,16.66%,IQGAP2;ARHGAP15;DOCK2;IQGAP1;NRP1;VAV3;DENND1A;AKAP13;ABR;ARHGAP10;ARHGAP25;ASAP1;ITSN1;STARD8;RIN3;ARHGAP22;DENND4C;FGD6;MYO9B;JUN;ARHGAP30;ARHGAP24;ARHGAP19;ARHGAP17;DOCK10;SIPA1;ARHGEF2;CYTH1;TBC1D15;DOCK11;VAV1;SGSM2;RGS1;HTR2B;TBC1D2B;RASGRP4;RAP1A;TBC1D9;FGD4;RIN2;DOCK8;ARFGEF1;RGL2;ARAP1;RAB3GAP1;RGS3;TBC1D5;ARHGAP18;FGD3;TBC1D1;SIPA1L2;RIC8B;DOCK5;ARHGEF10;TBC1D22A;PREB;EIF2B3;ARRB1;ARHGEF18;DENND2D;SIPA1L3;TBC1D16;EEF1B2;ALS2;TBC1D22B;RGS11;SH3BP1;TBC1D8B;FNIP1;VAV2;TBC1D8;NCKAP1L;CDC42EP2;ADAP1;TBC1D17;FLCN;ARFGEF2;ARHGEF11;CCDC88A;DNMBP;TBC1D10B;SBF2;CYTH3;RACGAP1;DENND3;RGS14;RASA1;RP2;RALGAPA2;TBC1D30;ACAP2;ARHGEF5;ARHGAP31;TBC1D7;BNIP2
prerank,thioesterase binding (GO:0031996),-0.7365995106929832,-1.7465293676222662,0.005376344086021506,0.08687601940745329,0.643,7/11,13.07%,RAC1;TRAF5;CDC42;TRAF3;TRAF1;HAUS7;TRAF2
prerank,cation channel activity (GO:0005261),0.43479413778887643,1.740576494730516,0.0,0.048645746597899706,0.829,22/94,11.28%,UNC80;TRPM3;CACNA1E;TRPC5;RYR2;KCNK10;SLC24A4;SLC24A2;NALCN;TRPC1;CACNB2;SLC24A3;KCNA1;PKD1L3;TRPM1;RYR1;SLC4A11;KCNF1;HCN1;TMEM175;KCNG1;PKD1
prerank,RNA binding (GO:0003723),-0.35211038259475563,-1.7357784240130838,0.0,0.09246546918550634,0.696,465/1321,25.30%,APOBEC1;RBM47;DIAPH1;MYO5A;RFTN1;FNDC3B;MBNL1;AHNAK;PTBP3;MSN;RBM39;GRB2;RBMS1;VIM;ZC3HAV1;TLR8;LRP1;SAMHD1;MYH9;CNOT4;JUN;YTHDF3;IREB2;DEK;AGO2;IPO5;ANXA11;DCP1A;MAP3K20;CANX;RPS18;MBNL2;FLNA;ANXA2;ERI3;SON;NFX1;TRA2B;DDX46;FARS2;TLR7;RPL7;RPS12;SRRM1;CDK13;UCHL5;RNASEL;RPS21;HNRNPA3;ADAT1;MKRN2;XPOT;BRCA1;ZCCHC9;RPS8;RPS24;GSPT1;TUT7;STAT3;DHX58;ANP32A;SEC63;CNOT1;HSPA9;ESF1;DHX9;AKAP8;RBPMS;CHD3;MPHOSPH10;RC3H1;NOC3L;NOA1;TEP1;DYNC1H1;TOP2A;NUP42;CCDC59;SARS1;FAM120A;RPL36;SF3B6;RPS6;MACF1;ELP5;TCF20;DHX40;BICC1;RPS20;EIF4G3;DDX60;PUS7;RPL11;DDX50;RPL10A;EIF4A2;ZC3H7B;DDX49;SNRNP35;RPL12;CRNKL1;RRBP1;YTHDC2;ERAL1;SNTB2;PUM3;EIF3A;CHTOP;PATL1;SRRT;FUS;SECISBP2;MRPL42;SRP14;SNRPG;ISG20L2;HNRNPH1;MBNL3;TUFM;RPS14;GRN;USP36;RBM18;EIF5;REXO4;HNRNPDL;RAE1;EDF1;NUFIP2;SNRPF;NOP14;ALKBH1;HNRNPL;NME1;EIF2AK2;PUM2;DALRD3;RPL32;ACIN1;CNBP;LARP4B;WDR36;DIMT1;CDC40;DCP2;RPS15A;NVL;RPS28;BST2;RPS13;NOL6;HELZ2;SPEN;PRMT1;ELP1;CAST;KMT2C;CWC22;AGFG1;RBM19;KHNYN;EXD1;YWHAE;KNOP1;DDX5;RALY;LARP4;FNDC3A;UBC;RPS27A;DARS1;RPL28;UBE2L3;PRPF8;RPS4X;SART1;FASTKD2;NUCKS1;ZC3H14;PUS1;DHX37;TPT1;TENT5A;SSBP1;KRR1;XPO5;APTX;CHCHD1;SF3B5;IBA57;DUSP11;MOV10;RPS23;EEF2;CSDE1;LRPPRC;GTPBP1;EIF3E;HSPE1;EIF4A1;XRCC6;KCTD12;PCBP2;ALYREF;ZYX;HNRNPUL1;MTPAP;TPR;PRDX1;IFIT1;NUDT21;HSP90B1;ZNF106;SNRPA;CELF1;LLPH;CCDC86;HNRNPLL;OASL;RPL22;GPATCH4;RPL14;RBM14;HSP90AB1;CPNE3;IFIT2;HMGB2;EEF1A1;PKM;CWC15;NYNRIN;ZBED4;LGALS1;OAS3;METTL14;RBM10;RPL34;WDR33;MKI67;UNK;RADX;MAP4;GTF2E2;MRPS11;DHX36;RPS11;YTHDC1;NIFK;POLR2A;ZNF326;RPL6;DUT;NGDN;CFAP20;MARK2;PSMA1;NOLC1;MANF;VIRMA;GAR1;RBMS2;NCBP1;PSPC1;EMG1;NGRN;FAU;SART3;DDX31;RAD51AP1;PPIL4;TFAM;SAMSN1;TMSB4X;NUSAP1;YY1;TRMT6;SNUPN;FASTKD3;PNISR;EIF4G1;RPS10;PPIG;CRKL;NCL;ANG;AATF;HLTF;THOC2;RPL18A;DAZAP1;KARS1;SF3A1;DDX1;OTUD4;DNAJC2;SRSF10;NUFIP1;EIF2A;ASS1;RPL37A;POLR2G;UTP6;UBE2I;MCAT;ZRANB2;G3BP1;ZCCHC3;DAP3;RBM4B;RPS9;SELENOH;HDLBP;MRPS15;MRPL21;HSPA1A;LSM6;RNPS1;TDRD7;RPS27;EIF3L;TWF2;WBP11;DNA2;GTPBP10;REPIN1;SNRNP70;TENT4B;ERH;ACAA2;SURF6;ABCF1;PPARGC1B;PDIA4;RPS3;NSRP1;MRPL45;MRPL22;CCT4;API5;HUWE1;HTATSF1;RPL23A;RPS16;HNRNPA1;WRAP53;HSPB1;TYW5;EXOSC10;MAGOH;DDX3X;PPIB;HMGB1;HMGB3;RPL9;AARS1;RBPMS2;RBM42;BUD13;EIF5B;PSMD4;C1QBP;CPSF3;ZNFX1;OAS2;DDX6;RTF1;SF3B1;RBM3;MRPL15;SMC1A;THUMPD1;S100A4;UBAP2;RBM11;GRSF1;MAZ;C1D;LSM5;DARS2;PTPN1;ZC3H12A;TSNAX;CPEB4;GDI2;TPD52L2;LSM14A;ATXN2L;HNRNPH2;TRIM25;LRRFIP1;DDX54;ANKHD1;KDM1A;RACK1;PCDHGA9;PNLDC1;HNRNPK;XRN2;ELAC2;NIP7;RBM38;EWSR1;SRPK1;EIF3H;DNTTIP2;RPL41;RPLP0;ANXA7;BRIX1;SUCLG1;SNU13;MEX3A;PRKDC;SYF2;CTNNA1;RPL7A;SRSF11;NONO;SMG1;MTREX;RRP8;TARDBP;PPP1CC;RPL19;MTDH;P4HB;PRRC2C;PUM1;MDH2;PABPC1L;RPS15;RPL39;PDIA3;RBM22;TES;EIF2S2;PRPF6;NQO1;DHX35;EIF1;DDX39B;PCBP4;UNC50;ARCN1;RPP40;GANAB;DHX38;DCN;GPATCH8;PTCD2;ASCC3;AKAP8L;DUSP14;PRR3;DSP;ESRP1;TRIM28;TSN;SND1;ACTN1;MRPS7;NHP2;GTF2F1;RBM15B;BUD23
prerank,ATP binding (GO:0005524),-0.39813267280467785,-1.733562021360051,0.0,0.08921647568906782,0.708,95/266,22.19%,ABCA1;MAP3K5;ABCG1;DAPK1;P2RX7;CDK6;MYH9;MYO9B;MTHFS;MAP4K3;PI4K2A;MYO1F;RUNX3;ERN1;MAP3K20;INSR;P2RX4;PEAK1;ABCD2;PRKAG2;MINK1;SMARCA5;TLK1;DYRK2;ERCC6;NLRC4;HSPA9;DHX9;ATP7A;PIM1;MTHFD1L;DAPK3;BLM;SMC4;STK3;ABCE1;RTEL1;CARS2;IRAK3;ABCF3;GUK1;NME1;MCM6;STK38;NVL;TGFBR1;TRIB1;NEK6;RAD51;SIK1;KIFC1;TAOK1;KIF14;TAP2;MTPAP;STK11;STK17B;CHD8;HSP90AB1;OAS3;KSR1;MKNK1;DHX36;MAST2;MARK2;ABCB8;PDXK;HSPA4;EIF4G1;MKNK2;LATS2;UBA2;ABCD3;HSPA1A;ZAP70;PGK1;TWF2;MLKL;ABCF1;PAPOLA;ENPP1;AARS1;HSPA2;CDC42BPG;OAS2;WNK1;VPS4A;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;MAP4K4;PYGL;RPS6KA5
prerank,cell adhesion mediator activity (GO:0098631),0.5840679295605791,1.7331125245530843,0.011363636363636364,0.050712193707409016,0.855,8/24,13.05%,LRRC4C;CNTN6;CNTN4;DSCAM;NTNG1;DSCAML1;ROBO3;VSTM2L
prerank,G protein-coupled receptor activity (GO:0004930),0.3867763725789224,1.729930264488966,0.0,0.051051103299907134,0.865,71/239,19.86%,ADGRB3;ADGRL3;GRM5;GRM8;HCRTR2;LGR5;RORB;GRM1;GPR37;P2RY12;PAX8;GPR173;GPR45;OPRD1;ADRA1B;GRM3;GPR149;NTSR1;ADGRV1;GABBR1;GPR101;GPR85;TRHR;GPR22;PTH1R;CX3CR1;GPR183;ADGRL2;GPR156;OPN3;OXTR;OPN1MW;OPN1MW3;OPN5;OPN4;GPR143;LGR6;GPR3;AGTR1;ADRA2C;TAS1R1;GALR1;LPAR2;LGR4;FFAR1;TAPT1;F2RL2;ADRA1D;ADRA1A;ADRB1;ADGRG1;GPR26;OPRK1;ADGRB2;ADGRA1;OPRL1;OPRM1;GPR157;ADGRL4;CRHR1;LANCL1;GRM4;GPR61;ADGRB1;TM2D1;CELSR2;GPR34;NMBR;ADGRG2;GPR35;GABBR2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.7035106803578265,1.7291759417914607,0.011111111111111112,0.05018648840456949,0.867,5/12,9.79%,OPN3;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5872294473271711,1.718345852499687,0.004842615012106538,0.0510368240698501,0.887,7/22,14.96%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,serotonin receptor activity (GO:0099589),0.5872294473271711,1.718345852499687,0.004842615012106538,0.0510368240698501,0.887,7/22,14.96%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5872294473271711,1.718345852499687,0.004842615012106538,0.0510368240698501,0.887,7/22,14.96%,HTR2C;CHRM2;CHRM3;HRH3;HTR1B;HRH2;HTR7
prerank,cAMP binding (GO:0030552),0.7096915800525457,1.7125361871075384,0.014354066985645933,0.052462312806810414,0.898,6/11,10.71%,PDE4B;PDE10A;PDE4D;POPDC2;HCN1;RAPGEF4
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.4392237827484583,-1.7117015894264038,0.0,0.10780413612745603,0.786,28/100,14.90%,IQGAP2;IQGAP1;OSBPL8;DENND1A;SH3PXD2B;ZFYVE26;GAB2;SNX3;SNX27;OGT;DAPP1;TECPR1;SNX24;KIF16B;ARAP1;ANKFY1;MYO1G;GOLPH3L;HIP1;OSBPL5;SESTD1;SNX13;NCF4;CYTH3;PLA2G4A;RNF34;RACGAP1;MYO10
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.5796253750724749,-1.7074586884443017,0.003552397868561279,0.10714452902153185,0.809,10/25,18.52%,GAB2;PLEK;DAPP1;KIF16B;MYO1G;HIP1;SESTD1;NCF1;PLEKHA2;PLEKHA4
prerank,WW domain binding (GO:0050699),-0.5706376791623391,-1.7004065216161468,0.0034904013961605585,0.10917906472592133,0.829,13/26,26.68%,LITAF;PMEPA1;KIF20B;NFE2;WBP11;NDFIP2;TCEAL5;CDC25C;SCNN1A;WBP1;TCEAL6;TCEAL3;RAPGEF2
prerank,manganese ion binding (GO:0030145),-0.4997183545955325,-1.6945374969792688,0.005145797598627788,0.11128056747629371,0.847,24/48,20.61%,FAM20C;MGAT5;ABL2;DYRK2;GYG1;PIM1;PRIMPOL;GALNT3;GALNT1;IMPA1;XXYLT1;B4GALT7;WRN;MTPAP;XYLT2;FEN1;POMGNT1;LARGE1;ARG2;MGAT2;XPNPEP3;PAPOLA;B4GALT1;MPPE1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.3674007306939939,-1.6909261634130472,0.0,0.11040355865874604,0.859,146/431,22.19%,ABCA1;MAP3K5;ABCG1;MFHAS1;DAPK1;P2RX7;CDK6;MYH9;MYO9B;RAB7A;MTHFS;RAC1;ARL8B;MAP4K3;RAP1B;DNM2;PI4K2A;MYO1F;RUNX3;ERN1;RHOA;ARL8A;RAP2B;MAP3K20;INSR;P2RX4;PEAK1;ABCD2;RAP2A;PRKAG2;RAB31;MINK1;SMARCA5;TLK1;RAP1A;DYRK2;ERCC6;CDC42;NLRC4;HSPA9;DHX9;ATP7A;PIM1;NOA1;MTHFD1L;DAPK3;BLM;SMC4;STK3;ARL11;ABCE1;RTEL1;RHOQ;RAB32;CARS2;IRAK3;ABCF3;GUK1;NME1;MCM6;GBP5;STK38;NVL;TGFBR1;RAB5A;TRIB1;NEK6;RAD51;ADSS1;RAB21;GBP2;SIK1;TGM2;KIFC1;TAOK1;KIF14;SEPHS1;TAP2;RRAGD;MTPAP;RAB11B;RAB29;STK11;STK17B;CHD8;HSP90AB1;EEF1A1;RAB10;OAS3;ARL5A;KSR1;MKNK1;ARL3;DHX36;TUBD1;MAST2;MARK2;GCH1;ANXA6;ABCB8;PDXK;HSPA4;EIF4G1;MKNK2;RAB13;LATS2;RND2;ARHGEF5;UBA2;RAB39A;ABCD3;HSPA1A;RALB;ZAP70;PGK1;TWF2;GTPBP10;KRAS;NRAS;MLKL;ARL1;ABCF1;ARFIP2;RHEB;GBP3;PAPOLA;ENPP1;AARS1;GBP7;HSPA2;RHOBTB1;GBP6;CDC42BPG;OAS2;WNK1;VPS4A;RHOF;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;MAP4K4;PYGL;TUBA4A;RPS6KA5
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.6217846482991373,1.679758220703446,0.019753086419753086,0.06638293329115426,0.941,8/17,16.11%,EPHA6;EPHA7;EPHA5;EPHB1;EPHA10;EPHB4;EPHB3;EPHA3
prerank,ephrin receptor activity (GO:0005003),0.6217846482991373,1.679758220703446,0.019753086419753086,0.06638293329115426,0.941,8/17,16.11%,EPHA6;EPHA7;EPHA5;EPHB1;EPHA10;EPHB4;EPHB3;EPHA3
prerank,potassium channel regulator activity (GO:0015459),0.47798693701013856,1.6754108668329633,0.007042253521126761,0.06727609105408149,0.946,6/49,2.07%,DPP10;KCNIP4;DPP6;KCNIP1;KCNMB3;KCNMB2
prerank,carboxylic acid binding (GO:0031406),0.5050818009041957,1.675292955575348,0.0069605568445475635,0.06590774817028197,0.947,10/38,9.00%,GRM7;GRIN2B;GRIN3A;GLRA1;EPDR1;GLDC;SESN3;UBR1;GLRA2;CASTOR2
prerank,single-stranded DNA binding (GO:0003697),-0.43857062888574283,-1.6650089249651705,0.003430531732418525,0.1403601599633754,0.917,40/93,23.37%,FAM111A;RBMS1;SAMHD1;TOP3A;RAD51B;DHX9;NABP1;BLM;WDR48;REXO4;POLR2H;MCM6;NEIL3;RAD51;NUCKS1;MCM9;SSBP1;APTX;MCM3;PCBP2;HMGB2;RADX;RPA3;DHX36;ERCC4;RAD51AP1;RAD52;MCM2;POLR2G;WBP11;RBBP8;HNRNPA1;NUP35;HMGB1;RTF1;DMC1;SMC6;CDC45;TWNK;MLH1
prerank,double-stranded RNA binding (GO:0003725),-0.4592162978214845,-1.6571030762943568,0.005076142131979695,0.14719644884897284,0.938,18/70,13.46%,RFTN1;MBNL1;MSN;VIM;TLR8;AGO2;TLR7;DHX58;DHX9;RC3H1;DDX60;EIF2AK2;APTX;EIF4A1;OASL;HSP90AB1;OAS3;DHX36
prerank,mannosyltransferase activity (GO:0000030),0.5607728109039856,1.6531113688579306,0.004878048780487805,0.07753928164882049,0.971,6/21,5.39%,TMTC2;TMTC1;DPY19L1;TMTC3;DPY19L2;POMT2
prerank,semaphorin receptor activity (GO:0017154),-0.7030456097303343,-1.6513925263711848,0.01206896551724138,0.1492369402291731,0.945,5/11,7.14%,NRP1;PLXNC1;PLXNA1;PLXND1;NRP2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.6227147701912549,-1.6500459591866583,0.006837606837606838,0.14581356457107464,0.947,6/18,10.17%,BIRC3;TNFAIP8;GAS6;SERPINB9;PRDX5;CD27
prerank,adenylate cyclase binding (GO:0008179),0.6995431130046453,1.645462565943731,0.02850877192982456,0.0804367116137451,0.975,6/10,13.07%,AKAP6;ADCY2;ADCY5;CALM1;CALM3;CALM2
prerank,retinoic acid receptor binding (GO:0042974),-0.6272351521124853,-1.6442708965888808,0.017452006980802792,0.14913311081288783,0.958,9/17,18.21%,PPARG;CNOT1;RARG;PRMT2;ASXL1;NSD1;NRIP1;ARID5A;NCOA6
prerank,low-density lipoprotein particle binding (GO:0030169),-0.6435319945672167,-1.6389813942413376,0.017452006980802792,0.1516680086714153,0.966,4/16,1.52%,MSR1;STAB1;PLTP;CD36
prerank,glycine binding (GO:0016594),0.6786196839059869,1.6382658101609993,0.033860045146726865,0.08342807431802647,0.979,6/11,14.35%,GRIN2B;GRIN3A;GLRA1;GLDC;GLRA2;GLRA3
prerank,Tat protein binding (GO:0030957),-0.7172404103685703,-1.6322187737932914,0.012259194395796848,0.15682241753078247,0.97,3/10,8.47%,MDFIC;ACTB;DNAJA1
prerank,amino acid binding (GO:0016597),0.5113197027079713,1.6295466221869987,0.009732360097323601,0.08683698999565029,0.983,7/31,9.00%,GRM7;GRIN2B;GRIN3A;GLRA1;GLDC;GLRA2;CASTOR2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.615469619233431,1.6144563881041807,0.018561484918793503,0.09404463479104629,0.987,8/16,8.63%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;PTPRK;PTPRB;PTPRZ1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.615469619233431,1.6144563881041807,0.018561484918793503,0.09404463479104629,0.987,8/16,8.63%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;PTPRK;PTPRB;PTPRZ1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.49598948177564034,1.6091877554248504,0.002457002457002457,0.09601398475136852,0.99,11/35,10.59%,PLCL1;MPPED2;APEX2;ENPP2;PDE11A;GDPD1;PLCE1;ENPP3;FAM83B;PLCXD3;ENPP6
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.5558396599170075,-1.6039484120852237,0.01415929203539823,0.20262553938267783,0.991,11/25,20.67%,ZC3HAV1;PARP11;PARP14;PARP4;TIPARP;PARP9;PARP8;SIRT3;TNKS2;PARP10;SIRT2
prerank,inward rectifier potassium channel activity (GO:0005242),0.5377256368599971,1.5980814347922618,0.029612756264236904,0.10264385481610361,0.99,7/24,13.03%,KCNN2;KCNJ3;KCNJ10;KCNJ6;KCNJ9;KCNJ16;KCNJ12
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6007011003310297,-1.5959899649022151,0.01730103806228374,0.20838234148193288,0.992,9/18,23.15%,ANXA2;S100A11;ANXA1;BAIAP2;PPP1CA;RAB10;TRIM29;PDLIM5;PDLIM1
prerank,glutamate receptor binding (GO:0035254),0.5920634002216097,1.5957963704274556,0.027600849256900213,0.1024475147297244,0.99,11/17,23.92%,SHISA6;SYNDIG1;SHANK3;HOMER1;CAMK2A;HOMER3;SHANK2;NSF;HOMER2;SHANK1;SHISA7
prerank,phosphatidate phosphatase activity (GO:0008195),0.6380887539260292,1.5950305738510662,0.03409090909090909,0.10134530541229106,0.99,3/13,2.69%,PLPP4;PLPPR1;PLPPR4
prerank,small GTPase binding (GO:0031267),-0.38487317033881924,-1.5926445234423,0.0,0.2086461752864664,0.994,50/169,18.65%,IQGAP2;IQGAP1;MYO5A;ABCA1;AKAP13;RIN3;PAK2;FGD6;MYO9B;GOLGA5;EPS8;FLNA;OPTN;ARHGEF2;GOLGA4;SGSM2;IFT20;KIF3B;RNF41;GGA3;FGD4;TNFAIP1;RAB3GAP1;ANKFY1;DAPK3;FGD3;TRIOBP;AP1G1;CYRIB;PICALM;EXOC4;ALS2;AP3M1;CDC42EP2;XPO5;RAB29;CIB1;GCC1;EHD1;BRK1;TBC1D30;RABGGTA;TBC1D7;SPHK2;EXOC2;RAB34;PDE6D;RILP;ARFIP2;RCC1
prerank,adrenergic receptor binding (GO:0031690),0.5889198530805668,1.5899754634521128,0.03456221198156682,0.10320038460657953,0.992,5/16,13.09%,MAGI2;PDE4D;NEDD4;ADRA2C;ADRB1
prerank,monocarboxylic acid binding (GO:0033293),-0.5887518088642991,-1.589853535126017,0.015789473684210527,0.2075998385840442,0.994,11/18,31.51%,PSAP;RXRA;RARA;CYP26C1;PYGL;NR1H4;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3883893210941471,-1.5871387283682088,0.0,0.2062607618457727,0.995,38/147,12.01%,DOCK2;VAV3;DENND1A;AKAP13;ABR;ITSN1;RIN3;DENND4C;FGD6;DOCK10;ARHGEF2;CYTH1;DOCK11;VAV1;RASGRP4;RAP1A;FGD4;RIN2;DOCK8;ARFGEF1;RGL2;RAB3GAP1;FGD3;RIC8B;DOCK5;ARHGEF10;PREB;EIF2B3;ARHGEF18;DENND2D;EEF1B2;ALS2;FNIP1;VAV2;ARFGEF2;ARHGEF11;CCDC88A;DNMBP
prerank,DNA binding (GO:0003677),-0.3339252479136114,-1.5868039588615386,0.0,0.20114979427509624,0.995,234/694,25.03%,RBPJ;ZEB2;FLI1;FAM111A;TCF4;RBMS1;TLR8;BCL6;SAMHD1;JUN;TOP3A;DDB2;MEF2A;CREBBP;CGAS;NUPR1;PPARD;ARID5B;BPTF;DNMT3A;NFE2L2;RAD51B;IRF2;ZNF148;NFYA;RPL7;PPARG;SMARCA5;BRCA1;GTF2A1;ZNF3;STAT3;ERCC6;FOXO3;E2F2;IKZF1;LYL1;RFC1;DHX9;USF2;DCLRE1C;RYBP;CHD3;HHEX;ZBTB21;TOP2A;RARG;BCL2;IRF5;CRLF3;NABP1;AIM2;PARP4;BLM;NR1H2;CIITA;TSG101;CUX1;BATF;DDX60;RAD1;SRRT;TAF6;WDR48;AHR;REXO4;ATF6;NR2F1;POLR2H;MCM6;E2F1;CNBP;ARID1A;RNF4;THAP1;CEBPG;E2F3;NEIL3;CBFB;RAD51;HIF1A;SIRT3;NUCKS1;EGR1;ARNT;MCM9;SSBP1;HP1BP3;APTX;RELA;MCM3;IKZF3;APP;TIMELESS;XBP1;DCLRE1A;XRCC6;PCBP2;WRN;MAU2;DNASE1L1;PCNA;CUL4B;PRDM2;NFE2;KMT2D;EXO1;OASL;FOXJ1;ARID3B;CHD8;FEN1;HMGB2;SPTY2D1;WDR76;RADX;RPA3;XRCC4;DHX36;RXRA;FOXJ3;CALCOCO1;TFAP4;POLR2A;RPL6;KLF2;ERCC4;RAD51AP1;ZMYM6;TFAM;TCF3;MAP1S;YY1;INO80;RAD52;TAF4B;ANG;TFCP2;HMGN1;QRICH1;NUFIP1;MCM2;NR4A1;BRIP1;APLP2;POLR2G;SOX10;TAF9;ZCCHC3;CHTF18;RPS27;WBP11;JRK;DNA2;CSRNP1;ATF5;REPIN1;SNAPC3;GATA3;SURF6;ARID5A;RPS3;DNTTIP1;RBBP8;HUWE1;TRIM16;TAF4;HNRNPA1;ZDHHC1;NUP35;DDX3X;MEIS3;HMGB1;HMGB3;MBD6;MAX;KDM5B;LIN9;EHF;RTF1;GTF3C5;SMC1A;RFC3;RLF;C1D;PDS5B;TIPIN;ZFPL1;ZC3H12A;STAT1;TSNAX;DMC1;NBN;POU3F1;LRRFIP1;HOXB2;FAN1;CCDC25;NLRP3;ZBTB7A;TBX2;SMC6;SNAI2;CEBPB;EGR2;BARX2;MYRFL;TOPORS;MTF1;POLG2;NR1H4;PALB2;CDC45;TWNK;PRKDC;HES7;ESR2;TARDBP;MLH1;RPS15;RFX5;MAFF;ZNF395;PAX6;MCM5;DRAP1;MYC;RAD51C;GZF1;DNASE2;DDB1;POGK;TRIM28;TSN
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.43420274373266227,1.586503584735824,0.010025062656641603,0.10418478798878072,0.994,22/60,17.02%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;BMPR1B;CSF1R;EPHB1;TIE1;ACVR1;ALK;EPHA10;ROS1;LTK;TYRO3;RET;EPHB4;EPHB3;ERBB3;EPHA3;ROR1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6777369722016466,1.5813452707119608,0.02534562211981567,0.10606102874499598,0.995,6/10,17.16%,DPYS;DPYSL5;DPYSL4;DPYSL3;DPYSL2;CAD
prerank,lipoprotein particle binding (GO:0071813),-0.5749271468075365,-1.575381484737239,0.024263431542461005,0.21673376690409826,0.996,4/20,1.52%,MSR1;STAB1;PLTP;CD36
prerank,damaged DNA binding (GO:0003684),-0.4715958528888941,-1.570330290041335,0.0142602495543672,0.21969589781791704,0.996,23/44,27.61%,DDB2;CREBBP;DCLRE1C;RAD1;NEIL3;APTX;DCLRE1A;PCNA;CUL4B;FEN1;HMGB2;RPA3;ERCC4;RPS3;RBBP8;HMGB1;NBN;SMC6;DDB1;MPG;XRCC1;DCLRE1B;EP300
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6690870749603683,1.5675950281111806,0.036855036855036855,0.11409882557633755,0.997,2/10,2.57%,CACNA1C;CACNB2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.6450892114414782,-1.5582462924289076,0.031746031746031744,0.23817900278724063,0.997,7/13,21.49%,GEN1;DNASE1L1;EXO1;FEN1;SLX4;DNA2;FAN1
prerank,death domain binding (GO:0070513),-0.6551485759702353,-1.5564160814236405,0.03220035778175313,0.23600289047176626,0.997,4/11,5.01%,MCL1;CRADD;RIPK1;BCL2
prerank,voltage-gated sodium channel activity (GO:0005248),0.5305745273134322,1.555960962015963,0.03416856492027335,0.1214753670519613,0.997,9/22,15.84%,SCN2A;SCN2B;SCN1A;SCN3A;SCN9A;HCN2;HCN1;CACNA1G;SCN10A
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6582531011479558,-1.5507853304079162,0.03527336860670194,0.24157373799938062,0.997,5/11,18.63%,MAP3K5;MAP3K1;MAP3K20;MAP3K15;TAOK2
prerank,cytokine receptor activity (GO:0004896),-0.4140119731670371,-1.5474368761379178,0.006837606837606838,0.24283975254741708,0.998,26/83,18.72%,CD44;CD74;CCR2;CSF2RA;IL10RB;IL6R;CCR1;IFNAR2;IL17RA;IL18RAP;IFNGR2;IL2RG;IL7R;IL4R;IFNAR1;IL20RA;CSF2RB;CCRL2;CNTFR;IL31RA;IL27RA;IL2RB;IL18R1;CMKLR1;IL17RD;IL1R2
prerank,cysteine-type peptidase activity (GO:0008234),-0.43205765598652707,-1.545668307530227,0.013266998341625208,0.2404473742423572,0.999,28/73,20.98%,CTSB;CTSZ;USP12;USP50;MALT1;USP18;USP8;USP36;USP9X;ATG4C;CTSC;CASP4;CTSH;OTULIN;CTSS;USP42;CASP7;CASP1;USP35;GGH;USP40;USP30;USP11;USP7;CASP8;CASP2;SFRP1;USP9Y
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.48304682566271767,1.5447119040899726,0.029197080291970802,0.12910308829926054,0.999,12/31,15.34%,KCNK10;SLC12A2;SLC12A8;SLC12A1;KCNA1;KCNF1;HCN1;TMEM175;KCNG1;SLC12A5;KCNA2;TMEM38A
prerank,translation initiation factor activity (GO:0003743),-0.48637954226003893,-1.5441060447767134,0.017953321364452424,0.2382172031084575,0.999,23/36,33.64%,AGO2;EIF4G3;EIF4A2;EIF2B3;EIF3A;EIF5;EIF3E;EIF4A1;EIF4G1;EIF2A;EIF3L;COPS5;EIF5B;EIF2B1;EIF3H;EIF2S2;EIF1;EIF1B;EIF2B2;EIF2B4;EIF4E;MTIF3;EIF2S1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5548127860233971,-1.5433859108604426,0.015985790408525755,0.23394802781609844,0.999,11/22,27.49%,ATP6V0D2;ATP6V1E1;ATP6V1A;TCIRG1;ATP2A3;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1;ATP2C1
prerank,ubiquitin-protein transferase activity (GO:0004842),-0.3457965631593666,-1.5426472235380468,0.0,0.23025795395891402,0.999,111/346,22.43%,BIRC3;RNF213;WWP1;CBL;ZNRF3;CNOT4;RNF150;HECTD1;BFAR;BIRC6;DDB2;RNF149;RNF19A;FBXW8;NEURL3;RNF111;NFX1;MALT1;MKRN2;TRAF5;BRCA1;MYLIP;WWP2;RNF41;AMFR;AREL1;RNF166;PELI1;CDC42;TNFAIP1;RC3H1;RNF20;FBXW11;UBE2R2;RNF31;RBCK1;TRAF3;UHRF2;UBE3B;MGRN1;UBR2;KCTD10;CBLL1;RNF4;RNF38;TRIM47;RNF123;UBA7;RFWD3;ANKRD39;UBE2L3;RNF8;TRAF1;NEDD4L;SEL1L;CUL4B;TSPAN17;TRIM24;MAEA;UBE3A;RNF180;RNF128;FBXO10;TRIM68;UHRF1;TRAF2;UBE2H;FBXW2;RNF185;CUL2;TRIM11;ARIH1;KCMF1;RNF25;RNF34;CBLB;RNF43;KLHL42;UBE2G1;UBE2T;RNF216;CDC34;HLTF;BRAP;TRIM14;RNFT2;UBE2C;MIB1;ASB4;FBXO7;DTX1;RNF121;HUWE1;TRIM39;UBE2M;FBXL6;TRIP12;DTX3;UBE3C;FBXO22;VPS18;DTX3L;RNF125;TRIM25;NEURL1B;SMURF2;RNF135;HECTD3;RNF115;TOPORS;RSPRY1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.3528979370152144,-1.538834228461966,0.0,0.23258459342642088,0.999,72/254,22.49%,RBPJ;MITF;ELF4;RUNX1;TCF4;RREB1;REL;LITAF;JUN;MEF2A;IRF2;NFIC;ATF3;ELF1;UBP1;ELK3;ETV1;STAT3;FOXO3;E2F2;STAT6;NFKB1;HHEX;SMARCD3;MLXIP;IRF5;MEF2B;KLF6;NR1H2;NRF1;NFATC3;ATF6;ATMIN;CEBPG;E2F3;HIF1A;MEF2C;TFEC;EGR1;RELA;ZNF319;KLF10;PRDM2;FOXJ1;FOSL2;FOXJ3;TFAP4;TCF3;YY1;TFCP2;NR4A1;SOX10;FOXJ2;NFATC1;ATF5;NR3C1;GATA3;MYB;TCF12;PLAG1;CASZ1;MEIS3;HOXD8;MDM4;EHF;RLF;ZSCAN21;HOXB2;EGR2;BARX2;MTF1;NR1H4
prerank,SH3 domain binding (GO:0017124),-0.43133500727032653,-1.537996951816537,0.00825082508250825,0.22917375117782332,0.999,20/62,14.50%,ABI1;GRB2;WIPF1;CYBA;CBL;DNM2;WASF2;SH3BP2;SYNJ1;PTPN12;PTPN22;ADAM9;AFAP1L2;NCF1;CRK;MICAL1;ZNF106;ADAM15;AFAP1L1;CBLB
prerank,amino acid:sodium symporter activity (GO:0005283),0.6459159890561437,1.5375452295335788,0.06004618937644342,0.13303655833799377,0.999,7/11,18.00%,SLC1A2;SLC6A15;SLC1A1;SLC6A1;SLC6A13;SLC6A11;SLC38A1
prerank,syntaxin-1 binding (GO:0017075),0.5329463540580937,1.5371732434657943,0.034403669724770644,0.13130986298390604,0.999,5/22,2.78%,SYT1;UNC13C;SNPH;SNAP25;CPLX1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.6434898884459064,-1.536087943310982,0.03098106712564544,0.2281179931867451,0.999,6/12,21.40%,KDM3A;JMJD1C;KDM7A;KDM3B;HR;KDM1A
prerank,5'-3' exonuclease activity (GO:0008409),-0.6178461187670199,-1.5358097499185699,0.02992957746478873,0.22402123611909924,0.999,10/14,26.18%,DCLRE1C;DCP2;DCLRE1A;EXO1;FEN1;CPSF3;FAN1;XRN2;MRE11;DCLRE1B
prerank,ribonuclease activity (GO:0004540),-0.44343046057403324,-1.5346667478011702,0.015151515151515152,0.2215119479715082,0.999,28/56,27.04%,SAMHD1;ERN1;AGO2;RNASEL;RNASE12;RNASE4;INTS11;RNASE7;EXOSC5;KHNYN;RNASE6;NYNRIN;ENDOG;ANG;EXOSC10;CPSF3;ZC3H12A;TSNAX;EXOSC4;ELAC2;YBEY;RPP40;SND1;RCL1;ZC3H12D;ERN2;LACTB2;EXOSC8
prerank,GTPase binding (GO:0051020),-0.3630484601032967,-1.5330600588813874,0.0015600624024961,0.22034644368741613,0.999,54/194,18.65%,IQGAP2;IQGAP1;MYO5A;ABCA1;AKAP13;RIN3;GNB1;PAK2;FGD6;MYO9B;GOLGA5;EPS8;FLNA;OPTN;ARHGEF2;GOLGA4;SGSM2;IFT20;KIF3B;RNF41;GGA3;FGD4;TNFAIP1;RAB3GAP1;ANKFY1;DAPK3;FGD3;TRIOBP;AP1G1;CYRIB;PICALM;EXOC4;ALS2;LCP1;AP3M1;CDC42EP2;XPO5;RRAGD;RAB29;CIB1;GCC1;EHD1;RASA1;BRK1;TBC1D30;RABGGTA;TBC1D7;SPHK2;EXOC2;RAB34;PDE6D;RILP;ARFIP2;RCC1
prerank,chloride channel activity (GO:0005254),0.41769125330098167,1.5321362773721365,0.015151515151515152,0.13368868069729312,0.999,13/59,8.86%,GABRB3;GABRB1;GABRG3;GLRA1;GABRA2;ANO4;GABRA3;GABRA5;GABRB2;ANO3;GABRG2;ANO5;GLRA2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.6501431434647709,-1.5268510260680002,0.03608247422680412,0.2275441313100031,0.999,5/11,17.54%,IQGAP1;AKAP13;MAP2K1;KSR1;SPAG9
prerank,GTPase inhibitor activity (GO:0005095),-0.6160304714932645,-1.5236504194765963,0.033003300330033,0.2293874030747296,0.999,4/13,7.69%,IQGAP2;IQGAP1;IPO5;GPS1
prerank,ligand-gated calcium channel activity (GO:0099604),0.5302240401048458,1.5227863136942668,0.03768844221105527,0.13969757602119498,0.999,4/19,1.30%,GRIN2A;RYR3;RYR2;GRIN2B
prerank,protein tyrosine kinase activator activity (GO:0030296),0.545155549514594,1.5186026285734981,0.050724637681159424,0.14136290275460453,1.0,5/19,3.32%,NRG3;NRG1;GRM5;EFNA5;EGF
prerank,adenyl ribonucleotide binding (GO:0032559),-0.34470385532422376,-1.51831668354694,0.001483679525222552,0.2351574045398759,0.999,97/291,22.19%,ABCA1;MAP3K5;ABCG1;DAPK1;P2RX7;CDK6;MYH9;MYO9B;MTHFS;MAP4K3;PI4K2A;MYO1F;RUNX3;ERN1;MAP3K20;INSR;P2RX4;PEAK1;ABCD2;PRKAG2;MINK1;SMARCA5;TLK1;DYRK2;ERCC6;NLRC4;HSPA9;DHX9;ATP7A;PIM1;MTHFD1L;DAPK3;BLM;SMC4;STK3;ABCE1;RTEL1;CARS2;IRAK3;ABCF3;GUK1;NME1;MCM6;COQ8A;STK38;NVL;TGFBR1;TRIB1;NEK6;RAD51;SIK1;KIFC1;TAOK1;CNBD2;KIF14;TAP2;MTPAP;STK11;STK17B;CHD8;HSP90AB1;OAS3;KSR1;MKNK1;DHX36;MAST2;MARK2;ABCB8;PDXK;HSPA4;EIF4G1;MKNK2;LATS2;UBA2;ABCD3;HSPA1A;ZAP70;PGK1;TWF2;MLKL;ABCF1;PAPOLA;ENPP1;AARS1;HSPA2;CDC42BPG;OAS2;WNK1;VPS4A;DARS2;NOL9;HSPA13;PRKAG1;SRPK1;MAP4K4;PYGL;RPS6KA5
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.4546397366189551,-1.5139111883159124,0.026785714285714284,0.24031937836087727,0.999,18/44,18.49%,NSD3;ASH1L;SMYD2;SMYD3;EZH2;KMT5B;EED;WDR5;KMT2C;KMT5C;KMT2D;SMYD1;SETDB1;DOT1L;NSD1;KMT5A;KMT2A;CXXC1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.6272844467301179,-1.5071547978584345,0.04384485666104553,0.24858222359863735,1.0,5/12,13.02%,APAF1;NOD1;CTSH;ATP2A3;CASP1
prerank,CARD domain binding (GO:0050700),-0.5965949158068716,-1.5055023703469899,0.04938271604938271,0.24760241886847806,1.0,10/14,31.13%,CARD11;CASP4;NOD1;CASP1;MAVS;NOD2;CARD10;CARD16;RIPK2;BCL10
prerank,calcium:sodium antiporter activity (GO:0005432),0.6418597903155688,1.5008719463006248,0.0630841121495327,0.1562055625207891,1.0,5/10,8.85%,SLC24A4;SLC24A2;SLC8A3;SLC24A3;SLC8A2
prerank,rRNA binding (GO:0019843),-0.461363506483833,-1.4975587768641592,0.021015761821366025,0.25823021966873483,1.0,18/42,25.77%,RPL11;RPL12;ERAL1;RPS14;RPS13;FASTKD2;MRPS6;MRPS11;EMG1;NGRN;ANG;RPS9;RPS3;GTF3A;RPLP0;MRPL18;MRPS7;RPL5
prerank,acetylation-dependent protein binding (GO:0140033),-0.5364165419172511,-1.4931854124582635,0.048494983277591976,0.25765310209559206,1.0,10/20,20.14%,BRD7;BRD4;PSME4;DPF2;ATAD2B;TRIM24;KMT2A;BRD2;ZMYND8;BRD9
prerank,lysine-acetylated histone binding (GO:0070577),-0.5364165419172511,-1.4931854124582635,0.048494983277591976,0.25765310209559206,1.0,10/20,20.14%,BRD7;BRD4;PSME4;DPF2;ATAD2B;TRIM24;KMT2A;BRD2;ZMYND8;BRD9
prerank,endodeoxyribonuclease activity (GO:0004520),-0.5412313506051595,-1.4903016337536812,0.037037037037037035,0.2589226121877047,1.0,11/20,26.01%,DCLRE1C;EXO1;FEN1;ENDOG;ERCC4;APLF;DNA2;RPS3;RBBP8;ZRANB3;MRE11
prerank,cGMP binding (GO:0030553),0.5998387478767397,1.4893414913100258,0.05417607223476298,0.16545689051950754,1.0,2/11,3.70%,PDE10A;PDE11A
prerank,neurexin family protein binding (GO:0042043),0.6328333975169116,1.4878895172719198,0.06701030927835051,0.16452907475299822,1.0,4/10,14.13%,NLGN1;CPE;SYTL2;NLGN2
prerank,histone acetyltransferase binding (GO:0035035),-0.5255704785934355,-1.4873191751849366,0.03832116788321168,0.26098130850458046,1.0,10/21,23.92%,MEF2A;HIF1A;EGR1;PCNA;TRIM68;SIRT2;STAT1;ZBTB7A;KANSL1;PAX6
prerank,retinoic acid binding (GO:0001972),-0.6189815410354096,-1.4855292060486611,0.04609929078014184,0.2604890009684064,1.0,8/12,31.51%,RXRA;RARA;CYP26C1;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1
prerank,P-type ion transporter activity (GO:0015662),-0.6195111480052877,-1.483630260730347,0.04864864864864865,0.260388510374729,1.0,4/12,9.56%,ATP2B1;ATP6V1E1;ATP7A;ATP2A3
prerank,Toll-like receptor binding (GO:0035325),-0.6176711192546684,-1.4808441640789665,0.05132450331125828,0.261520966243419,1.0,3/11,8.18%,CD36;UNC93B1;MYD88
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5762940396940299,-1.478044885565164,0.04504504504504504,0.2588465168736682,1.0,8/16,26.80%,ATP6V0D2;ATP6V1A;TCIRG1;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5762940396940299,-1.478044885565164,0.04504504504504504,0.2588465168736682,1.0,8/16,26.80%,ATP6V0D2;ATP6V1A;TCIRG1;ATP6V0B;ATP6V0E1;ATP6V0D1;ATP5F1B;ATP6V0A1
prerank,hyaluronic acid binding (GO:0005540),-0.6395779641119227,-1.4771920404304955,0.055357142857142855,0.25668256426138125,1.0,2/10,1.51%,CD44;LYVE1
prerank,phospholipase inhibitor activity (GO:0004859),-0.6397118591485619,-1.4766831548022226,0.05776173285198556,0.2539941203136431,1.0,4/10,5.43%,ANXA4;ANXA2;ANXA5;ANXA1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.5132403677421771,-1.4703339811456357,0.032758620689655175,0.26172313409724374,1.0,10/24,17.08%,MAPKAPK3;DAPK1;CAMK1D;MAPKAPK2;PTK2B;PHKG2;CAMKK1;MKNK1;MKNK2;PNCK
prerank,store-operated calcium channel activity (GO:0015279),0.6162992344912837,1.4662186506849149,0.09535452322738386,0.18638732088048082,1.0,2/10,2.25%,TRPC5;TRPC1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6315320695093308,1.4654181804571889,0.07188160676532769,0.18491779034362765,1.0,6/10,23.92%,SHISA6;SHANK3;SHANK2;NSF;SHANK1;SHISA7
prerank,cholesterol binding (GO:0015485),-0.4449138903034727,-1.4650359631440395,0.03833333333333333,0.2683090129504185,1.0,12/47,15.20%,OSBPL8;ABCA1;ABCG1;OSBPL3;GRAMD1B;VDAC2;OSBPL5;ERLIN1;STARD5;NPC2;ANXA6;NPC1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.45470284904177183,-1.4633341486261184,0.027777777777777776,0.2677916795705585,1.0,11/38,11.21%,DENND1A;SH3PXD2B;ZFYVE26;SNX3;SNX27;TECPR1;KIF16B;HIP1;SESTD1;SNX13;NCF4
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.5984293644691432,-1.4629963726197235,0.05150976909413854,0.26473834301301985,1.0,6/12,21.55%,CNOT1;CNOT2;PAN3;CNOT6L;CNOT8;PNLDC1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.3268960129124492,-1.4618644710494821,0.0,0.2629365965531962,1.0,107/334,23.07%,PRKCH;MAP3K8;MAP3K5;TAOK3;PRKCB;MAPKAPK3;FAM20C;DAPK1;SYK;PAK2;CDK6;PRKCD;ROCK1;MAP4K3;CAMK1D;MAP3K1;ERN1;MAP3K20;CSNK2A1;BRD4;VRK2;CDK13;MINK1;RIPK1;ALPK1;IRAK2;TLK1;MAPKAPK2;SGK1;GRK3;DYRK2;RIOK3;PIM1;PTK2B;IRAK4;DAPK3;PHKG2;STK3;MAPK14;ULK2;IRAK3;GRK5;PLK2;VRK3;EIF2AK2;STK38;TGFBR1;CDK14;NEK6;MASTL;MAPK7;SIK1;TAOK1;CDK1;DYRK1A;MAP2K1;CAMKK1;STK11;HTATIP2;STK17B;PRKD3;CPNE3;MAP3K15;PLK3;STK24;MKNK1;ACVR2A;TGFBR2;MAST2;MARK2;TRIO;IKBKB;MAP3K10;TTK;MKNK2;LATS2;PNCK;CDKL4;AURKA;BRD2;PKN3;STK10;TAOK2;MAK;MOK;PAK6;ATM;STK16;CHEK1;BMPR2;CDC42BPG;CDK16;WNK1;GSK3B;CDK5;CSNK1G3;CCNK;GRK6;SRPK1;MAP4K4;MAST3;MAPK1;RPS6KA5;ILK;NEK3;PRKDC;SMG1
prerank,four-way junction DNA binding (GO:0000400),-0.5561332229095625,-1.4589218718585626,0.05381944444444445,0.2650083617218953,1.0,9/17,19.44%,RAD51B;BLM;GEN1;WRN;HMGB2;YY1;XRCC3;HMGB1;HMGB3
prerank,histone deacetylase binding (GO:0042826),-0.3848700755622737,-1.454560327627235,0.021311475409836064,0.269518345259246,1.0,25/88,18.64%,MEF2A;SPI1;AKAP8;NIPBL;TOP2A;MEF2B;YWHAE;MEF2D;MEF2C;SUDS3;HDAC10;RELA;IKZF3;NUDT21;HSP90AB1;MTA3;HDAC5;SP2;DHX36;TFAP4;ANKRA2;RBBP4;HSPA1A;RAD9A;MIER1
prerank,RNA polymerase II complex binding (GO:0000993),-0.47530603800781135,-1.4511888917505866,0.034071550255536626,0.2716925910880696,1.0,11/32,16.97%,AGO2;BRD4;CTR9;DHX9;SMYD2;PCIF1;RPRD2;ELOF1;ZNF326;WAC;ELP4
prerank,dipeptidyl-peptidase activity (GO:0008239),0.5976190808725006,1.450357167460522,0.09954751131221719,0.19947655621562682,1.0,2/10,0.18%,DPP10;DPP6
prerank,triglyceride lipase activity (GO:0004806),-0.5177481374615405,-1.4466048656738635,0.0657439446366782,0.27784040466604726,1.0,9/20,38.00%,DAGLB;LPL;ABHD5;LIPE;PLA2G15;LIPH;LCAT;PNPLA1;LIPG
prerank,growth factor activity (GO:0008083),0.37151392122976606,1.4439699973482651,0.026570048309178744,0.20406390557586732,1.0,16/74,14.63%,NRG3;NRG1;TGFA;EGF;PTN;GDNF;VEGFD;PGF;FGF10;BDNF;AMELX;AREG;CLEC11A;ANGPTL3;IGF2;INHBA
prerank,GTP binding (GO:0005525),-0.34286648618685184,-1.4371162676941278,0.004878048780487805,0.293840739187192,1.0,66/172,26.03%,MFHAS1;RAB7A;RAC1;ARL8B;RAP1B;DNM2;RHOA;ARL8A;RAP2B;INSR;RAP2A;RAB31;RAP1A;CDC42;NOA1;ARL11;RHOQ;RAB32;NME1;GBP5;RAB5A;ADSS1;RAB21;GBP2;TGM2;SEPHS1;RRAGD;RAB11B;RAB29;EEF1A1;RAB10;ARL5A;ARL3;TUBD1;GCH1;ANXA6;RAB13;RND2;ARHGEF5;RAB39A;RALB;GTPBP10;KRAS;NRAS;ARL1;ARFIP2;RHEB;GBP3;GBP7;RHOBTB1;GBP6;RHOF;TUBA4A;TUBB1;TUBA8;RABL3;RND1;RAB26;RAB4A;GBP4;RAB1B;RAB35;REM1;ARL4A;RND3;NUDT16
prerank,PDZ domain binding (GO:0030165),0.3976536800809066,1.4316725993715838,0.02564102564102564,0.2162115702479339,1.0,18/61,16.83%,NLGN1;GRID2;SYNJ2;GRIA1;FZD8;TBC1D10A;TMEM88;TMEM88B;CLCN3;SDC2;ADRB1;PRKN;ATP2B4;ATP2B2;SLC22A5;ADAM17;TGFBR3;CIT
prerank,nuclease activity (GO:0004518),-0.4155862153540205,-1.431090079936238,0.03367003367003367,0.30236413750387114,1.0,25/52,26.19%,SAMHD1;RNASEL;RNASE12;REXO5;RNASE4;ISG20L2;REXO4;RNASE7;NME1;WRN;DNASE1L1;RNASE6;EXO1;FEN1;ENDOG;MAP1S;ANG;DDX1;DNA2;ENPP1;ZC3H12A;XRN2;SND1;MRE11;ERN2
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.39227244342394474,-1.429076946498815,0.024232633279483037,0.30336305625332155,1.0,27/78,20.98%,CTSB;CTSZ;USP12;MALT1;USP18;CFLAR;USP8;USP36;USP9X;CTSC;CASP4;CTSH;CAPN15;CTSS;USP42;CASP7;CASP1;USP35;USP40;CAPNS1;USP30;USP11;USP7;CASP8;CASP2;SFRP1;USP9Y
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.5479807655683748,-1.4274805500247085,0.0658578856152513,0.3032291806721102,1.0,6/16,9.62%,MTM1;MTMR10;SYNJ1;MTMR3;MTMR14;MTMR6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.5696532662060478,-1.4263512635149411,0.07652173913043478,0.3020694235598324,1.0,4/14,29.02%,DHRS3;AKR1A1;RDH12;RDH10
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.5681245922138135,-1.4258891438059949,0.07394957983193277,0.29943806869294637,1.0,6/14,13.02%,APAF1;NOD1;CTSH;ATP2A3;EBAG9;CASP1
prerank,bHLH transcription factor binding (GO:0043425),-0.5246435272718557,-1.4249002952936436,0.0762081784386617,0.2981569526169093,1.0,8/19,21.40%,CREBBP;USF2;BHLHE40;TCF3;MAP3K10;TCF12;LMO2;KDM1A
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.3417971705925992,-1.424439066693691,0.008038585209003215,0.2955686186953985,1.0,56/181,23.33%,RBPJ;MDFIC;RB1;JUN;MEF2A;CREBBP;PPARD;ANXA4;NFE2L2;PPARG;PIAS1;SPI1;WWP2;RERE;STAT3;DHX9;ACTB;SMARCD3;MAPK14;TAF6;CTNNB1;BHLHE40;FIZ1;ARID1A;DNAJA1;SPEN;PARP9;HIF1A;ARNT;RELA;MTA3;HDAC5;RXRA;SIN3A;ID2;RNF25;TCF3;TAF4B;HCLS1;FAF1;NRIP1;NFATC1;RBBP8;TAF4;MIER1;HSPB1;LMO2;GSK3B;DTX3L;STAT1;JUP;KDM1A;EGR2;NR1H4;MTDH;SETD6
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.34102262496758223,-1.4238162416819098,0.006430868167202572,0.2933418765996376,1.0,52/188,18.20%,FLI1;RUNX1;TFEB;JUN;ZNF568;ARID5B;NFE2L2;BRD7;NFYA;ATF3;PPARG;SPI1;BRCA1;STAT3;FOXO3;DHX9;CHD3;NFKB1;HHEX;CIITA;AHR;TBL1XR1;ATF6;CREB3L2;HNRNPL;ATMIN;MEF2C;EGR1;RELA;ZBTB20;XRCC6;KMT2D;FOXJ1;TCF7;HMGB2;ZBED4;HDAC5;DHX36;RXRA;CALCOCO1;TFAP4;PSPC1;TFAM;YY1;KLF11;SOX10;TAF9;ATF5;TFE3;GATA3;ARID5A;TCF12
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.5701086285191864,-1.4222417833538676,0.06666666666666667,0.2929950167515978,1.0,6/14,9.62%,MTM1;MTMR10;SYNJ1;MTMR3;MTMR14;MTMR6
prerank,phosphatidylglycerol binding (GO:1901611),-0.5825258919012088,-1.4214206276956631,0.07787610619469026,0.2914378333988677,1.0,4/13,8.96%,PLTP;PITPNC1;PITPNA;GSDME
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5762704588273038,1.4199001304985217,0.09750566893424037,0.22822197294017993,1.0,2/12,3.01%,B3GALT1;B3GALT5
prerank,DNA secondary structure binding (GO:0000217),-0.4692702051098109,-1.414464050436641,0.05,0.30185158115687694,1.0,14/31,19.44%,RAD51B;BLM;NEIL3;MEF2C;GEN1;WRN;HMGB2;RAD51AP1;YY1;KMT2A;XRCC3;RBBP8;HMGB1;HMGB3
prerank,DNA-binding transcription factor binding (GO:0140297),-0.33619349069806265,-1.412584275261141,0.0015772870662460567,0.30214467106136356,1.0,55/189,21.99%,RBPJ;RB1;JUN;MEF2A;CREBBP;PPARD;NFE2L2;PPARG;PIAS1;SPI1;WWP2;RERE;STAT3;DHX9;USF2;HHEX;BCL2;DAPK3;CIITA;CTNNB1;SKI;BHLHE40;FIZ1;SPEN;NEK6;MEF2D;TLE3;MEF2C;SIK1;RELA;MTA3;HDAC5;SIN3A;CRTC3;ID2;TCF3;MAP3K10;HCLS1;TLE4;TAF9;NFATC1;TCF12;ZMYND8;RBBP8;MIER1;HSPB1;LMO2;HMGB1;GSK3B;STAT1;NBN;KDM1A;NLRP3;ZBTB7A;EGR2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.5802200062848991,-1.4090940811574855,0.09660107334525939,0.3062046400150807,1.0,8/12,29.29%,GAB2;BLNK;STAP1;FRS2;TRADD;SHC1;SH2B1;TRAT1
prerank,retinoid X receptor binding (GO:0046965),-0.6107105726975695,-1.4090031430514844,0.08596491228070176,0.30313584218290557,1.0,6/11,18.21%,PPARG;RARG;NSD1;NRIP1;ARID5A;NCOA6
prerank,single-stranded DNA helicase activity (GO:0017116),-0.5192625057825087,-1.4071405945306805,0.07360861759425494,0.30361561118322644,1.0,9/19,24.41%,DHX9;MCM6;RAD51;RFC2;MCM2;CHTF18;DNA2;RFC3;MCM5
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.5454119180011916,-1.4037906905092996,0.08348134991119005,0.30762410392658635,1.0,9/15,19.63%,PI4K2A;PI4K2B;PIK3CB;PIK3CG;PI4KB;PIK3CA;PIK3CD;PIK3C2A;ATM
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5850709625208813,-1.4033528371211113,0.0905861456483126,0.3053094353256942,1.0,3/12,6.76%,IGF1;INSR;ARRB1
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.45136756390756383,-1.4032138704757362,0.06333333333333334,0.302365125330047,1.0,11/33,16.97%,AGO2;CTR9;DHX9;SMYD2;MAF1;RPRD2;SPTY2D1;ELOF1;ZNF326;WAC;ELP4
prerank,chemokine activity (GO:0008009),-0.45506315355343907,-1.4027083052611553,0.0594059405940594,0.3001848806416342,1.0,15/31,44.64%,CKLF;PF4;CXCL16;CCL5;CCL7;CCL24;CCL4;CCL25;CCL19;CCL8;CXCL9;CXCL1;CCL14;CXCL10;CCL3
prerank,CCR chemokine receptor binding (GO:0048020),-0.4714375704175935,-1.4018285858929895,0.06735751295336788,0.29904420482308375,1.0,13/28,39.74%,CCR2;NES;CCL5;CCRL2;CNIH4;CCL7;CCL24;CCL4;CCL25;CCL19;CCL8;MSMP;CCL14
prerank,ubiquitin protein ligase binding (GO:0031625),-0.32381024280490384,-1.3994969480288322,0.014331210191082803,0.3004231155156395,1.0,72/254,18.13%,MFHAS1;RB1;JUN;SNX9;TNFRSF1B;RIPK1;TRAF5;BRCA1;ARRB2;HSPA9;RNF20;BCL2;UBXN7;PTPN22;RNF31;TSG101;AXIN1;RPL11;TRIOBP;TRAF3;ARRB1;WFS1;DET1;SKI;ATXN3;LAPTM5;DNAJA1;TRIB1;JAK1;NEK6;YWHAE;HIF1A;UBC;RPS27A;UBE2L3;TRIB2;RNF8;RELA;TRAF1;DERL1;LRPPRC;PCBP2;CUL4B;TMBIM6;TPI1;HSP90AB1;TRAF2;POLR2A;CUL2;CD40;ARIH1;ARRDC1;ANKRA2;RNF34;GABARAP;UBE2G1;UBE2T;HLTF;CXCR4;HM13;FAF1;USP7;UQCRC1;ISG15;ASB4;CASP8;HSPA1A;RALB;SMAD7;FBXO7;LAPTM4B;DTX1
prerank,cadherin binding (GO:0045296),-0.31770391195014414,-1.3986902968706298,0.0078003120124804995,0.2992267722281674,1.0,132/315,26.01%,IQGAP1;AHNAK;ABI1;ASAP1;ZC3HAV1;PAK2;MYH9;SWAP70;CBL;SNX2;NIBAN2;PTPRJ;SNX9;IDH1;RARS1;FLNA;ANXA2;P2RX4;CAPZB;EHD4;WASF2;TAGLN2;FXYD5;S100A11;CHMP5;RAB1A;ITGB1;USP8;SNX5;ANXA1;TLN1;ARHGAP18;MACF1;CAPG;PICALM;GOLGA3;CTNNB1;ABCF3;EIF5;EPS15;BAIAP2;PPP1CA;STK38;CKAP5;CAST;YWHAE;ESYT2;LIMA1;MRTFB;DIAPH3;PACSIN2;SCRIB;EEF2;EIF3E;RAB11B;PRDX1;FMNL2;CD46;TMPO;RPL14;CLINT1;STX5;HSP90AB1;PKM;CAPZA1;RAB10;STK24;RPL34;PLCB3;SH3GLB1;TJP2;RPL6;SH3GL1;MARK2;EHD1;CRKL;BAG3;CDH24;EIF2A;VAPB;VASN;HDLBP;HSPA1A;TWF2;PTPRO;SNX1;EFHD2;PTPN11;ARFIP2;RPL23A;CLIC1;DDX3X;PAK6;TRIM29;BMPR2;DDX6;UBAP2;PTPN1;STAT1;JUP;ATXN2L;KDR;TRIM25;LRRFIP1;RACK1;HNRNPK;PDLIM5;SFN;RANBP1;CHMP4B;PPFIBP1;CNN2;CTNNA1;RPL7A;MPRIP;PDLIM1;SPTAN1;PPL;TES;MICALL1;AHSA1;ARGLU1;LASP1;CCNB2;CHMP2B;SND1;ATIC;NUDC;EEF1D;NCK1;PFN1;MRE11
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3651953222543896,1.3946126515472301,0.04591836734693878,0.2586337820509199,1.0,13/73,11.47%,SORCS1;HCRTR2;LGR5;SORCS3;GPR37;OPRD1;PTH1R;CX3CR1;CCKBR;OXTR;NPSR1;GALR1;LGR4
prerank,1-phosphatidylinositol binding (GO:0005545),-0.539311789216731,-1.3939955262811894,0.07952622673434856,0.3051718798389594,1.0,6/15,10.92%,SNX10;SNX9;WDFY3;PICALM;EEA1;SESTD1
prerank,SUMO transferase activity (GO:0019789),-0.535641267670487,-1.3929080595963401,0.08896797153024912,0.30426098434394605,1.0,8/16,28.82%,NSMCE2;PIAS1;UBE2I;EGR2;TOPORS;RANBP2;TRIM28;PIAS2
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5396865271952773,1.3901758540628253,0.12114014251781473,0.26184976745742294,1.0,8/13,25.44%,RYR2;SOX9;PKIA;PJA2;PRKAR1A;PRKAR2B;PRKAR1B;KCNQ1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5376938932177059,1.3884701246229814,0.11510791366906475,0.2608165355327853,1.0,4/14,7.65%,SPOCK1;SPOCK3;TIMP3;COL4A3
prerank,voltage-gated ion channel activity (GO:0005244),0.5365264848123494,1.387896064693847,0.1016949152542373,0.2582603305785124,1.0,2/14,0.88%,KCND2;CACNA1E
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.3176702402924455,-1.3874385500324231,0.011111111111111112,0.31199132858470113,1.0,100/269,27.06%,MFHAS1;RB1;JUN;SNX9;TNFRSF1B;RIPK1;TRAF5;BRCA1;ARRB2;HSPA9;RNF20;BCL2;UBXN7;PTPN22;RNF31;TSG101;AXIN1;RPL11;TRIOBP;TRAF3;ARRB1;WFS1;DET1;SKI;ATXN3;LAPTM5;DNAJA1;TRIB1;JAK1;NEK6;YWHAE;PARP9;HIF1A;UBC;RPS27A;UBE2L3;TRIB2;RNF8;RELA;TRAF1;DERL1;LRPPRC;PCBP2;CUL4B;TMBIM6;TPI1;HSP90AB1;TRAF2;POLR2A;CUL2;CD40;ARIH1;ARRDC1;ANKRA2;RNF34;GABARAP;UBE2G1;UBE2T;HLTF;CXCR4;HM13;FAF1;USP7;UQCRC1;UBE2C;ISG15;ASB4;CASP8;HSPA1A;RALB;SMAD7;FBXO7;LAPTM4B;DTX1;WRAP53;UBXN1;GSK3B;TXNIP;DTX3L;STAT1;BLZF1;FAF2;BAG6;SMC6;EGR2;BECN1;SUMO3;CCNB1;SLC22A18;STAT2;TRIM28;SPOP;MID1;UBE2N;RNF40;RPL5;PML;VCP;HSPA8;CUL3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.39441577861911525,1.384777410983779,0.04639175257731959,0.25942564399980667,1.0,9/48,10.80%,UNC80;TRPM3;SLC12A2;NALCN;TRPC1;PKD1L3;TRPM1;SLC4A11;MMGT1
prerank,thyroid hormone receptor binding (GO:0046966),-0.46067429622578554,-1.3843569817472816,0.09401709401709402,0.31523584184990194,1.0,11/28,25.18%,JMJD1C;PRMT2;MED24;MED4;OASL;NSD1;ARID5A;NCOA6;TRIP12;GAS2L1;NCOR1
prerank,phosphatidic acid binding (GO:0070300),-0.5143232821364123,-1.3802550481616684,0.09074733096085409,0.3207539222961721,1.0,6/19,10.92%,PLTP;PITPNC1;GRAMD1B;PITPNM1;PACSIN2;SESTD1
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.5714986254178471,-1.3761445576650821,0.09866220735785954,0.32647589167098406,1.0,6/12,16.56%,GNS;GALNS;ARSA;SULF2;ARSK;ARSJ
prerank,endoribonuclease activity (GO:0004521),-0.44970737175871667,-1.3754357375482882,0.08034188034188035,0.32491306791461644,1.0,17/32,28.81%,ERN1;AGO2;RNASEL;INTS11;KHNYN;NYNRIN;ENDOG;CPSF3;ZC3H12A;TSNAX;YBEY;SND1;RCL1;ZC3H12D;ERN2;LACTB2;ZC3H12C
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.3210630593267768,-1.3734039136615068,0.012558869701726845,0.32594079457667186,1.0,94/232,31.07%,NSMCE2;BIRC3;WWP1;CBL;ZNRF3;RNF150;HECTD1;BFAR;RNF149;RNF19A;NEURL3;RNF111;NFX1;MKRN2;PIAS1;MYLIP;WWP2;RNF41;AMFR;AREL1;RNF166;PELI1;CDC42;RC3H1;UHRF2;UBE3B;MGRN1;UBR2;CBLL1;RNF38;RFWD3;RNF8;NEDD4L;TRIM24;UBE3A;RNF180;RNF128;TRIM68;UHRF1;RNF185;TRIM11;ARIH1;KCMF1;RNF25;RNF34;CBLB;RNF43;RNF216;HLTF;BRAP;TRIM14;RNFT2;DTX1;RNF121;HUWE1;TRIM39;TRIP12;DTX3;UBE3C;VPS18;DTX3L;RNF125;TRIM25;NEURL1B;SMURF2;RNF135;EGR2;RNF115;TOPORS;MEFV;TRIM72;ZNRF1;TRIM69;RNF187;RNF19B;VPS11;LRSAM1;SIAH2;SMURF1;CUL3;COP1;RNF2;RNF26;PIAS2;HACE1;RNF167;GID4;RBBP6;TRIM41;MKRN3;RNF10;TRIM55;TRAF6;XIAP
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.4488989205135062,-1.372577303555852,0.07871198568872988,0.32468004166783976,1.0,11/32,19.24%,SLC38A6;SLC6A6;MFSD12;SLC43A2;SLC38A7;SLC36A4;SFXN2;SLC7A5;SFXN1;SLC6A9;SLC38A2
prerank,anion channel activity (GO:0005253),0.37546602822557373,1.3720790041402786,0.05198019801980198,0.2737496896848046,1.0,13/61,8.86%,GABRB3;GABRB1;GABRG3;GLRA1;GABRA2;ANO4;GABRA3;GABRA5;GABRB2;ANO3;GABRG2;ANO5;GLRA2
prerank,calcium activated cation channel activity (GO:0005227),0.4974523735000023,1.3720430413277076,0.09112709832134293,0.27053501522401047,1.0,3/17,2.07%,KCNN2;KCNMB3;KCNMB2
prerank,MHC protein binding (GO:0042287),-0.4922078747543689,-1.3711395024428916,0.0907563025210084,0.3243200388372268,1.0,12/20,33.06%,CD74;LILRB1;TAPBP;DERL1;TAP2;PILRA;ATP5F1B;KIR3DL2;CD8B;CD4;ATP5F1A;CD8A
prerank,ferrous iron binding (GO:0008198),-0.4896394728851434,-1.3699336758997949,0.08,0.3240544617971066,1.0,7/21,15.22%,FTL;CDO1;ALKBH1;EGLN1;FTO;TET2;ACP5
prerank,chemokine binding (GO:0019956),-0.44700833037903204,-1.3678418732765358,0.07719298245614035,0.325615481381397,1.0,5/30,4.91%,ITGA4;CCR2;CCR1;ITGB1;ITGAV
prerank,nuclear localization sequence binding (GO:0008139),-0.5084121173486769,-1.367550768315648,0.08347826086956522,0.32320107795037295,1.0,5/18,18.34%,KPNA4;IPO5;KPNA3;BRAP;NUP153
prerank,pentosyltransferase activity (GO:0016763),-0.4324458636022097,-1.3671605612257003,0.0823327615780446,0.32112385851050934,1.0,12/36,17.36%,ZC3HAV1;PARP11;PARP14;PARP4;TIPARP;PARP9;PARP8;SIRT3;QTRT1;TNKS2;LARGE1;PARP10
prerank,neuropeptide hormone activity (GO:0005184),0.47498780331685275,1.3671578025767548,0.09048723897911833,0.2741119741502517,1.0,8/22,18.75%,PNOC;SPX;CORT;GHRH;CALCB;PENK;GRP;CRH
prerank,nuclear receptor binding (GO:0016922),-0.35089090147743623,-1.3604336037606637,0.03709949409780776,0.3319118334917397,1.0,40/111,25.18%,FOXP1;PRKCB;KDM3A;JMJD1C;CNOT1;SMARCD3;PRMT2;MED24;CTNNB1;STAT5B;ARID1A;WBP2;DDX5;TGFB1I1;HIF1A;ASXL1;STRN;MED4;OASL;TRIM68;RXRA;NSD1;NR4A1;NRIP1;PPARGC1B;ARID5A;NCOA6;TRIP12;MMS19;STAT1;JUP;GAS2L1;DDX54;KDM1A;ZBTB7A;NR1H4;PRPF6;DCAF1;TADA3;NCOR1
prerank,histone demethylase activity (GO:0032452),-0.45524862351178397,-1.3582232768929732,0.08808290155440414,0.33358631843363956,1.0,13/27,30.88%,KDM3A;JMJD1C;KDM7A;KDM3B;JARID2;KDM2A;HR;KDM5B;KDM1A;FBXL19;KDM2B;KDM6A;RIOX2
prerank,endopeptidase activator activity (GO:0061133),-0.601614255279742,-1.3577284411206896,0.10327868852459017,0.3319471946501777,1.0,3/10,11.38%,PSME3;NLRC4;PSENEN
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.5169734841672452,1.3573365697553883,0.12531328320802004,0.28474035258296443,1.0,4/14,7.87%,SLC1A2;SLC17A6;SLC1A6;SLC1A1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5597207170098923,-1.3509237664403568,0.10278745644599303,0.34291518824934747,1.0,6/12,22.16%,CDK6;BRD4;CDK13;CDK1;CCNK;MAPK1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.5162648911385179,1.3485934939166935,0.1116751269035533,0.2945170498801299,1.0,4/13,15.44%,BMP7;BMP3;CDH5;GDF15
prerank,RNA polymerase binding (GO:0070063),-0.5009176311755685,-1.3452293008554506,0.1172291296625222,0.3519117580262207,1.0,6/18,10.42%,BRCA1;DHX9;ANP32B;STOM;YTHDC2;PHRF1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.4280530613518293,-1.3400694152545976,0.08499095840867993,0.3600899083461092,1.0,13/34,21.68%,ERI3;CNOT1;CNOT2;EXOSC5;ERI2;PAN3;CNOT6L;ANGEL1;EXOSC10;CNOT8;EXOSC4;PNLDC1;XRN2
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5464613784282328,-1.3378735009497142,0.12072072072072072,0.3618058882362199,1.0,11/13,40.13%,EIF5;ITGB1BP1;CCDC88A;RGS14;GDI2;RANBP1;GDI1;ARHGDIB;SH3BP4;ARHGDIA;ARHGDIG
prerank,heme binding (GO:0020037),-0.3782031259941898,-1.3362701584585337,0.07394366197183098,0.362487920698346,1.0,20/65,25.42%,CYBB;TBXAS1;HEBP1;BACH1;CYP27A1;EIF2AK1;HMOX2;FLVCR1;RSAD1;CYB5B;CYP46A1;PGRMC1;CYP2R1;CYB5R4;CAT;PXDNL;HMOX1;CYP1B1;CYCS;CYB5A
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.5020754488516955,1.3361066542133537,0.12971698113207547,0.31058241214321064,1.0,7/15,25.40%,ALDH1A1;ALDH1A3;ALDH7A1;ALDH1L1;ALDH9A1;ALDH3A2;ALDH2
prerank,ADP binding (GO:0043531),-0.464103725479629,-1.3355611371476275,0.08996539792387544,0.36104828220062135,1.0,6/25,7.94%,ABCG1;MYH9;MYO9B;ERN1;PRKAG2;COQ8A
prerank,GABA receptor binding (GO:0050811),-0.5580449980300847,-1.3351829200482432,0.1258741258741259,0.3590709990709198,1.0,4/11,14.52%,TRAK1;PLCL2;ARFGEF2;GABARAP
prerank,ubiquitin protein ligase activity (GO:0061630),-0.3141828122394939,-1.3350766413936028,0.020440251572327043,0.356534108058419,1.0,92/228,31.07%,BIRC3;WWP1;CBL;ZNRF3;RNF150;HECTD1;BFAR;RNF149;RNF19A;NEURL3;RNF111;NFX1;MKRN2;MYLIP;WWP2;RNF41;AMFR;AREL1;RNF166;PELI1;CDC42;RC3H1;UHRF2;UBE3B;MGRN1;UBR2;CBLL1;RNF38;RFWD3;RNF8;UBE4B;NEDD4L;TRIM24;UBE3A;RNF180;RNF128;TRIM68;UHRF1;RNF185;TRIM11;ARIH1;KCMF1;RNF25;RNF34;CBLB;RNF43;RNF216;HLTF;BRAP;TRIM14;RNFT2;DTX1;RNF121;HUWE1;TRIM39;TRIP12;DTX3;UBE3C;VPS18;DTX3L;RNF125;TRIM25;NEURL1B;SMURF2;RNF135;RNF115;TOPORS;MEFV;TRIM72;ZNRF1;TRIM69;RNF187;RNF19B;VPS11;LRSAM1;SIAH2;SMURF1;CUL3;COP1;UBE4A;RNF2;RNF26;HACE1;RNF167;GID4;RBBP6;TRIM41;MKRN3;RNF10;TRIM55;TRAF6;XIAP
prerank,transition metal ion binding (GO:0046914),-0.29422108081442505,-1.3338387186691594,0.009188361408882083,0.35611522545435925,1.0,112/397,20.94%,ADAM33;GDA;FAM20C;LITAF;TET3;SAMHD1;FTL;ANPEP;SLC30A5;ACER3;MGAT5;ETHE1;P2RX4;ARHGEF2;PPARG;KDM3A;ABL2;ZNF3;DHX58;DYRK2;TAB2;GYG1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;CHD3;ATP7A;PIM1;RC3H1;LNPEP;BLM;GALT;ABCE1;PRIMPOL;KDM7A;PITRM1;CRIP1;GALNT3;KDM2A;SKI;EEA1;TIMP2;QPCTL;THAP1;GALNT1;IMPA1;ATAD3A;XXYLT1;AGMO;POLR2L;SIRT3;ADAM8;MSRB1;EGR1;RNF8;HDAC10;B4GALT7;SEC24A;WRN;CHMP1A;MTPAP;SEC24D;PRDM2;TRIM24;XYLT2;FEN1;POMGNT1;UHRF1;MT2A;RXRA;TET2;AOC2;SORD;MOXD1;GCH1;ARIH1;CBLB;LARGE1;PDXK;NSD1;ANG;ARG2;CYP2R1;IKZF4;TNFSF10;KMT2A;RPS27;LIMS1;WDFY1;ZMYND8;MMP8;MGAT2;XPNPEP3;TYW5;PAPOLA;MDM4;B4GALT1;ENPP1;RABGGTB;SLU7;SLC11A2;KDM5B;MPPE1;SIRT2;PTPN1;ZFPL1;RNF125
prerank,cation:chloride symporter activity (GO:0015377),0.5678864365343889,1.3321625504616288,0.14123006833712984,0.312665388113409,1.0,5/10,11.73%,SLC12A2;SLC12A8;SLC12A1;SLC6A1;SLC12A5
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.4582974415191284,-1.331855532522217,0.12315270935960591,0.3570546221740477,1.0,8/25,14.91%,POR;CYP27A1;KMO;MICAL1;MICAL2;CH25H;FMO5;CYP46A1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.37651173657818704,1.3309588044681793,0.06965174129353234,0.31088522122466533,1.0,17/55,14.99%,TRPC5;RYR2;SLC24A4;SLC24A2;TRPC1;CACNB2;SLC24A3;PKD1L3;TRPM1;SLC8A2;RYR1;PKD1;ATP2B4;ATP2B2;ATP2A1;CHRNA7;TRPV3
prerank,metal ion binding (GO:0046872),0.2741288760870158,1.3303606260247054,0.0,0.30845144265622737,1.0,107/477,14.76%,KCNIP4;NRXN1;ADGRL3;ASTN2;CDH18;SPOCK1;CDH8;RYR3;RYR2;CDH10;SYT1;ADCY2;EML1;CDH2;SLIT3;SLIT2;CDH20;CDH11;PCLO;KCNIP1;SYT10;ENPP2;CDC42BPA;NCS1;CDH13;TUBB4A;PAM;TESC;MMP12;SYT2;RAN;CDH12;PITPNM3;CDH22;SCUBE1;SLIT1;EYA2;CDH19;CDH7;ACVR1C;PDCD6;MARK1;SPARCL1;SLC25A23;CASQ2;MAP2K7;DCHS1;GNAI1;PRNP;GSS;SYT5;YDJC;PLA2G4E;ENPP3;KCNIP2;GLCE;HMGCLL1;ADGRV1;CDH6;PCDHB6;CALR3;LETM1;CCDC47;SYT11;SYT12;CETN3;CDH17;PLA2G10;CRP;RYR1;PCDHA4;MMP13;THTPA;DSC3;DSC2;CABCOCO1;DNER;CDHR3;SMOC2;GSN;TTN;CDH9;CDK5R1;CAPN3;AMY1C;AMY1B;AMY1A;DYSF;NDUFAB1;BRSK1;RET;CALM1;F9;CALM3;SYT7;CALM2;PRKACB;MICU3;CDH1;DYRK3;NOL3;CDH5;CLEC3B;MVK;ATP2A1;MCTP2;IDH3A
prerank,myosin binding (GO:0017022),0.369010435637606,1.32968605094438,0.07352941176470588,0.30603306741105785,1.0,19/55,17.62%,DMD;STXBP5L;RAB3C;RAB6B;SHROOM4;RAB27B;RAB6A;ACTA1;SHROOM1;MLPH;NKD2;GSN;CALD1;LARP6;USH2A;MYRIP;RAB3A;RAB3B;HAP1
prerank,endonuclease activity (GO:0004519),-0.3926771032056524,-1.3286659886363046,0.09322033898305085,0.36050916476409284,1.0,24/49,26.52%,ERN1;AGO2;RNASEL;INTS11;REXO4;KHNYN;FEN1;NYNRIN;ENDOG;ERCC4;APLF;ANG;RPS3;CPSF3;ZC3H12A;TSNAX;YBEY;ZRANB3;SND1;RCL1;MRE11;ZC3H12D;ERN2;LACTB2
prerank,transcription cis-regulatory region binding (GO:0000976),-0.2893231141394684,-1.3276554344019698,0.004451038575667656,0.3599345927531743,1.0,97/406,18.74%,FLI1;FOXP1;RUNX1;TRPS1;TFEB;RREB1;RB1;JUN;ZNF568;MEF2A;ETV6;RUNX3;AGO2;ARID5B;NFE2L2;BRD7;IRF2;NFX1;NFYA;ATF3;PPARG;ELK3;SPI1;BRCA1;FOXN2;ZNF3;STAT3;FOXO3;E2F2;STAT6;CHD3;NFKB1;HHEX;MLXIP;TIPARP;CIITA;CUX1;AHR;TBL1XR1;ATF6;CREB3L2;HNRNPL;E2F1;ATMIN;E2F3;MEF2D;HIF1A;MEF2C;FOXN3;PRDX5;EGR1;ARNT;RELA;ZBTB20;XBP1;XRCC6;OSR1;KLF10;PRDM2;NFE2;KMT2D;FOXJ1;ZFP57;FOSL2;TCF7;HMGB2;ZFP41;UHRF1;ZBED4;HDAC5;DHX36;RXRA;CALCOCO1;E2F8;TFAP4;DR1;PSPC1;ZBTB46;TFAM;TCF3;YY1;TFCP2;ZNF177;KLF11;SOX10;TAF9;RARA;ATF5;SNAPC3;NR3C1;TFE3;GATA3;ARID5A;RPS3;TCF12;TAF4;CASZ1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4932648139218647,1.3272179640464221,0.13691931540342298,0.3064738544168542,1.0,4/15,7.87%,SLC1A2;SLC17A6;SLC1A6;SLC1A1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.4380282603669108,-1.3267288280995344,0.10732538330494037,0.35915144953061356,1.0,10/30,15.44%,BIRC3;TNFAIP8;BIRC6;GAS6;CAST;SERPINB9;PRDX5;CD27;CST7;CST3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5815887846785255,-1.3244049627080856,0.12647554806070826,0.3607943166568128,1.0,6/10,18.91%,CFLAR;CASP4;CASP7;CASP1;CASP8;CASP2
prerank,carbohydrate kinase activity (GO:0019200),-0.5548848967274103,-1.3242426065176494,0.1400709219858156,0.35836152164244617,1.0,6/11,29.56%,FGGY;POMK;HK3;GALK2;GALK1;GNE
prerank,phospholipid transfer activity (GO:0120014),-0.48049644498320376,-1.3216732026830427,0.12169312169312169,0.3609255672704918,1.0,6/21,9.89%,PLTP;PITPNC1;PITPNA;PITPNM1;GLTP;PRELID2
prerank,clathrin adaptor activity (GO:0035615),-0.5141153948944699,-1.3194806740286973,0.1302170283806344,0.36254311964488484,1.0,4/15,7.99%,DAB2;AP1G1;HIP1;AP2A2
prerank,BMP receptor binding (GO:0070700),0.5162745739364422,1.3194634654907595,0.1388888888888889,0.31580271927486003,1.0,4/12,15.44%,BMP7;BMP3;CDH5;GDF15
prerank,deubiquitinase activity (GO:0101005),-0.3506197467195671,-1.3180298765597918,0.048818897637795275,0.36271972746980485,1.0,36/88,28.84%,USP12;USP50;OTUD5;UCHL5;USP18;USP8;MINDY2;USP36;USP9X;USP3;ATXN3;OTULIN;USP42;USP35;USP40;JOSD1;USP30;OTUD4;USP11;USP7;STAMBPL1;MINDY1;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1;EIF3H;MINDY3;USP34;USP16;STAMBP;USP28;JOSD2;USP51
prerank,protease binding (GO:0002020),-0.34441296270556604,-1.3172892463593455,0.06397306397306397,0.36174272842149047,1.0,23/99,12.79%,PSAP;CRADD;BFAR;ANXA2;AMFR;RIOK3;CFLAR;NLRC4;RHBDD2;ITGB1;DPP4;ITGAV;BCL2;FN1;TIMP2;CD28;SERPINB9;SELENOS;UBC;DERL1;FAP;ITGA3;SERPINE1
prerank,protein homodimerization activity (GO:0042803),-0.2809981301881752,-1.3168526587583402,0.0058823529411764705,0.36007364419369753,1.0,172/589,22.40%,EXT1;APOE;MAP3K5;ABCG1;LILRB1;PSAP;XDH;TPD52;MCL1;PLEK;MYH9;MYO9B;SNX2;GOLGA5;SNX9;IDH1;ERN1;PDCD6IP;ABCB7;FLNA;PIP4K2A;ATF3;ABCD2;KYNU;RIPK1;IRAK2;IL6R;S100A11;STAT3;GYG1;ATG7;NLRC4;USF2;RBPMS;SNX6;DPP4;HHEX;TOP2A;PRMT2;BCL2;CENPF;SARS1;MTHFD1L;KIF20B;TPST1;DAPK3;BLM;TSG101;AXIN1;NRF1;TBC1D22A;TPM4;LRP6;AHR;IRAK3;DGKD;CEP57;HIP1;ALS2;MFSD1;VEGFA;EEA1;EIF2AK1;BHLHE40;GBP5;DCK;BST2;B2M;THAP1;IMPA1;EXD1;NOD1;JAML;ST6GAL1;LPL;GBP2;RPE;ARNT;RNF8;SSBP1;RELA;AGXT;IKZF3;ZDHHC2;GEN1;MYOM1;RABEP1;CLN6;WRN;CHMP1A;MTPAP;TPR;CCDC88A;NUDT21;FAP;GADD45A;CPQ;QTRT1;KYAT1;TPI1;PPCS;CCL5;HSP90AB1;TRIM68;DEFA6;SH3GLB1;TFAP4;KNSTRN;CST7;GREM1;GCH1;S100A6;TKT;PDXK;TCF3;IKBKB;PGRMC1;MAP3K10;NADK2;ANG;KARS1;TARS2;PEX7;PAPSS1;TRIM14;HM13;CYP2R1;VAPB;APPL2;ABCD3;GALE;GALM;ACOX1;KMT2A;BNIP3L;MIGA2;PTPRO;SNX1;DNTTIP1;STK10;MGAT2;XPNPEP3;ADRB2;HSPB1;GBP3;TYW5;MMUT;ENPP1;SLC8B1;RBPMS2;PLN;CARNMT1;CSF1;CAT;RBM11;APPL1;DARS2;PNPO;STAT1;JUP;LRRFIP1;PDGFA;RACK1;BCL2L2;CEBPB;MASP1;SHMT1;GTF2A2;HPS4;PHETA1;CHMP4B;CHMP4A
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.38606551513056103,-1.3168473250054655,0.0979381443298969,0.3574910645655046,1.0,21/53,24.96%,CYBB;XDH;POR;CYB5R1;GSR;CYB5R3;KMO;GFER;MICAL1;MICAL2;ACOX1;DLD;PPOX;FOXRED2;MTHFR;KDM1A;ACADVL;NQO2;ACOXL;QSOX1;CYB5R2
prerank,sodium channel regulator activity (GO:0017080),0.39607569455535463,1.31639155115984,0.13023255813953488,0.31713492452777803,1.0,6/37,8.69%,FGF14;FGF12;SCN2B;PTPN3;NEDD4;FXYD6
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.362758014609913,1.3151592225849467,0.06716417910447761,0.3154383828209061,1.0,20/60,17.02%,ERBB4;NTRK3;EPHA6;NTRK2;EPHA7;EPHA5;CSF1R;EPHB1;TIE1;ALK;EPHA10;ROS1;LTK;TYRO3;RET;EPHB4;EPHB3;ERBB3;EPHA3;ROR1
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.4326104434853966,-1.3135920193924404,0.12041884816753927,0.36193822059018715,1.0,12/29,20.83%,MAPKAPK3;PTPRJ;MAPKAPK2;MAPK14;PRMT1;MAPK7;DUSP6;TPR;GCH1;NFATC1;DUSP5;ATF7
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.45702161780729783,1.3100980524529628,0.1662870159453303,0.319842431491953,1.0,7/18,25.40%,FAR2;ALDH18A1;ALDH1A1;ALDH1A3;ALDH9A1;ALDH3A2;ALDH2
prerank,iron ion binding (GO:0005506),-0.38428335769325045,-1.30639828294437,0.09322033898305085,0.3740732589629884,1.0,19/48,27.00%,FTL;CDO1;ETHE1;KDM3A;ABCE1;KDM7A;ALKBH1;EGLN1;AGMO;FTO;TET2;ACP5;CYP2R1;TYW5;ALKBH3;FTH1;FDX1;ALOX15;LCN2
prerank,deoxyribonuclease activity (GO:0004536),-0.5205626064884462,-1.3046125999405105,0.14928057553956833,0.3753334002154768,1.0,8/14,26.01%,NME1;DNASE1L1;ERCC4;APLF;MAP1S;RPS3;ZRANB3;MRE11
prerank,aspartic-type peptidase activity (GO:0070001),-0.568614571923595,-1.3021918903144736,0.17137809187279152,0.3777782032151806,1.0,3/10,15.21%,CTSD;DDI2;CTSE
prerank,titin binding (GO:0031432),0.5055388975126521,1.301490675565271,0.16783216783216784,0.3299529423370986,1.0,4/13,13.07%,CAPN3;CALM1;CALM3;CALM2
prerank,MHC class I protein binding (GO:0042288),-0.5272678329930026,-1.3001292104544981,0.15505226480836237,0.37963390798664876,1.0,9/13,33.06%,LILRB1;TAPBP;DERL1;TAP2;PILRA;ATP5F1B;CD8B;ATP5F1A;CD8A
prerank,semaphorin receptor binding (GO:0030215),0.44321304064425093,1.2989919899529607,0.1368909512761021,0.33074156465544025,1.0,7/23,11.05%,RIT2;SEMA6D;SEMA6A;SEMA3E;SEMA5A;SEMA3F;SEMA5B
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5182058679725268,-1.2988716547031178,0.16363636363636364,0.3794626712657917,1.0,4/14,10.38%,IREB2;CIAO3;RSAD2;RSAD1
prerank,transcription coactivator binding (GO:0001223),0.45787874487800356,1.2979756398736413,0.15434782608695652,0.3288973598534277,1.0,3/20,2.48%,RORA;PGR;THRB
prerank,protein heterodimerization activity (GO:0046982),-0.31064260070844796,-1.2970456340174552,0.046052631578947366,0.3806513743175079,1.0,56/178,22.47%,EXT1;CYBB;ABCG1;TCF4;HEXA;SDCBP;CYBA;MCL1;SNX2;MEF2A;ATF3;IRAK2;GTF2A1;TLR4;USF2;ITGB1;TOP2A;BCL2;TPM4;AHR;IRAK3;DGKD;ATF6;HIP1;BHLHE40;YWHAE;HIF1A;MEF2C;ARNT;XBP1;RRAGD;GADD45A;ITGA3;QTRT1;NOLC1;TCF3;IKBKB;RALGAPA2;NR4A1;VAPB;UBA2;AURKA;LSM6;MIGA2;FBXO7;SNX1;RCC1;PAFAH1B1;SMC1A;LSM5;PDGFA;KCNB1;BCL2L2;GTF2A2;CD3E;SRI
prerank,kinase binding (GO:0019900),-0.282365958417062,-1.2963475533358757,0.011560693641618497,0.3797156972420433,1.0,131/434,21.22%,IQGAP1;SASH1;PTPRC;LYST;MSN;BCAR3;FGR;SP100;GRB2;PLCG2;PAK2;PRKCD;RB1;RAC1;ITGB2;PTPRJ;MAP3K1;RHOA;KIF13B;FLNA;IBTK;PRKAG2;VRK2;MAML1;KIF11;STAT3;FOXO3;CDC42;CCND3;BLNK;STAP1;ADIPOR1;ACTB;IRF5;IFNAR2;IRAK4;PTPN22;RPS6;DUSP3;AXIN1;MVP;CAB39;UTRN;IRAK3;CTNNB1;DGKD;SKI;AP2A2;NEK6;HIF1A;SLC12A7;PTPN6;SIK1;SPRED1;TPX2;SPRY2;TNIP2;RELA;KIF14;LCK;CDK5RAP1;EEF2;CDC25A;MYOM1;DCTN1;SPRED2;CRK;TICAM1;GADD45A;HSP90AB1;CACUL1;TRIM68;EEF1A1;CASP1;STK11IP;TRAF2;RB1CC1;POLR2A;PPP1R12A;BTG1;ANKRA2;RACGAP1;IKBKB;RELB;MAVS;CSPG4;IL31RA;TRIM14;SGO1;RND2;HCLS1;FAF1;KIF20A;STRADA;GPRC5B;DNAJC3;CD226;EXOC2;AURKA;MAP2K3;RAD9A;ATF5;LIMS1;FBXO7;NR3C1;CDKN2C;LAPTM4B;RPS3;NISCH;FAM83D;PTPN11;PDGFRB;TRADD;HSPB1;JTB;NOD2;RHOBTB1;PRAM1;GDF3;SUFU;PIP5K1A;WNK1;PRC1;GSK3B;RHOF;MIDN;PTPN1;CEP192;MOB1B;CDC25C;LAX1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5068656373174601,1.296190979254298,0.15165876777251186,0.32840706394084385,1.0,7/13,25.40%,ALDH1A1;ALDH1A3;ALDH7A1;ALDH1L1;ALDH9A1;ALDH3A2;ALDH2
prerank,I-SMAD binding (GO:0070411),-0.5199826801138735,-1.2960203379462407,0.15129151291512916,0.37783077348020055,1.0,9/13,33.27%,AXIN1;CTNNB1;TGFBR1;TGFB1I1;SMAD7;SMAD4;SMURF1;SMAD2;SMAD1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.4187079478346738,-1.2959226824364083,0.11900826446280992,0.37546403503484566,1.0,13/33,25.44%,AGO2;CTR9;DHX9;SMYD2;RPRD2;LLPH;ELOF1;ZNF326;WAC;ELP4;URI1;DRAP1;RECQL5
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.31146295789340916,-1.2954138785605218,0.04715447154471545,0.3739976132961701,1.0,43/173,17.97%,MITF;ZEB2;FOXP1;TRPS1;BCL6;JUN;ETV6;PPARD;ZBTB34;BACH1;ZNF148;NFX1;ATF3;PPARG;ELK3;ZNF3;FOXO3;NFKB1;HHEX;ZBTB21;NFATC3;ZBTB2;NR2F1;SKI;BHLHE40;THAP1;TFEC;RELA;ZBTB20;PRDM2;ZFP57;TGIF1;SP2;E2F8;BATF3;TCF3;YY1;KLF8;ZNF177;ZBTB12;ZBTB25;NR3C1;GATA3
prerank,ribonuclease P RNA binding (GO:0033204),0.5528966288730572,1.2951764784779376,0.15647921760391198,0.32683696312214955,1.0,6/10,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,magnesium ion binding (GO:0000287),-0.32566022849401305,-1.2930598778528555,0.056105610561056105,0.3760969196786572,1.0,32/135,15.31%,MAP3K5;PI4K2A;IDH1;ERN1;MAP3K20;RAP2A;ABL2;DYRK2;NLRC4;TOP2A;STK3;IRAK3;NME1;STK38;HPRT1;NEK6;IMPA1;XXYLT1;SIK1;GEN1;WRN;MTPAP;STK11;XYLT2;FEN1;DHX36;MAST2;DUT;MARK2;TKT;PDXK;RP2
prerank,tubulin binding (GO:0015631),0.27999256032402264,1.2927467940870132,0.014619883040935672,0.3275742394391424,1.0,80/295,17.65%,UNC5C;NAV3;MAP2;DNM3;AGBL4;KIF5C;SGIP1;TTLL11;MAP1B;MTUS2;EML1;NCALD;SNPH;MAPRE3;TTLL7;EML5;ARHGEF7;NEFH;KIFC2;IFT81;DST;KIF1B;KIF26B;CLASP2;KIF21A;DLEC1;PPP1R42;DYNC1I1;TTLL5;APC2;KIF5A;DNM1;PRNP;SYBU;KIF2A;HOOK3;MAP7D3;FYN;REEP1;KIF6;HOOK1;FMR1;MTCL1;FAM161A;MAP6D1;AGBL1;PACRG;MACO1;CETN3;EML2;MAP9;CDK5R1;FSD1;FNTA;BRSK1;GAS8;GAS2L2;CDK5RAP2;GOLGA2;PRKN;EML6;TTLL9;KIF3A;NDRG1;TUBGCP5;HDGFL3;CAPN6;RAD51D;CCDC170;SNCA;KIF3C;MTUS1;TUBGCP3;GABARAPL2;PRUNE1;MAP1A;TERF1;DIXDC1;NEFM;MAP1LC3A
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5310607785736137,-1.2924529167535972,0.1702127659574468,0.37476090039282167,1.0,7/12,41.98%,SLC25A42;ENTPD6;ENTPD3;NUDT15;ENTPD7;NUDT5;ENTPD1
prerank,peptidase activator activity (GO:0016504),-0.45843926523392153,-1.2915897227519306,0.1254125412541254,0.37410797976669763,1.0,5/22,11.38%,PSME4;PSME3;NLRC4;EBAG9;PSENEN
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5548708380352932,-1.2915513899591782,0.14745762711864407,0.3717284833469411,1.0,6/11,18.91%,CFLAR;CASP4;CASP7;CASP1;CASP8;CASP2
prerank,ribosomal small subunit binding (GO:0043024),-0.48423659753527093,-1.2879159816837553,0.14853195164075994,0.3765859958640946,1.0,9/17,33.45%,PIM1;ABCE1;ERAL1;NME1;DDX3X;EIF1;EIF1B;MTIF3;EIF4H
prerank,regulatory RNA binding (GO:0061980),-0.3959635665822085,-1.2833695002283219,0.11888111888111888,0.38364158150098066,1.0,7/38,7.95%,AGO2;TLR7;TUT7;DHX9;RC3H1;ZC3H7B;PUM2
prerank,SH2 domain binding (GO:0042169),-0.4320859324700395,-1.2817278320260679,0.13550600343053174,0.38444835714553416,1.0,11/31,21.46%,SH3PXD2B;LILRB1;BLNK;AFAP1L2;LCK;CRK;CCDC88A;LAT2;LAX1;RACK1;NUP62
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.5386232242868308,-1.2796193999426781,0.17647058823529413,0.38624989513546143,1.0,8/11,39.14%,PRMT2;PRMT1;PRMT3;PRMT6;NDUFAF7;CARM1;PRMT5;PRMT8
prerank,protein phosphatase binding (GO:0019903),-0.32481397978646914,-1.2792889149842412,0.0779436152570481,0.38445427932007686,1.0,26/117,13.07%,IQGAP1;MAP3K5;MFHAS1;LILRB1;SNX3;STAT3;CD22;STAT6;MTMR3;MAPK14;TRAF3;MVP;CTNNB1;VRK3;SIRPA;JAK1;SLC9A1;MASTL;AKAP11;STYXL1;LCK;STRN;PPP6R3;HSP90B1;PPP1R3E;TRAF2
prerank,solute:sodium symporter activity (GO:0015370),0.42499609339506345,1.277911546388815,0.14841849148418493,0.34846982014130246,1.0,5/27,10.00%,SLC4A10;SLC4A4;SLC5A7;SLC13A5;SLC5A10
prerank,guanyl ribonucleotide binding (GO:0032561),-0.299725004604697,-1.2767296576729479,0.04313099041533546,0.38724620625580675,1.0,72/196,26.83%,RAB8B;MFHAS1;RAB7A;RAC1;ARL8B;RAP1B;DNM2;RHOA;ARL8A;RAP2B;GNAI3;INSR;RAP2A;RAB31;RAP1A;CDC42;NOA1;ARL11;RHOQ;RAB32;NME1;GBP5;RAB5A;ADSS1;RAB21;GBP2;TGM2;SEPHS1;RRAGD;RAB11B;RAB29;EEF1A1;RAB10;ARL5A;ARL3;TUBD1;GCH1;ANXA6;RAB13;RND2;ARHGEF5;RAB39A;RALB;GTPBP10;KRAS;NRAS;ARL1;RAB12;ARFIP2;RHEB;GBP3;GBP7;RHOBTB1;GBP6;RHOF;TUBA4A;TUBB1;TUBA8;RABL3;RND1;RAB26;RAB4A;GBP4;RAB1B;RAB35;REM1;ARL4A;RND3;NUDT16;RAPGEF2;RAB22A;CNGB3
prerank,E-box binding (GO:0070888),-0.4056722372496003,-1.2766430901597625,0.13833333333333334,0.3849293725919415,1.0,14/34,28.00%,MITF;TCF4;PPARG;AHR;BHLHE40;CIART;TFAP4;TCF3;GATA3;MAX;SNAI2;MYC;CLOCK;SCRT2
prerank,NAD+ binding (GO:0070403),-0.527093695358496,-1.2765621865653694,0.189419795221843,0.3826817001785517,1.0,3/12,9.53%,ZC3HAV1;PARP9;SIRT3
prerank,protein kinase binding (GO:0019901),-0.27728012727844764,-1.2762799752927037,0.015965166908563134,0.3810662496888816,1.0,145/479,21.67%,IQGAP1;SASH1;PTPRC;NEDD9;BANK1;PRKCB;LYST;MSN;FGR;GRB2;MAPKAPK3;PLCG2;PAK2;PLEK;PRKCD;RAC1;ITGB2;PTPRJ;MAP3K1;RHOA;KIF13B;IBTK;PRKAG2;VRK2;MAML1;MAPKAPK2;KIF11;STAT3;FOXO3;CDC42;ITGB1;CCND3;BLNK;STAP1;ADIPOR1;ACTB;TOP2A;ITGAV;IRF5;IFNAR2;IRAK4;ADAM9;RPS6;DUSP3;AXIN1;MVP;UTRN;IRAK3;GRK5;SKI;SIRPA;AP2A2;STK38;TRIB1;NEK6;HIF1A;SLC12A7;PTPN6;MAPK7;SIK1;TRIB2;SPRED1;TPX2;SPRY2;TNIP2;RELA;PIN1;KIF14;LCK;CDK5RAP1;EEF2;DUSP6;CDC25A;DCTN1;SPRED2;TPR;CRK;CCDC88A;TICAM1;CACUL1;TRIM68;EEF1A1;STK11IP;TRAF2;HDAC5;RB1CC1;TJP2;GCH1;PPP1R12A;ANKRA2;TCF3;RACGAP1;IKBKB;RELB;MAVS;CSPG4;IL31RA;TRIM14;RND2;HCLS1;FAF1;KIF20A;GPRC5B;DNAJC3;CD226;EXOC2;AURKA;MAP2K3;SPAG9;RARA;TWF2;RAD9A;LIMS1;FBXO7;NR3C1;CDKN2C;RPS3;NISCH;FAM83D;PTPN11;PDGFRB;TAOK2;DUSP5;HSPB1;JTB;NOD2;RHOBTB1;PRAM1;GDF3;SUFU;BMPR2;WNK1;PRC1;GSK3B;APPL1;RHOF;PTPN1;ATF7;CEP192;CDC25C;LAX1;RACK1;PDLIM5;CCNK;PRKAG1
prerank,phospholipase C activity (GO:0004629),0.4183422476993649,1.27470254092171,0.14797136038186157,0.3501679660052866,1.0,8/25,12.29%,PLCB1;PLCL1;CHRM3;PLCH2;PLCE1;PLCZ1;PLCD3;F2RL2
prerank,frizzled binding (GO:0005109),-0.4085189742820479,-1.2737248949596653,0.1359724612736661,0.3836972256003142,1.0,13/34,27.99%,SDCBP;ZNRF3;LRP6;RNF43;RYK;WNT3;SFRP1;DVL2;CCDC88C;WNT7B;FZD1;FZD7;WNT6
prerank,beta-tubulin binding (GO:0048487),-0.4143271143147076,-1.2735502233696605,0.16183986371379896,0.3817567236314836,1.0,13/31,20.57%,ARL8B;PEX14;ARL8A;EML4;TAOK1;LRPPRC;GABARAP;RACGAP1;MAP1S;VAPB;UXT;PDCD5;APPL1
prerank,MHC class II protein complex binding (GO:0023026),-0.5475255323524872,-1.2728096269579583,0.16607773851590105,0.38097425813504876,1.0,5/11,12.82%,CD74;ANXA11;YWHAE;HSP90AB1;PKM
prerank,metalloendopeptidase activity (GO:0004222),0.33050799909289136,1.272701582586859,0.10194174757281553,0.3502081153296464,1.0,23/76,17.17%,OMA1;MMP16;ADAMTS17;MMP12;MME;ADAMTS16;ADAMTSL1;ECE2;IDE;MMP15;THSD4;MMEL1;MMP13;EEF1AKMT4-ECE2;PMPCB;ADAMTS5;ADAMTS12;TRABD2B;ADAMTS6;ECE1;ADAM17;ADAMTSL2;PHEX
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.4287583134164781,-1.2718555992810823,0.1646234676007005,0.3807060787066313,1.0,11/27,21.10%,PRIMPOL;POLR2F;POLR2L;POLR2A;POLR3B;POLR2G;PRIM1;POLR1F;POLR3A;MED20;POLR2I
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.33983575340316147,-1.2613137075490748,0.09455128205128205,0.40041970829830853,1.0,33/83,28.84%,USP12;USP50;OTUD5;UCHL5;USP18;USP8;USP36;USP9X;USP3;ATXN3;OTULIN;USP42;USP35;USP40;JOSD1;USP30;OTUD4;USP11;USP7;STAMBPL1;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1;MINDY3;USP34;USP16;STAMBP;USP28;JOSD2;USP51
prerank,cell-cell adhesion mediator activity (GO:0098632),0.37684113374818795,1.2589256309029686,0.13253012048192772,0.36971024317381634,1.0,7/42,7.78%,LRRC4C;CNTN6;CNTN4;DSCAM;NTNG1;DSCAML1;CD200
prerank,acylglycerol lipase activity (GO:0047372),0.5223008529028014,1.2575834563926238,0.19594594594594594,0.36872483363347736,1.0,3/11,5.15%,ABHD16A;ABHD15;ABHD3
prerank,protein kinase activator activity (GO:0030295),-0.3623864745644642,-1.2564002303863926,0.12241379310344827,0.40782180718012245,1.0,18/60,12.09%,IQGAP1;ABI1;PAK2;PRKAG2;ERCC6;INCENP;STK3;CAB39;GAS6;ALS2;NCKAP1L;TPX2;AFAP1L2;SPRY2;TAOK1;DBF4;MAP2K1;STK11
prerank,receptor ligand activity (GO:0048018),0.27739382749587493,1.2562191811661898,0.030303030303030304,0.3674528055676381,1.0,35/245,12.73%,NRG3;NRG1;TAFA1;SEMA6D;TAFA2;EPHA7;SEMA6A;TGFA;SEMA3E;EGF;EDA;SEMA5A;WNT9A;PTN;GDNF;TAFA5;VEGFD;PGF;FGF10;APLN;BDNF;BMP7;SEMA3F;AMELX;AREG;BMP15;EDN1;CLEC11A;TGFB2;NBL1;SEMA5B;ANGPTL3;SCG2;NTS;BMP3
prerank,ubiquitin-specific protease binding (GO:1990381),-0.46092049960540826,-1.2553272094447383,0.17975567190226877,0.40767742335088264,1.0,5/19,14.40%,AMFR;RHBDD2;SELENOS;DERL1;SART3
prerank,motor activity (GO:0003774),-0.3535799586937913,-1.2519340439101097,0.12454873646209386,0.41274114159146186,1.0,22/60,17.99%,MYH9;KLC1;KIF13B;KIF3B;KIF11;KIF16B;KIF20B;KIF23;KIF15;STARD9;KIF4A;CENPE;DNAH8;MYO1E;KIFC1;PIN1;KIF14;KIF21B;KIF2C;KIF20A;DNAH3;KIF18B
prerank,sequence-specific DNA binding (GO:0043565),-0.26606453355503323,-1.2511284670427534,0.017191977077363897,0.41212416544829916,1.0,143/590,23.23%,RBPJ;ZEB2;FLI1;ELF4;FOXP1;BACH2;TFEB;TCF4;ELF2;BCL6;TET3;JUN;MEF2A;RUNX3;PPARD;BPTF;NFE2L2;MBNL2;IRF2;ZNF148;NFIC;ATF3;ELF1;UBP1;PPARG;ELK3;FOXN2;ETV1;KLF13;FOXO3;E2F2;USF2;HHEX;ZBTB21;RUNX2;RARG;BCL2;IRF5;MAF;MEF2B;KLF6;CUX1;BATF;TEF;ETV3;CHTOP;NFATC3;ZBTB2;AHR;KLF3;ATF6;NR2F1;KDM2A;BHLHE40;E2F1;PRMT1;THAP1;CEBPG;E2F3;CBFB;MEF2D;HIF1A;MEF2C;TFEC;SIRT3;OLIG2;EGR1;ARNT;IKZF3;UPF2;ZBTB20;XBP1;XRCC6;OSR1;KLF10;PRDM2;NFE2;TCF7;ZFP41;UHRF1;TGIF1;SP2;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;KLF2;TEN1;TFAM;YY1;NCL;TFCP2;ZNF177;NR4A1;ZBTB12;KLF11;IRX5;SOX10;FOXJ2;KMT2A;LRWD1;RARA;NFATC1;CSRNP1;ATF5;NR3C1;TFE3;GATA3;ERH;ARID5A;TCF12;GMEB2;CXXC1;MEIS3;HOXD8;WDR77;MAX;SP9;KDM5B;PKNOX1;ATF7;POU3F1;KDM1A;HOXB2;NLRP3;ZBTB7A;TBX2;SNAI2;CEBPB;EGR2;BBX;ZNF296;BARX2;MYRFL;MTF1;NR1H4;HOXD9;HES7;SOX7;SMG1;ZNF32
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.48674952169045355,1.2491015194572543,0.19002375296912113,0.37563187823984107,1.0,3/14,6.77%,KCND3;KCNJ3;KCNIP2
prerank,tRNA binding (GO:0000049),-0.3755920976109378,-1.244256544341787,0.14886164623467601,0.4238639926819269,1.0,14/43,20.70%,FARS2;XPOT;SARS1;ELP5;ALKBH1;DALRD3;ELP1;PUS1;EEF1A1;KARS1;EIF2A;TYW5;AARS1;DARS2
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.2879987243735969,-1.2434843529620603,0.04945904173106646,0.4229636163646266,1.0,71/248,20.61%,ATP2B1;RAB8B;RNF213;GNB1;MYH9;RAB7A;RAC1;ARL8B;KLC1;RAP1B;DNM2;RHOA;ARL8A;RAP2B;GNAI3;ABCD2;RAP2A;RAB31;GNA12;RAP1A;RAB20;GSPT1;CDC42;DHX9;RAB1A;CHD3;KIF20B;KIF15;GNA15;RHOQ;RAB32;GNA11;GBP5;RAB5A;RAB21;GBP2;MYO1E;PIN1;KIF14;EFL1;GNA13;EEF2;GTPBP1;RAB24;RRAGD;RAB11B;SAR1A;RAB29;EEF1A1;GCH1;GNA14;RND2;TBC1D24;HSPA1A;RALB;DNA2;GTPBP10;KRAS;NRAS;KIF18B;ARL1;RHEB;GBP3;DDX3X;MMUT;GBP7;RHOBTB1;GBP6;ABCA4;RAB11A;RHOF
prerank,double-stranded DNA binding (GO:0003690),-0.2660813553650155,-1.2423695632335354,0.025185185185185185,0.4228807574215812,1.0,132/531,23.23%,FLI1;ELF4;FOXP1;BACH2;TFEB;TCF4;RBMS1;ELF2;BCL6;JUN;CGAS;RUNX3;PPARD;MBNL2;RAD51B;IRF2;NFIC;ATF3;ELF1;UBP1;PPARG;ELK3;FOXN2;ETV1;KLF13;FOXO3;E2F2;DHX9;USF2;RUNX2;RARG;IRF5;MAF;MEF2B;AIM2;KLF6;CUX1;BATF;DDX60;TEF;ETV3;NFATC3;ZBTB2;WDR48;AHR;KLF3;REXO4;ATF6;NR2F1;BHLHE40;E2F1;CEBPG;E2F3;NEIL3;RAD51;MEF2D;MEF2C;TFEC;OLIG2;NUCKS1;EGR1;ARNT;APTX;ZBTB20;XBP1;XRCC6;OSR1;MAU2;KLF10;NFE2;FEN1;TCF7;HMGB2;ZFP41;UHRF1;TGIF1;SP2;RXRA;FOXJ3;E2F8;TFAP4;BATF3;KLF2;RAD51AP1;YY1;TFCP2;ZNF177;NR4A1;ZBTB12;KLF11;IRX5;SOX10;FOXJ2;ZCCHC3;RARA;NFATC1;NR3C1;TFE3;GATA3;RPS3;TCF12;RBBP8;GMEB2;MEIS3;HOXD8;HMGB1;HMGB3;MAX;SP9;KDM5B;PKNOX1;ATF7;STAT1;DMC1;POU3F1;HOXB2;ZBTB7A;TBX2;SNAI2;CEBPB;EGR2;BBX;ZNF296;BARX2;MTF1;POLG2;HOXD9;PRKDC;HES7;SOX7;TARDBP;ZNF32
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.34777480400759464,-1.2393783841178527,0.14462081128747795,0.42665027168557673,1.0,12/60,10.82%,PPM1H;PPP4C;CTDSPL2;MTMR3;LRRC39;PPM1B;LRRK1;PPP1CA;SSU72;MTMR6;LCK;CDKN3
prerank,estrogen receptor binding (GO:0030331),-0.4087384182454224,-1.2361016270170253,0.18312387791741472,0.4309216370708253,1.0,16/32,30.06%,CNOT1;PRMT2;CTNNB1;WBP2;STRN;NSD1;NRIP1;PPARGC1B;ARID5A;NCOA6;MMS19;DDX54;DCAF1;ESR1;LEF1;PPID
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4053708719511619,1.233585587948115,0.16129032258064516,0.3996209260943493,1.0,7/26,17.48%,B3GALT1;CHSY3;B3GALT5;B3GNT5;B4GALNT4;B4GALNT2;B3GALT4
prerank,GDP binding (GO:0019003),-0.3437417180365476,-1.232981898905679,0.11650485436893204,0.43537263771787277,1.0,21/63,18.69%,RAB8B;RAB7A;ARL8B;RAP1B;RAP2B;GNAI3;RAP2A;RAB31;RAP1A;RAB5A;RAB21;RRAGD;RAB11B;RAB29;RAB10;ARL3;RALB;KRAS;NRAS;RAB12;RHEB
prerank,actinin binding (GO:0042805),0.422826500380748,1.231489776938018,0.1845102505694761,0.39965832383057265,1.0,7/21,15.17%,CACNA1C;KCNN2;SYNPO2;CSRP1;TTN;PDLIM4;MAGI1
prerank,acid-thiol ligase activity (GO:0016878),0.47892499100107216,1.23082145922934,0.22121896162528218,0.39732775119617225,1.0,4/13,20.05%,SLC27A2;ACSS2;ACSM3;ACSS1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.46976867140433115,-1.2307765559327508,0.20136518771331058,0.43760210799130095,1.0,8/16,36.19%,CDO1;ETHE1;BCO2;IDO2;ALOX15;HGD;HAAO;ALOX12
prerank,endopeptidase regulator activity (GO:0061135),-0.3792106905797507,-1.2268887359270795,0.19110378912685339,0.44380383331612816,1.0,9/40,15.44%,UCHL5;PSME3;NLRC4;TFPI;PROS1;CAST;PSENEN;CST7;CST3
prerank,ubiquitin binding (GO:0043130),-0.3361236252978466,-1.2257854354934394,0.13550600343053174,0.443832437047544,1.0,32/73,32.40%,GGA3;TOP2A;UBXN7;RNF31;TSG101;RBCK1;DDI2;UBAP1;WDR48;RAE1;MVB12B;RNF185;USPL1;CXCR4;FAF1;FBXO7;HSPB1;UBXN1;SIRT2;FAF2;NUP62;CKS2;RNF19B;UBE2N;USP16;ASCC2;MARK4;MVB12A;SQSTM1;AUP1;USP5;RNFT1
prerank,chemokine receptor binding (GO:0042379),-0.3858178803452272,-1.2256357640680735,0.15625,0.441694642304119,1.0,14/35,39.74%,CKLF;PF4;CXCL16;CCL5;CCRL2;CCL7;CCL24;CCL4;CCL25;CCL19;CCL8;CXCL9;CXCL1;CCL14
prerank,LRR domain binding (GO:0030275),0.4662486808269241,1.225626750747577,0.21830985915492956,0.40303596407826414,1.0,2/14,5.16%,ROBO1;MRTFA
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.39008575773182386,-1.224534682133291,0.17513134851138354,0.4416087946157348,1.0,9/34,11.58%,IQGAP1;INCENP;STK3;CAB39;ALS2;SPRY2;TAOK1;DBF4;MAP2K1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.26087601965344726,-1.223948468120771,0.033478893740902474,0.4406668641523153,1.0,121/597,18.20%,FLI1;ELF4;FOXP1;RUNX1;BACH2;TFEB;TCF4;ELF2;BCL6;JUN;ZNF568;RUNX3;PPARD;ARID5B;NFE2L2;BRD7;MBNL2;IRF2;NFIC;NFYA;ATF3;ELF1;UBP1;PPARG;ELK3;SPI1;BRCA1;FOXN2;ETV1;STAT3;KLF13;FOXO3;E2F2;DHX9;USF2;CHD3;NFKB1;HHEX;RUNX2;RARG;IRF5;MAF;MEF2B;KLF6;CIITA;CUX1;BATF;TEF;ETV3;NFATC3;ZBTB2;AHR;TBL1XR1;KLF3;ATF6;NR2F1;CREB3L2;HNRNPL;MCM6;BHLHE40;E2F1;ATMIN;CEBPG;E2F3;MEF2D;MEF2C;TFEC;OLIG2;EGR1;ARNT;MCM9;RELA;MCM3;ZBTB20;XBP1;XRCC6;OSR1;KLF10;NFE2;KMT2D;ORC5;FOXJ1;MLH3;KAT7;TCF7;HMGB2;ZFP41;ZBED4;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;PSPC1;KLF2;TFAM;YY1;KIF2C;TFCP2;ZNF177;MCM2;NR4A1;ZBTB12;KLF11;IRX5;SOX10;FOXJ2;TAF9;RARA;NFATC1;ATF5;NR3C1;TFE3;GATA3;ARID5A;TCF12
prerank,transaminase activity (GO:0008483),0.5056968519364923,1.2223632763251366,0.2100656455142232,0.4056950161397404,1.0,5/11,18.41%,GOT1;BCAT1;ABAT;PSAT1;BCAT2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.49564631513998,-1.211893899418022,0.2459605026929982,0.46425297766022444,1.0,5/12,13.07%,TRAF5;TRAF3;BABAM2;TRAF1;TRAF2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.4083942639044148,-1.2114521149580486,0.22123893805309736,0.46276964471839543,1.0,11/28,22.31%,RIPK1;TRAF5;TRAF3;BABAM2;MYD88;TRAF1;TRAF2;BID;STAT1;FEM1B;TNFSF9
prerank,protein kinase C activity (GO:0004697),-0.4786078279636263,-1.2084756960755365,0.23208191126279865,0.4666955713843295,1.0,3/14,1.37%,PRKCH;PRKCB;PRKCD
prerank,omega peptidase activity (GO:0008242),-0.3228269073693834,-1.2079118759522092,0.14516129032258066,0.46537812246726806,1.0,34/89,28.84%,USP12;USP50;OTUD5;UCHL5;USP18;USP8;USP36;USP9X;USP3;ATXN3;OTULIN;USP42;USP35;GGH;USP40;JOSD1;USP30;OTUD4;USP11;USP7;STAMBPL1;BRCC3;COPS5;BAP1;ZC3H12A;USP9Y;ZRANB1;MINDY3;USP34;USP16;STAMBP;USP28;JOSD2;USP51
prerank,3'-5' exonuclease activity (GO:0008408),-0.36297457981988285,-1.207851660423393,0.1646234676007005,0.4630143032471927,1.0,18/45,26.01%,ERI3;RAD1;REXO4;EXOSC5;ERI2;EXD1;WRN;APLF;CNOT6L;RAD9A;ANGEL1;EXOSC10;CNOT8;EXOSC4;PNLDC1;XRN2;ANGEL2;MRE11
prerank,mRNA binding (GO:0003729),-0.2762996257446881,-1.2075800797047587,0.07434402332361516,0.4611018695701781,1.0,84/249,26.09%,RBM47;PTBP3;RBMS1;YTHDF3;IREB2;AGO2;DCP1A;TRA2B;RPL7;DHX9;RBPMS;RC3H1;RNF20;SF3B6;EIF4G3;SNRNP35;PUM3;EIF3A;SECISBP2;RPS14;HNRNPL;PUM2;CNBP;LARP4B;RPS13;KHNYN;DDX5;LARP4;XPO5;EIF4A1;PCBP2;TPR;NUDT21;CELF1;HNRNPLL;RBM14;PKM;NYNRIN;BOLL;METTL14;UNK;MRPS11;DHX36;YTHDC1;RBMS2;NCBP1;EIF4G1;NCL;THOC2;DAZAP1;EIF2A;G3BP1;RBM4B;HDLBP;RNPS1;TDRD7;SNRNP70;MARF1;RPS3;NSRP1;DDX3X;RBPMS2;C1QBP;DDX6;SF3B1;GRSF1;ZC3H12A;CPEB4;LSM14A;HNRNPK;SHMT1;RPL41;TARDBP;PUM1;PABPC1L;EIF2S2;PCBP4;ESRP1;MRPS7;RNF40;RPL5;ANGEL2;NUDT16;ZC3H12D
prerank,alpha-actinin binding (GO:0051393),0.4021686786038736,1.2062535645357677,0.20537897310513448,0.4312804130340223,1.0,8/24,17.40%,CACNA1C;KCNN2;PRICKLE4;SYNPO2;TTN;PDLIM4;MAGI1;PDLIM7
prerank,myosin II binding (GO:0045159),0.5104401621090564,1.2048100178916974,0.23162583518930957,0.42994525355851865,1.0,4/10,10.85%,STXBP5L;SHROOM4;SHROOM1;GSN
prerank,amyloid-beta binding (GO:0001540),-0.3218029710358179,-1.1961575586532402,0.1721311475409836,0.48399486979094886,1.0,13/79,4.11%,APOE;MSR1;CD74;GSAP;LILRB3;LILRB1;LRP1;CD36;ITGB2;C1QA;INSR;APBB2;TLR4
prerank,kinase activator activity (GO:0019209),-0.4012763545769493,-1.1919342861100524,0.22395833333333334,0.4914552234954062,1.0,19/30,37.18%,PRKAG2;MALT1;CAB39;NCKAP1L;TPX2;STK11;MARK2;STRADA;GPRC5B;WNK1;MOB1B;MT3;GPRC5C;IL2;BCL10;FGF13;GPRC5A;GPRC5D;WNT11
prerank,myosin V binding (GO:0031489),0.4469119666721489,1.191861122761488,0.23114355231143552,0.45113875598086123,1.0,4/15,5.97%,RAB3C;RAB6B;RAB27B;RAB6A
prerank,proton transmembrane transporter activity (GO:0015078),-0.36681845617882936,-1.1883401521145438,0.22393162393162394,0.4970736637050564,1.0,16/39,28.84%,CLCN5;SLC33A1;CTNS;SLC9A1;COX4I1;MFSD3;COX10;UQCRC1;COX8A;NNT;SLC11A2;NDUFA4;CYB5A;COX5A;COX6A2;UQCRQ
prerank,poly(U) RNA binding (GO:0008266),-0.4263415578858831,-1.1847323026359489,0.23013245033112584,0.5025495110356212,1.0,8/20,23.42%,RBMS1;PATL1;HNRNPH1;RBMS2;DAZAP1;ATXN1;RBM11;PABPC1L
prerank,lipid phosphatase activity (GO:0042577),0.4589501242687278,1.184118244516031,0.22325581395348837,0.46274300543346036,1.0,2/14,2.69%,PLPPR1;PLPPR4
prerank,SUMO binding (GO:0032183),-0.47781272167786554,-1.1820589469402238,0.25569176882662,0.5061496851450398,1.0,6/13,26.76%,RNF111;RNF4;USPL1;UBA2;SIMC1;PML
prerank,voltage-gated anion channel activity (GO:0008308),-0.4593225281160014,-1.1751553351986663,0.25880281690140844,0.5193285594200517,1.0,3/15,6.00%,ANO6;VDAC2;CLCN5
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.49340959087915237,1.172577793578178,0.2523809523809524,0.4813533395959515,1.0,2/11,5.21%,KCND3;KCNJ3
prerank,GTPase activity (GO:0003924),-0.27892371977852354,-1.169860266792766,0.13870967741935483,0.529321878345514,1.0,56/192,20.61%,RAB8B;GNB1;RAB7A;RAC1;ARL8B;RAP1B;DNM2;RHOA;ARL8A;RAP2B;GNAI3;RAP2A;RAB31;GNA12;RAP1A;RAB20;GSPT1;CDC42;RAB1A;GNA15;RHOQ;RAB32;GNA11;GBP5;RAB5A;RAB21;GBP2;EFL1;GNA13;EEF2;GTPBP1;RAB24;RRAGD;RAB11B;SAR1A;RAB29;EEF1A1;GCH1;GNA14;RND2;TBC1D24;RALB;GTPBP10;KRAS;NRAS;ARL1;RHEB;GBP3;DDX3X;MMUT;GBP7;RHOBTB1;GBP6;ABCA4;RAB11A;RHOF
prerank,alanine transmembrane transporter activity (GO:0022858),-0.48654005773945497,-1.1688186580495117,0.2807017543859649,0.5293641024678497,1.0,3/12,8.64%,SLC6A6;SLC38A7;SLC36A4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4928749217413183,-1.1678269471083886,0.2911813643926789,0.5292903414564305,1.0,3/11,14.63%,SASH1;STK38;TCF3
prerank,hexosyltransferase activity (GO:0016758),0.28798320337801786,1.1673404754423546,0.1450381679389313,0.4882306220095694,1.0,13/101,5.39%,MGAT4C;B3GALT1;TMTC2;TMTC1;FUT9;CHSY3;B3GALT5;HEXB;DPY19L1;B4GALT4;TMTC3;DPY19L2;POMT2
prerank,nuclear import signal receptor activity (GO:0061608),-0.4520209705799637,-1.1666156705693513,0.2699490662139219,0.5293651532982347,1.0,4/15,20.47%,KPNA4;IPO5;KPNA3;TNPO3
prerank,sterol binding (GO:0032934),-0.342185351536192,-1.1647795679021313,0.2459016393442623,0.5311499362894416,1.0,11/56,11.01%,OSBPL8;ABCA1;ABCG1;OSBPL3;GRAMD1B;VDAC2;OSBPL5;ERLIN1;OSBPL11;STARD5;NPC2
prerank,metallopeptidase activity (GO:0008237),0.28580345690239145,1.1645710736629713,0.17,0.4900031131034334,1.0,30/113,17.17%,OMA1;METAP2;ADAM12;MMP16;ADAMTS17;MMP12;MME;ADAMTS16;ADAMTSL1;ADAM23;ECE2;IDE;MMP15;THSD4;MMEL1;MMP13;BMP1;EEF1AKMT4-ECE2;PMPCB;ADAMTS5;ADAMTS12;TRABD2B;ADAMTS6;METAP1;ECE1;ADAM11;ADAM18;ADAM17;ADAMTSL2;PHEX
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.44535608492286627,-1.1639093424439082,0.2534722222222222,0.5305588402135352,1.0,2/15,2.65%,P2RX7;P2RX4
prerank,RNA cap binding (GO:0000339),-0.4473380638920971,-1.1628991778741955,0.2793103448275862,0.5302325019413048,1.0,4/16,14.94%,AGO2;EIF4A1;NCBP1;SNUPN
prerank,peptidoglycan binding (GO:0042834),-0.5098861890940927,-1.1614354517185939,0.28291814946619215,0.5311601114896253,1.0,5/10,29.00%,RNASE7;NOD1;NOD2;NLRP3;PGLYRP2
prerank,metallocarboxypeptidase activity (GO:0004181),0.38207589838653355,1.1556030138525677,0.2669902912621359,0.5044168027438872,1.0,5/26,12.68%,AGBL4;AGBL1;CPE;CPA2;FOLH1
prerank,lipase activity (GO:0016298),-0.3504709273600655,-1.1540255356772193,0.23478260869565218,0.5456148773689656,1.0,9/43,14.13%,LIPA;DDHD1;PLBD1;ABHD12;PLBD2;DAGLB;LPL;ABHD5;LDAH
prerank,DNA polymerase binding (GO:0070182),-0.42443792602447566,-1.1521125868442912,0.2777777777777778,0.547203035596701,1.0,10/18,32.45%,RTEL1;RAD51;PCNA;HSP90AB1;HMGB1;FANCD2;POLG2;CDK2AP1;LONP1;FANCI
prerank,R-SMAD binding (GO:0070412),-0.43111996371513733,-1.1520132271262797,0.2973451327433628,0.5447764417574427,1.0,9/18,31.76%,JUN;PMEPA1;DDX5;LDLRAD4;PAX6;SMAD4;SMURF1;SMAD2;DROSHA
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3931425744040413,-1.151388421810469,0.2626427406199021,0.5436472592133788,1.0,6/27,14.35%,APOE;LRP1;PICALM;DNAJA1;HSP90B1;ANKRA2
prerank,3'-5' DNA helicase activity (GO:0043138),-0.4449272041953921,-1.1486164208292116,0.28421052631578947,0.5476689273791197,1.0,8/16,25.44%,DHX9;BLM;MCM6;WRN;MCM2;MCM5;ASCC3;RECQL5
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.33068761987223083,-1.1473568674300316,0.23339011925042588,0.5479238213216535,1.0,14/55,20.26%,SLC16A7;SLC38A6;SLC6A6;SLC38A10;SLC38A7;SLC36A4;ABCC1;SLC7A5;SLC16A6;SLC23A1;SLC23A2;SLC38A2;SLC25A10;SLC16A1
prerank,microtubule binding (GO:0008017),0.25362844305970694,1.1470671227600029,0.13793103448275862,0.517891681430951,1.0,61/222,17.65%,NAV3;MAP2;DNM3;KIF5C;SGIP1;MAP1B;MTUS2;EML1;SNPH;MAPRE3;EML5;NEFH;KIFC2;DST;KIF1B;KIF26B;CLASP2;KIF21A;DYNC1I1;APC2;KIF5A;DNM1;PRNP;SYBU;KIF2A;CLIP4;HOOK3;MAP7D3;REEP1;KIF6;HOOK1;FMR1;MTCL1;FAM161A;MAP6D1;MACO1;CETN3;EML2;CEP290;MAP9;FSD1;FNTA;GAS8;GAS2L2;CDK5RAP2;GOLGA2;EML6;KIF3A;NDRG1;TUBGCP5;HDGFL3;CAPN6;CCDC170;KIF3C;MTUS1;TUBGCP3;GABARAPL2;MAP1A;TERF1;NEFM;MAP1LC3A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.4991734093381029,-1.1460694472107273,0.31841652323580033,0.5483371871326059,1.0,2/10,0.71%,APOBEC1;GDA
prerank,potassium ion antiporter activity (GO:0022821),0.44225030794299125,1.1445417859334717,0.267260579064588,0.5190117442366247,1.0,4/15,5.38%,SLC24A4;SLC24A2;SLC24A3;SLC9A2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.3640988606341279,-1.141232182167331,0.2807017543859649,0.5568874059963654,1.0,11/33,21.68%,ERI3;EXOSC5;ERI2;DCP2;CNOT6L;ANGEL1;EXOSC10;CNOT8;EXOSC4;PNLDC1;XRN2
prerank,syntaxin binding (GO:0019905),0.31403872262951893,1.140384619370126,0.20812182741116753,0.523988711613745,1.0,16/61,14.31%,STXBP5L;SYT1;UNC13C;SYT10;SNPH;SNAP25;CPLX1;SYT2;SYT5;SYT12;PRRT2;NAPB;UNC13B;GOLGA2;SCFD1;VAMP8
prerank,miRNA binding (GO:0035198),-0.3666124650994286,-1.1403751923775631,0.2539130434782609,0.5563550976551993,1.0,9/30,23.36%,AGO2;TUT7;RC3H1;ZC3H7B;PUM2;RBM10;HNRNPA1;ZC3H12A;PUM1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.31027323255242817,-1.1400713174003563,0.24262295081967214,0.5545126496730853,1.0,32/74,30.92%,FAM20C;DGKZ;PANK2;NADK;PIK3CB;PIK3CG;DGKD;PI4KB;FGGY;POMK;HK3;PIK3CA;PKM;PIK3CD;PDXK;PIK3C2A;NADK2;DGKG;PAPSS1;SPHK2;GALK2;NMRK1;NOL9;PIK3C2G;FCSK;DGKA;GALK1;GK5;IDNK;GNE;TKFC;FAM20B
prerank,zinc ion binding (GO:0008270),-0.25776402965258555,-1.138157666400809,0.14664586583463338,0.5565634000014404,1.0,77/293,20.94%,ADAM33;GDA;LITAF;TET3;SAMHD1;ANPEP;SLC30A5;ACER3;P2RX4;ARHGEF2;PPARG;ZNF3;DHX58;TAB2;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;CHD3;RC3H1;LNPEP;BLM;GALT;PRIMPOL;KDM7A;PITRM1;CRIP1;KDM2A;SKI;EEA1;TIMP2;QPCTL;THAP1;ATAD3A;POLR2L;SIRT3;ADAM8;MSRB1;EGR1;RNF8;HDAC10;SEC24A;CHMP1A;SEC24D;PRDM2;TRIM24;UHRF1;MT2A;RXRA;TET2;SORD;GCH1;ARIH1;CBLB;PDXK;NSD1;IKZF4;TNFSF10;KMT2A;RPS27;LIMS1;WDFY1;ZMYND8;MMP8;MDM4;ENPP1;RABGGTB;SLU7;KDM5B;SIRT2;PTPN1;ZFPL1;RNF125
prerank,transferrin receptor binding (GO:1990459),-0.49835482272163845,-1.1364420623463614,0.30915371329879104,0.5582352064049183,1.0,4/10,18.23%,SNX2;IKBKB;SNX1;SNX4
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5003376134514087,-1.1355744726025814,0.29236499068901306,0.5576661276764575,1.0,4/10,15.15%,NSD3;ASH1L;SMYD2;NSD1
prerank,chloride channel regulator activity (GO:0017081),-0.44523634650285693,-1.134243697844093,0.29349736379613356,0.5582425552831137,1.0,3/14,5.15%,STX7;SGK1;STX8
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.3641488039664601,-1.1329740532500847,0.26440677966101694,0.5587987176713318,1.0,14/35,28.66%,FOXP1;AGO2;GTF2A1;RELA;KLF10;DR1;SNAPC3;NR3C1;TAF4;STAT1;DRAP1;MYC;UBTF;ZBTB17
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.46588001170839827,1.1325919335060624,0.3058823529411765,0.5370493175086477,1.0,2/12,3.39%,PDE4B;PDE4D
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.38505515757791065,-1.130416699268286,0.3038194444444444,0.562152222754019,1.0,8/24,18.55%,OSBPL8;SNX3;GOLPH3L;OSBPL5;SESTD1;PLA2G4A;ARFIP1;ARFIP2
prerank,poly-pyrimidine tract binding (GO:0008187),-0.3928486276882033,-1.1292085127273666,0.2654424040066778,0.5624626819448746,1.0,9/23,26.35%,RBMS1;PATL1;HNRNPH1;RBMS2;DAZAP1;ATXN1;RBM11;PABPC1L;U2AF2
prerank,protein kinase regulator activity (GO:0019887),-0.30147003525704374,-1.1290562951068888,0.22772277227722773,0.5602496965841655,1.0,39/95,32.66%,TAOK3;CCNL1;PRKAG2;CCND3;CCNY;CAB39;TRIB1;NCKAP1L;TPX2;CCNL2;STK11;GMFG;MARK2;GMFB;CCNE1;FAF1;STRADA;GPRC5B;ELP4;DNAJC3;CNPPD1;SOCS3;WNK1;CCNK;PRKAG1;CCNF;CCNB1;ITPRIP;CCNB2;MT3;NCK1;SH3BP5;GPRC5C;ANKRD54;CSNK2B;FGF13;KIDINS220;CCNJL;GSKIP
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.4132181546589677,1.1277152579491467,0.28604651162790695,0.5437298380329688,1.0,5/17,15.00%,DPYD;PECR;DHCR24;DHCR7;DECR2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3650006659033259,-1.1263297606852294,0.28547008547008546,0.5641408591144992,1.0,10/32,21.08%,TET3;KDM7A;ALKBH1;KDM2A;EGLN1;FTO;TET2;TMLHE;TYW5;ALKBH3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.2844252192270349,1.1255383561967713,0.23308270676691728,0.5444031916050458,1.0,22/91,15.09%,FRMPD4;PLCB1;PLEKHA5;PARD3;SNAP91;CLVS1;KCNH1;SNX14;MARK1;TIRAP;PLA2G4E;SNX21;PLCZ1;PIRT;AMER2;GSN;GSDMD;SYT7;SYTL2;OSBPL2;MYO1B;RPH3A
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.23638015351902902,-1.124372127143192,0.0953757225433526,0.5662471132150599,1.0,140/732,18.47%,RBPJ;MITF;ZEB2;ELF4;FOXP1;RUNX1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;JUN;ZNF568;MEF2A;RUNX3;PPARD;BPTF;ZBTB34;BACH1;DNMT3A;NFE2L2;IRF2;ZNF148;NFIC;NFYA;ZSCAN12;ATF3;ELF1;UBP1;PPARG;ELK3;SPI1;FOXN2;ETV1;STAT3;KLF13;FOXO3;E2F2;IKZF1;LYL1;ZSCAN26;STAT6;DHX9;USF2;NFKB1;HHEX;NLRC5;RUNX2;RARG;MLXIP;IRF5;SARS1;MAF;MEF2B;KLF6;TIPARP;NR1H2;BATF;NRF1;TEF;NFATC3;ZBTB2;MYNN;AHR;KLF3;STAT5B;STAT4;ATF6;NR2F1;SKI;BHLHE40;E2F1;THAP1;WBP2;CEBPG;E2F3;MEF2D;HIF1A;MEF2C;TFEC;OLIG2;FOXN3;EGR1;ARNT;PROX2;CIART;RELA;ZNF569;IKZF3;ZBTB20;XBP1;ZNF319;KLF10;NFE2;SALL3;FOXJ1;FOSL2;TCF7;HMGB2;UHRF1;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;KLF2;TCF3;ZNF628;YY1;RELB;NSD1;TFCP2;KLF8;NR4A1;ZBTB12;NRIP1;KLF11;IRX5;IKZF4;SOX10;FOXJ2;ZBTB25;RARA;NFATC1;ZBTB24;SNAPC3;NR3C1;TFE3;GATA3;MYB;TCF12;PLAG1;GMEB2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.40131344725717955,-1.1243217047093816,0.3057553956834532,0.5613572135267502,1.0,12/21,35.22%,CDK6;CDK13;CDK14;CDK1;CDKL4;CDK5;CCNK;CDK20;CDKL1;CDK8;CDK12;CDK7
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.40131344725717955,-1.1243217047093816,0.3057553956834532,0.5613572135267502,1.0,12/21,35.22%,CDK6;CDK13;CDK14;CDK1;CDKL4;CDK5;CCNK;CDK20;CDKL1;CDK8;CDK12;CDK7
prerank,receptor antagonist activity (GO:0048019),-0.41548231751076825,-1.1240104524997643,0.30619469026548674,0.5596223650480299,1.0,7/17,33.02%,DKK2;CCL5;ESR2;WFIKKN1;DKK3;AGTR2;IL18BP
prerank,ATPase regulator activity (GO:0060590),-0.3510818407891615,-1.1220760493872834,0.2810344827586207,0.5616010170983357,1.0,13/38,20.57%,FNIP2;DNAJC1;ATP1B3;SIL1;DNAJA1;FNIP1;TOR1AIP1;HSPH1;BAG3;GRPEL2;MYBPC3;PLN;DNAJB6
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.4382819491744597,-1.1197887085301368,0.3176043557168784,0.5647148481082331,1.0,6/15,28.43%,CCR2;CCR1;CCRL2;CMKLR1;GPR17;XCR1
prerank,mannose binding (GO:0005537),-0.4689993899433786,-1.118833167878738,0.3291592128801431,0.564411628314056,1.0,7/12,40.75%,CLEC4D;CLEC6A;LMAN2L;ACR;LMAN2;LMAN1L;CLN5
prerank,ATP hydrolysis activity (GO:0140603),-0.3456931238427352,-1.1149107862953087,0.3010204081632653,0.5715537572781301,1.0,12/41,20.18%,ATP2B1;RNF213;ABCD2;DHX9;CHD3;KIF20B;MYO1E;KIF14;HSPA1A;DNA2;DDX3X;ABCA4
prerank,methyl-CpG binding (GO:0008327),-0.39981896743898904,-1.1141796897193716,0.3182608695652174,0.5706902959173866,1.0,8/22,19.57%,TET3;ZBTB21;CHTOP;PRMT1;UHRF1;LRWD1;ERH;WDR77
prerank,voltage-gated chloride channel activity (GO:0005247),-0.49087391521263024,-1.1133958769614412,0.33158813263525305,0.5700504414792446,1.0,2/10,6.00%,ANO6;CLCN5
prerank,potassium:proton antiporter activity (GO:0015386),-0.487577830072206,-1.1102308079213472,0.3251318101933216,0.5752377413027768,1.0,3/10,8.82%,SLC9A9;SLC9A8;SLC9A1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.32748033062262016,-1.1098817433801418,0.30017152658662094,0.5735075453173699,1.0,20/49,22.95%,OPTN;TAB2;RNF169;MINDY2;ABRAXAS1;EPS15;BABAM2;ZFAND6;PRPF8;TNIP2;UBQLN4;TNIP3;MINDY1;PARP10;BRCC3;UBXN1;PSMD4;BAG6;ZRANB1;ZRANB3
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.37710212003152865,1.1088815625583657,0.28743961352657005,0.577615586149691,1.0,7/23,12.29%,PLCB1;CHRM3;PLCH2;PLCE1;PLCZ1;PLCD3;F2RL2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.303904756732364,-1.1063301987062661,0.2697594501718213,0.5794761037420412,1.0,29/75,37.00%,DHRS3;PGD;IMPDH2;ME2;NSDHL;CBR3;CBR1;ABCC4;HSD17B7;SORD;AKR1A1;KDSR;MDH1;MDH2;RDH12;DHRS4;KCNAB3;HSD17B10;RDH10;HSD3B2;SDR42E1;PTGR1;HADH;ADH5;CBR4;DHRS11;LDHAL6B;AKR1C1;MDH1B
prerank,retinoid binding (GO:0005501),-0.39190736111053426,-1.103576246531347,0.3220338983050847,0.5834305509275775,1.0,11/22,33.95%,RXRA;RARA;ABCA4;CYP26C1;RBP4;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;RBP1
prerank,calcium channel regulator activity (GO:0005246),0.3299434020583199,1.1007468050637204,0.27710843373493976,0.5921346137116472,1.0,5/37,7.24%,NRXN1;PRKG1;NRXN2;NPY2R;CACNG4
prerank,endopeptidase activity (GO:0004175),-0.25498534936434897,-1.1001399207092446,0.22402597402597402,0.5888011325930186,1.0,81/257,25.76%,CTSB;ADAM33;CTSZ;USP12;PLAU;MALT1;USP18;MBTPS2;PSMB7;DPP4;USP8;ADAM9;PREP;PSMB9;DDI2;HGF;PITRM1;PCSK7;USP36;USP9X;RHBDF1;TPP2;ADAMTS10;RHBDF2;CTSC;CASP4;CTSH;PSMA8;KLK3;PRSS36;F7;FAP;ADAMTS18;CTSS;USP42;HTRA3;CASP7;CASP1;USP35;PSMB10;USP40;PSMA1;CD5L;ADAMTSL5;CTSE;USP30;USP11;USP7;TPP1;PSMB8;ADAM19;CASP8;MMP8;MMP17;GZMM;CASP2;F10;PSMA5;MMP27;RHBDD3;PSMB3;ADAMTS1;MMP2;SFRP1;MMP1;USP9Y;HPR;HP;MASP1;ADAMTSL3;PDIA3;ADAMTS20;ADAMTS2;FURIN;PSMB1;RCE1;PSEN2;PRTN3;ZMPSTE24;USP34;USP16
prerank,insulin-like growth factor binding (GO:0005520),-0.4347939344022607,-1.0977690469290464,0.3462214411247803,0.5918678917913108,1.0,5/15,12.21%,INSR;IGF1R;ITGAV;IGF2R;IGFBP3
prerank,peptidase inhibitor activity (GO:0030414),-0.35275003856790943,-1.0961501823949964,0.33276157804459694,0.5931980386084443,1.0,11/33,27.59%,UCHL5;TFPI;PROS1;TIMP2;CAST;CST7;CST3;SPINT2;RENBP;SIMC1;A2M
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.32167584916537306,-1.096136642097125,0.29537366548042704,0.59075481149181,1.0,10/47,14.69%,SLC38A6;SLC6A6;SLC43A2;SLC38A10;SLC7A7;SLC38A7;SLC36A4;SLC66A1;SLC7A5;SLC25A44
prerank,"DNA binding, bending (GO:0008301)",-0.431648138848503,-1.0940044554808583,0.3386243386243386,0.5934722977970817,1.0,6/14,19.44%,HHEX;TOP2A;HMGB2;TFAM;HMGB1;HMGB3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.47491599017487934,-1.0901920408618868,0.3489583333333333,0.60020522859324,1.0,4/10,12.54%,DCLRE1C;DCLRE1A;EXO1;FEN1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4803185052242974,-1.0882414832780059,0.3513986013986014,0.6025565241230852,1.0,5/10,16.94%,DSE;RPE;FUOM;GALE;GALM
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.22850106594516328,-1.088085914782581,0.16475644699140402,0.6004680946271354,1.0,137/731,18.47%,RBPJ;MITF;ZEB2;ELF4;FOXP1;RUNX1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;JUN;ZNF568;MEF2A;RUNX3;PPARD;BPTF;ZBTB34;BACH1;DNMT3A;NFE2L2;IRF2;ZNF148;NFIC;NFYA;ZSCAN12;ATF3;ELF1;UBP1;PPARG;ELK3;SPI1;ETV1;STAT3;KLF13;FOXO3;E2F2;IKZF1;LYL1;ZSCAN26;STAT6;DHX9;USF2;NFKB1;HHEX;NLRC5;RUNX2;RARG;MLXIP;IRF5;SARS1;MAF;MEF2B;KLF6;NR1H2;BATF;NRF1;TEF;NFATC3;ZBTB2;MYNN;AHR;KLF3;STAT5B;STAT4;ATF6;NR2F1;CREB3L2;SKI;BHLHE40;E2F1;THAP1;WBP2;CEBPG;E2F3;MEF2D;HIF1A;MEF2C;TFEC;OLIG2;EGR1;ARNT;PROX2;CIART;RELA;ZNF569;IKZF3;ZBTB20;XBP1;ZNF319;KLF10;NFE2;TRIM24;SALL3;FOXJ1;FOSL2;TCF7;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;KLF2;TCF3;ZNF628;YY1;RELB;NSD1;TFCP2;KLF8;NR4A1;ZBTB12;NRIP1;KLF11;IRX5;IKZF4;SOX10;FOXJ2;ZBTB25;RARA;NFATC1;ZBTB24;SNAPC3;NR3C1;TFE3;GATA3;MYB;TCF12;PLAG1;GMEB2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.43976040616317313,-1.0867309279448554,0.3542039355992844,0.6012723312863355,1.0,7/13,31.33%,SLC7A7;SLC38A7;SLC66A1;SLC15A4;SLC7A2;SLC7A4;SLC7A1
prerank,microtubule motor activity (GO:0003777),-0.3161435901860595,-1.0867061214724163,0.31272727272727274,0.5988779319000506,1.0,18/51,17.99%,KIF13B;KIF3B;KIF11;KIF16B;KIF20B;KIF23;KIF15;STARD9;KIF4A;CENPE;DNAH8;KIFC1;KIF14;KIF21B;KIF2C;KIF20A;DNAH3;KIF18B
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.38664430358949703,-1.085698624555323,0.3466003316749585,0.59867974705042,1.0,7/20,22.00%,USP50;OTUD5;USP9X;SENP3;USP7;COPS5;EIF3H
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.4360549172981896,-1.0852907037924813,0.3495798319327731,0.5972473455295322,1.0,4/13,7.83%,ITGA5;PTPRJ;ERN1;VEGFA
prerank,poly-purine tract binding (GO:0070717),-0.3642793821756154,-1.084910882202117,0.337228714524207,0.595765078971818,1.0,11/27,19.06%,RBMS1;RBPMS;PATL1;HNRNPDL;LARP4;ZC3H14;RBMS2;DAZAP1;DDX1;ATXN1;DDX3X
prerank,C-C chemokine receptor activity (GO:0016493),-0.38704160199444115,-1.0815609884212298,0.3498233215547703,0.6014017093595269,1.0,4/21,15.96%,CCR2;CCR1;CCRL2;CXCR4
prerank,Wnt-activated receptor activity (GO:0042813),0.4104235315270167,1.0813794353217863,0.34953703703703703,0.6338545600642829,1.0,6/15,20.48%,FZD8;TSPAN12;PKD1;ROR1;FZD4;FZD10
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.43975526957566674,-1.0803550360780603,0.3513986013986014,0.6018354495715907,1.0,7/13,19.99%,PIP4K2A;PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;PIP5K1A
prerank,metalloexopeptidase activity (GO:0008235),0.30723546925664263,1.080035207463523,0.337995337995338,0.6321508956463283,1.0,11/51,14.94%,METAP2;AGBL4;MMP16;TRHDE;MMP15;AGBL1;CPE;CPA2;FOLH1;METAP1;LTA4H
prerank,epidermal growth factor receptor binding (GO:0005154),0.3621390228324584,1.0773724868996415,0.3325635103926097,0.6342839874806634,1.0,6/25,9.47%,ERBB4;LINGO1;TGFA;EGF;FAM83B;AREG
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.4219072582793022,-1.0767721812338398,0.3606837606837607,0.6079359167230766,1.0,7/15,26.90%,WDR5;KMT2C;KMT2D;KMT2A;CXXC1;RBBP5;ASH2L
prerank,histone deacetylase activity (GO:0004407),-0.39148965825783366,-1.0717320339808125,0.3565217391304348,0.6176098594674737,1.0,7/19,23.03%,SIRT3;SUDS3;HDAC10;HDAC5;MIER1;SIRT2;HDAC8
prerank,cytokine receptor binding (GO:0005126),-0.28572735894691487,-1.0702749395787612,0.3103448275862069,0.618498854134407,1.0,28/83,33.38%,SDCBP;SYK;CD300LF;IL6R;PIBF1;IL18;VEGFA;JAK1;SPRED1;SPRED2;CCL5;CCRL2;IL34;IL27RA;CSF1;TNFSF9;IL6;TYK2;KITLG;IL12RB1;IL2;IL27;TRAF6;SMAD2;CCL25;CCL19;IL13RA1;ERAP1
prerank,vitamin D receptor binding (GO:0042809),-0.4396658108959123,-1.0691633360820874,0.38035714285714284,0.6187264245896562,1.0,3/14,13.54%,MED24;MED4;RXRA
prerank,steroid hydroxylase activity (GO:0008395),-0.4104895358656032,-1.068926216827159,0.3607705779334501,0.6168685972093852,1.0,6/16,29.54%,CYP27A1;CH25H;CYP46A1;CYP2R1;CYP1B1;CYP2S1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4515183378228474,1.06873974816316,0.40625,0.6506042990787688,1.0,2/10,3.01%,B3GALT1;B3GALT5
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.43607620924288104,1.0677627388928277,0.3704600484261501,0.6482881252718574,1.0,2/11,1.17%,RYR3;RYR2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.28245763101876675,1.0669817699330892,0.3114754098360656,0.6453625361410332,1.0,11/71,8.63%,PTPRD;PTPRG;PTPRN2;PTPRR;PTPRT;EYA2;PTPRK;TNS2;PTPN3;PTPRB;PTPRZ1
prerank,TBP-class protein binding (GO:0017025),-0.3812573118944289,-1.066724879608675,0.378839590443686,0.619681366300076,1.0,7/21,27.34%,GTF2A1;HHEX;AHR;DR1;GTF2A2;DRAP1;ESR1
prerank,exopeptidase activity (GO:0008238),0.3037647017148422,1.06541743723268,0.3237410071942446,0.6445098376634717,1.0,5/50,4.07%,DPP10;DPP6;METAP2;MME;TRHDE
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.3524775886988122,-1.0643763825843122,0.3787878787878788,0.6228825401076872,1.0,10/29,21.76%,PRKAG2;PKIB;INCA1;SPRED1;SPRY2;SPRED2;CIB1;CDKN2C;HSPB1;SFN
prerank,exonuclease activity (GO:0004527),-0.31733762079224465,-1.061503792838862,0.36795774647887325,0.6273352740786621,1.0,19/46,21.68%,DCLRE1C;RAD1;REXO5;ISG20L2;REXO4;EXOSC5;EXD1;WRN;EXO1;FEN1;APLF;RAD9A;EXOSC10;ENPP1;CPSF3;ZC3H12A;EXOSC4;FAN1;XRN2
prerank,general transcription initiation factor binding (GO:0140296),-0.3646254730279993,-1.0609674985277,0.3924268502581756,0.6261903985552387,1.0,8/25,27.34%,GTF2A1;HHEX;AHR;RELA;DR1;GTF2A2;DRAP1;ESR1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.46021239449578144,-1.0588936852713724,0.40585009140767825,0.6287449190187211,1.0,7/10,25.58%,PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;ATM;PIK3C2G
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.4213245970912646,-1.0588087686704748,0.39008264462809916,0.626562443257221,1.0,6/14,17.05%,OTUD5;MINDY2;USP9X;ATXN3;USP7;MINDY1
prerank,cation transmembrane transporter activity (GO:0008324),-0.31596135839250467,-1.0551650722996155,0.3603448275862069,0.6328543033306119,1.0,24/48,38.51%,SLC38A6;SLC6A6;MFSD12;SLC38A7;SLC36A4;SFXN2;SLC66A1;SLC7A5;SFXN1;SLC6A9;SLC38A2;SLC8B1;SLC15A4;SLC22A3;SLC7A2;SLC36A3;SLC7A1;SLC38A9;SLC7A8;ATP1B4;SLC38A5;SLC22A2;SLC6A14;SLC29A4
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.4033753315999832,1.0549382086478107,0.4028776978417266,0.666128486865745,1.0,3/15,13.06%,SLC26A3;SLC4A11;SLC26A8
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.36331258278851586,1.0537206153305403,0.3844282238442822,0.6642659648705569,1.0,3/21,3.41%,AKAP6;RYR2;WASF1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.35195643373100605,-1.0535602295897852,0.3754325259515571,0.6343216674360308,1.0,16/29,39.01%,ACER3;HPSE;GUSB;NEU1;PGGHG;GANC;ADPRS;CTBS;GANAB;PARG;ACER2;GALC;MGAM;CHIT1;LCT;NEU3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.44853926369013614,-1.0527106063067961,0.407871198568873,0.6338924921470602,1.0,4/11,23.16%,SGMS1;GNPTAB;SAMD8;AASDHPPT
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.43651727944567426,1.0516296942653862,0.40046838407494145,0.6647756912943515,1.0,4/10,13.04%,IDE;ANKRD13A;FAAP20;DNAJB2
prerank,phosphatase binding (GO:0019902),-0.2698116028868238,-1.0456722324417145,0.3654485049833887,0.6485761178829963,1.0,22/105,13.77%,IQGAP1;MAP3K5;SNX3;STAT3;CD22;STAT6;MTMR3;MAPK14;TRAF3;MVP;CTNNB1;VRK3;SIRPA;CTSC;JAK1;SPRED1;STYXL1;LCK;PPP6R3;HSP90B1;TRAF2;MAST2
prerank,insulin-like growth factor I binding (GO:0031994),-0.42688560305254897,-1.0432134877306578,0.403747870528109,0.6518030534845131,1.0,4/13,12.21%,INSR;IGF1R;ITGAV;IGFBP3
prerank,galactosyltransferase activity (GO:0008378),-0.4402435992250306,-1.0394250102185048,0.42560553633217996,0.6589832800100393,1.0,4/11,19.30%,B4GALT5;B4GALT7;B4GALT3;B4GALT1
prerank,ephrin receptor binding (GO:0046875),-0.37925673323731485,-1.0381941530297447,0.4115586690017513,0.6594668593647843,1.0,4/21,6.59%,LYN;GRB2;CBL;PIK3CG
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.21629800241252037,-1.0367873381801138,0.30071942446043165,0.6605489595558699,1.0,177/831,22.11%,RBPJ;MITF;ZEB2;ELF4;FOXP1;RUNX1;TRPS1;BACH2;TFEB;TCF4;RREB1;REL;LITAF;BCL6;RB1;JUN;ZNF568;MEF2A;ETV6;RUNX3;PPARD;BPTF;ZBTB34;BACH1;DNMT3A;NFE2L2;IRF2;ZNF148;NFIC;NFX1;NFYA;ZSCAN12;ATF3;ELF1;UBP1;PPARG;ELK3;SPI1;GTF2A1;ZNF3;ETV1;STAT3;KLF13;FOXO3;E2F2;IKZF1;LYL1;ZSCAN26;STAT6;DHX9;USF2;NFKB1;HHEX;NLRC5;RUNX2;RARG;MLXIP;IRF5;SARS1;MAF;MEF2B;KLF6;NR1H2;CUX1;BATF;NRF1;TEF;NFATC3;ZBTB2;MYNN;KLF3;STAT5B;STAT4;ATF6;NR2F1;SKI;BHLHE40;E2F1;THAP1;WBP2;CEBPG;E2F3;MEF2D;HIF1A;MEF2C;TFEC;OLIG2;EGR1;ARNT;PROX2;CIART;RELA;ZNF569;IKZF3;ZBTB20;XBP1;ZNF319;OSR1;KLF10;PRDM2;NFE2;SALL3;FOXJ1;ZFP57;FOSL2;TCF7;ZFP41;HDAC5;TGIF1;SP2;DHX36;RXRA;FOXJ3;CALCOCO1;E2F8;TFAP4;BATF3;KLF2;ZBTB46;TCF3;ZNF628;YY1;RELB;NSD1;TFCP2;KLF8;ZNF177;NR4A1;ZBTB12;NRIP1;KLF11;IRX5;IKZF4;SOX10;FOXJ2;ZBTB25;RARA;NFATC1;ZBTB24;ATF5;SNAPC3;NR3C1;TFE3;GATA3;MYB;RPS3;TCF12;PLAG1;GMEB2;CASZ1;MEIS3;HOXD8;MAX;SP9;EHF;CIC;ZFP28;MAZ;PKNOX1;ATF7;STAT1;ZFP2;POU3F1;GTF2IRD1;LRRFIP1;ZSCAN21;HOXB2;ZKSCAN1;ZBTB7A;TBX2;HEYL;SNAI2;CEBPB;EGR2;BBX;ZNF296;BARX2
prerank,microtubule minus-end binding (GO:0051011),-0.41862421519977616,-1.0354693509975865,0.4036697247706422,0.6612527098172808,1.0,7/13,26.81%,MACF1;TUBGCP4;HAUS4;HAUS7;CAMSAP2;TUBGCP2;CAMSAP1
prerank,tropomyosin binding (GO:0005523),0.39082798659802986,1.0352035518783689,0.41876430205949655,0.7013316798237901,1.0,4/16,11.26%,SMTNL2;NEBL;TNNT2;CALD1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4390681333744039,-1.0344677245167524,0.43760399334442596,0.6611691073456325,1.0,5/11,37.91%,PADI4;ARG2;ARG1;AGMAT;PADI1
prerank,chemokine receptor activity (GO:0004950),-0.36214026623719775,-1.0333499754882767,0.40608228980322003,0.6614617980753799,1.0,11/24,38.99%,CCR2;CCR1;CCRL2;CXCR4;CMKLR1;GPR17;XCR1;CXCR2;ACKR3;CCR7;CCR9
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.4251190835142417,1.0330394251068487,0.42488262910798125,0.7015365896991343,1.0,2/11,2.25%,TRPC5;TRPC1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.3483030080182702,-1.0314863958688318,0.40619621342512907,0.6635124457332695,1.0,3/26,4.06%,SLC16A7;SLC6A6;SLC27A1
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.3493328673746904,-1.0309803283806216,0.41421143847487,0.6622392000035906,1.0,9/27,21.10%,POLR2F;POLR2L;POLR2A;POLR3B;POLR2G;POLR1F;POLR3A;MED20;POLR2I
prerank,DNA replication origin binding (GO:0003688),-0.3599079530007345,-1.0303119471369775,0.4466338259441708,0.6613586216072082,1.0,9/23,24.41%,DHX9;MCM6;MCM9;MCM3;ORC5;KAT7;MCM2;CDC45;MCM5
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3681703557336269,-1.0287151523259,0.4546952224052718,0.662863607905871,1.0,5/22,14.35%,APOE;PICALM;DNAJA1;HSP90B1;ANKRA2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2729734474689021,1.0281841133823169,0.3970223325062035,0.7088824146710183,1.0,17/72,15.09%,FRMPD4;PLCB1;PARD3;SNAP91;MARK1;TIRAP;PLA2G4E;SNX21;PLCZ1;AMER2;GSN;GSDMD;SYT7;SYTL2;OSBPL2;MYO1B;RPH3A
prerank,methylated histone binding (GO:0035064),-0.29032496891249815,-1.0281637662077978,0.39603960396039606,0.6618615037779265,1.0,21/62,27.23%,BPTF;NCAPG2;KDM7A;DPF2;WDR5;MORC3;TRIM24;SPIN1;CHD8;UHRF1;NCAPD3;LRWD1;ZMYND8;CXXC1;PHF13;MORC4;RRP8;CDYL;RBBP5;CBX8;CBX2
prerank,single-stranded RNA binding (GO:0003727),-0.3091369112156447,-1.027282741784806,0.42857142857142855,0.661429739415122,1.0,13/43,20.54%,TLR8;AGO2;TLR7;DHX58;DHX9;DDX60;CNBP;PUS1;POLR2G;HNRNPA1;EXOSC10;DDX3X;RBM11
prerank,ribonuclease P activity (GO:0004526),0.4238743045584059,1.025749364360331,0.4105011933174224,0.7101452080614761,1.0,6/11,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,C-C chemokine binding (GO:0019957),-0.3653363575354812,-1.0252773089244196,0.40463458110516937,0.6637601716649273,1.0,10/22,39.18%,CCR2;CCR1;CCRL2;CXCR4;XCR1;CXCR2;ACKR3;CCR7;CCR9;ZFP36
prerank,calcium-dependent phospholipid binding (GO:0005544),0.28774235825432604,1.0237380903917603,0.38106796116504854,0.7104046077004995,1.0,14/49,15.09%,SYT1;PCLO;SYT10;SYT2;CPNE4;SYT5;PLA2G4E;SYT11;SYT12;CPNE8;DYSF;SYT7;MCTP2;RPH3A
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.4002639969471154,1.02255540247721,0.44495412844036697,0.7084824253546808,1.0,3/12,5.08%,BMPR1B;ACVR1;LTBP1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.329444405688518,-1.021777106224958,0.43134087237479807,0.6695301665535518,1.0,9/34,16.75%,BIRC6;UBE2R2;UBE2L3;UBE2H;UBE2G1;UBE2T;CDC34;UBE2C;UBE2I
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.33291618488669644,-1.0216290851006293,0.4166666666666667,0.6674777671871632,1.0,8/31,16.52%,BIRC6;UBE2R2;UBE2L3;UBE2H;UBE2G1;UBE2T;CDC34;UBE2C
prerank,mRNA 5'-UTR binding (GO:0048027),-0.35265370632101045,-1.0190734969079787,0.45320197044334976,0.6713624852241351,1.0,9/24,25.77%,RPS14;RPS13;MRPS11;DHX36;NCL;DDX3X;SHMT1;RPL41;RPL5
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4258429210762764,1.0189214265803053,0.42168674698795183,0.7125691205581841,1.0,3/11,21.97%,PPP1R14C;PABIR1;PPP1R17
prerank,alpha-tubulin binding (GO:0043014),-0.3337194079470718,-1.0161682957120381,0.43189964157706096,0.676145953611188,1.0,8/31,14.84%,ARL8B;ARL8A;EML4;EFHC2;TAOK1;TBCE;RACGAP1;INO80
prerank,signal sequence binding (GO:0005048),-0.3260171925846316,-1.0156443101775716,0.43865546218487395,0.6751831977251611,1.0,10/35,23.01%,KPNA4;IPO5;BABAM2;TIMM22;KPNA3;BRAP;NUP153;CAT;TOMM20L;TOMM70
prerank,protein tyrosine kinase activity (GO:0004713),-0.26631621341555045,-1.0151278020054673,0.406807131280389,0.6741546546271108,1.0,27/108,18.61%,LYN;FGR;SYK;AXL;INSR;IGF1R;PEAK1;FES;ABL2;DYRK2;TEC;FLT1;PTK2B;PKDCC;CAMKK2;JAK1;LCK;DYRK1A;ITK;FRK;TXK;TTK;ZAP70;WEE1;RYK;HCK;PDGFRB
prerank,neuropeptide receptor binding (GO:0071855),0.39576958800253703,1.01409277561236,0.44675925925925924,0.7200488814173025,1.0,3/14,12.32%,APLN;GHRH;NTS
prerank,mRNA 3'-UTR binding (GO:0003730),-0.2755040418613081,-1.0131938470587827,0.4260731319554849,0.6763310278379959,1.0,29/79,27.04%,RBMS1;RC3H1;RNF20;SECISBP2;PUM2;LARP4B;DDX5;LARP4;NUDT21;CELF1;BOLL;DHX36;RBMS2;DAZAP1;RNPS1;ZC3H12A;CPEB4;EXOSC4;RPL41;TARDBP;PUM1;PABPC1L;PCBP4;CPSF1;RNF40;RPL5;ANGEL2;ZFP36L1;EXOSC8
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.41662344259207396,-1.0121015633916866,0.44851657940663175,0.6765409068551546,1.0,6/12,19.63%,PIK3CB;PIK3CG;PIK3CA;PIK3CD;PIK3C2A;ATM
prerank,nuclear receptor coactivator activity (GO:0030374),-0.29567176101287906,-1.009969364356877,0.4232081911262799,0.6793095503038199,1.0,14/52,21.40%,ZMIZ1;PRKCB;SS18;MED24;RNF4;HELZ2;MED4;RBM14;CALCOCO1;ZMIZ2;PPARGC1B;NCOA6;WDR77;KDM1A
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.38630057601820916,-1.005401362963467,0.45486725663716815,0.6878694647625312,1.0,7/16,19.08%,CD38;MACROD1;NEIL3;BST1;NEIL2;RPS3;ADPRS
prerank,translation elongation factor activity (GO:0003746),-0.4008502373429283,-0.9998466809306809,0.4507512520868113,0.6984671449237857,1.0,6/14,18.59%,TUFM;EEF1B2;EEF2;GTPBP1;EEF1A1;GTPBP2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.30471749685920707,0.9993727123251008,0.4538834951456311,0.7542013889902526,1.0,6/38,11.93%,SPOCK1;SERPINI1;SERPING1;SERPINB5;WFDC3;SERPINE3
prerank,leak channel activity (GO:0022840),0.3585511582091507,0.9990708459777405,0.4636363636363636,0.7499878555893866,1.0,4/18,10.81%,KCNK10;NALCN;KCNK2;TMEM175
prerank,FMN binding (GO:0010181),-0.41906705289443563,-0.9988073221903508,0.4880546075085324,0.6985911338900768,1.0,6/11,39.07%,POR;PNPO;NOS2;HAO1;NDOR1;PPCDC
prerank,NADP binding (GO:0050661),0.31084941347015393,0.9985091017406821,0.4470588235294118,0.7464211620946625,1.0,13/32,23.35%,CRYZ;DPYD;ME3;DHCR7;HSD11B1;DHFR;ME1;CRYZL1;DUS2;KCNAB1;GMDS;GRHPR;NOS1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.38798246123720354,0.9985084567128494,0.4666666666666667,0.741510496554566,1.0,6/14,16.37%,CAPN3;CAPN10;CAPN6;CAPNS2;CAPN5;CAPN2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.31747999303109203,-0.9982046783516869,0.4675324675324675,0.6977085974680984,1.0,15/37,33.99%,RARS1;FARS2;SARS1;CARS2;DARS1;KARS1;TARS2;AARS1;DARS2;IARS1;EARS2;TARS3;WARS2;VARS2;RARS2
prerank,methylation-dependent protein binding (GO:0140034),-0.28741523385273626,-0.998040283160988,0.4543918918918919,0.6956998472529146,1.0,20/57,27.23%,BPTF;NCAPG2;KDM7A;WDR5;MORC3;TRIM24;SPIN1;CHD8;UHRF1;NCAPD3;LRWD1;ZMYND8;CXXC1;PHF13;MORC4;RRP8;CDYL;RBBP5;CBX8;CBX2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.3158694955324676,-0.996268154905378,0.4406196213425129,0.6977890067211839,1.0,18/34,35.13%,NSD3;SMYD2;SMYD3;EZH2;KMT5B;SMYD1;SETDB1;DOT1L;KMT5A;EEF2KMT;SETD6;METTL21A;TTLL12;SETD7;SETD2;ETFBKMT;ANTKMT;SETD4
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.4208345147067654,0.9906079226283205,0.46522781774580335,0.7569268138747453,1.0,4/10,20.57%,SLC6A1;SLC6A13;SLC6A11;SLC10A1
prerank,kinesin binding (GO:0019894),-0.33515609879526653,-0.9902756188987716,0.4757785467128028,0.7094358720893251,1.0,10/27,20.29%,PLEKHM2;ACTB;ARHGEF10;AP1G1;NEK6;RAB29;SPAG9;KIF18B;FAM83D;PRC1
prerank,sulfotransferase activity (GO:0008146),0.31136775309460946,0.9893115529473502,0.4567307692307692,0.7555056913508414,1.0,8/33,13.79%,GAL3ST3;HS3ST1;CHST5;CHST7;CHST9;CHST8;CHST14;SULT4A1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3101773006819747,0.984644298782034,0.4740740740740741,0.7626054301309125,1.0,6/29,13.06%,SLC1A6;SLC26A3;SLC1A1;SLC13A5;SLC25A11;SLC26A8
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2976656514318124,0.9829872969492952,0.45011600928074247,0.7621214574898786,1.0,3/38,0.80%,MAGI2;SORBS1;GRIP1
prerank,protein tyrosine kinase binding (GO:1990782),-0.27331847836129936,-0.9826382639365143,0.5035335689045937,0.7252305345225005,1.0,18/71,14.50%,NEDD9;BANK1;CBL;RNF41;ITGB1;BLNK;PITPNM1;DUSP3;GAS6;SIRPA;FIZ1;ANGPT2;ITGAX;CRK;PCNA;CPNE3;TJP2;CBLB
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.40180272321749394,-0.9815751382721613,0.4802065404475043,0.7252185762182396,1.0,6/12,25.82%,TENT5A;MTPAP;TENT5C;TENT4B;PAPOLA;TENT5D
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.28189774948147317,0.9807673939303337,0.4822222222222222,0.7632441244185371,1.0,7/46,9.73%,MGAT4C;B3GALT1;B3GALT5;HEXB;MGAT3;EXTL1;B3GNT5
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.40381953472124343,0.9793207297713175,0.47494033412887826,0.7621535174897176,1.0,2/11,10.58%,HCN2;HCN1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.39826487768511176,-0.9762920979243799,0.5017182130584192,0.7353836027665944,1.0,3/12,16.06%,DDI2;CTSE;HM13
prerank,ATPase binding (GO:0051117),-0.27203784220990396,-0.9757353190252699,0.49572649572649574,0.7343447844441312,1.0,20/71,19.56%,ABCA1;SNX10;ATP6V1E1;TCIRG1;PEX26;ATP1B3;NR1H2;WFS1;ATXN3;SELENOS;ATP6V1G1;DERL1;LCK;BBC3;TOR1AIP1;NUFIP1;TAF9;RALB;UBXN1;PLN
prerank,microtubule plus-end binding (GO:0051010),0.3483853349656878,0.9742368789883343,0.47815533980582525,0.7708638538494998,1.0,4/20,6.90%,MAPRE3;DST;CLASP2;CLIP4
prerank,kinase activity (GO:0016301),-0.2480136757032619,-0.9730311851694479,0.5192629815745393,0.7382769479407438,1.0,30/109,21.91%,LYN;ITPKB;DGKZ;CSNK2A1;PANK2;NADK;PIK3CB;PIK3CG;DGKD;PI4KB;COQ8A;MASTL;POMK;TAOK1;SEPHS1;PIK3CA;PRKD3;PIK3CD;PDXK;PIK3C2A;NADK2;DGKG;PAPSS1;SPHK2;PGK1;IP6K3;NMRK1;GSK3B;CDK5;MAP4K4
prerank,palmitoyltransferase activity (GO:0016409),-0.32743050349834635,-0.9718252648864409,0.5024793388429752,0.7386919245656371,1.0,10/28,24.44%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;ZDHHC5;GOLGA7;HHAT;ZDHHC13;ZDHHC6
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.33461385568807767,-0.9699782007342295,0.4882943143812709,0.7408332382520253,1.0,5/23,10.92%,SH3PXD2B;SNX3;KIF16B;HIP1;SESTD1
prerank,transforming growth factor beta binding (GO:0050431),-0.3376962611127702,-0.9692479576206366,0.5080500894454383,0.7400953611989705,1.0,7/23,17.00%,CD36;NRROS;ITGAV;TGFBR1;LTBP4;TGFBR2;VASN
prerank,actin binding (GO:0003779),-0.2347462311891701,-0.9691560961890986,0.5384615384615384,0.7378914696672516,1.0,52/170,23.93%,IQGAP2;MTSS1;PHACTR2;MYH9;MYO9B;MYO1F;EPS8;CAPZB;GAS2L3;FXYD5;ABL2;PARVB;ITGB1;MACF1;CAP1;UTRN;NRAP;LIMA1;CORO7;LCP1;MSRB1;MICAL1;CCDC88A;ARPC1A;MICAL2;MAEA;SSH3;CAPZA1;SPEF1;TMSB4X;MAP1S;COTL1;ANG;SSH1;CXCR4;TWF2;PDLIM2;NOD2;SYNPO;TNNT3;MYL4;PDLIM5;RUSC1;FLII;VPS16;PHACTR4;MEFV;PDLIM1;HPCA;P4HB;SMTN;SYNE2
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.23904697573920014,-0.9677657069538842,0.5136876006441223,0.7388409154415956,1.0,52/134,34.11%,SLC16A7;SLC38A6;CD36;SLC6A6;MFSD12;SLC27A1;SLC25A24;SLC35D2;SLC38A7;SLC36A4;CTNS;SFXN2;ABCC1;SLC25A42;SLC25A25;SLC66A1;ABCC4;SLC7A5;SFXN1;SLC23A1;SLC23A2;SLC6A9;SLC6A8;SLCO5A1;SLC38A2;SLC16A1;SLC25A22;SLC52A2;SLC15A4;SLC25A13;SLC35B3;SLC22A3;SLC17A9;SLC25A18;SLC52A1;PDPN;SLC7A2;SLC4A1;SLC35B1;SLC26A4;SLC2A2;SLCO1B1;SLC4A8;SLC36A3;SLC7A1;SLC19A1;GJA1;SLC38A9;SLC25A17;SLC26A7;SLC7A8;SLC25A1
prerank,serine-type peptidase activity (GO:0008236),-0.25118254936644996,-0.9671939631415555,0.5538720538720538,0.737789593497243,1.0,31/96,29.48%,PLAU;DPP4;PREP;HGF;PCSK7;RHBDF1;RHBDF2;CTSH;KLK3;PRSS36;F7;FAP;HTRA3;CD5L;TPP1;MMP8;GZMM;F10;RHBDD3;MMP2;HPR;HP;MASP1;FURIN;PRTN3;TMPRSS7;ACR;F11;PRSS53;GZMK;KLK9
prerank,histone acetyltransferase activity (GO:0004402),-0.3158992680721803,-0.9671056039782986,0.48947368421052634,0.7356216488718241,1.0,11/30,29.43%,CREBBP;ARRB1;NAA50;KAT7;BAZ1A;EPC1;TAF9;TADA3;CLOCK;EP300;EPC2
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3757360892567528,-0.9662083485457015,0.5135135135135135,0.7351986173688049,1.0,7/15,27.91%,COX4I1;COX10;COX8A;NDUFA4;CYB5A;COX5A;COX6A2
prerank,receptor tyrosine kinase binding (GO:0030971),-0.28382133987834585,-0.9658651593989112,0.5305755395683454,0.7336304132863448,1.0,20/56,21.87%,GAB2;CBL;RNF41;BLNK;STAP1;PITPNM1;DUSP3;GAS6;FIZ1;FRS2;ANGPT2;ITGAX;PCNA;CPNE3;CBLB;TOB1;TRADD;PTPN1;RACK1;SOCS5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3801391152564381,-0.9644828184345996,0.4838709677419355,0.7342904924125115,1.0,4/15,14.49%,SH3PXD2B;SNX3;SESTD1;PLA2G4A
prerank,nucleotidyltransferase activity (GO:0016779),-0.3597590620832691,-0.9638125453999349,0.506993006993007,0.7335433971486438,1.0,6/19,17.98%,CGAS;TUT7;MTPAP;MOCS3;PAPSS1;TENT4B
prerank,channel activity (GO:0015267),-0.29516957291490065,-0.9632350577734633,0.5304347826086957,0.7325918102861606,1.0,10/41,28.54%,BCL2;MCUB;PANX1;TMEM120B;KCNK3;MPV17;TRPV2;PRF1;PDPN;AQP1
prerank,growth factor receptor binding (GO:0070851),-0.2532619687055225,-0.9629049195986017,0.5499181669394435,0.7311526119934915,1.0,12/95,8.26%,GRB2;SDCBP;SNX2;ITGA5;PTPRJ;ERN1;CD300LF;IL6R;PIBF1;HIP1;VEGFA;FRS2
prerank,telomerase RNA binding (GO:0070034),-0.34579935812031254,-0.9621838694383262,0.5111876075731497,0.7305576911768742,1.0,7/22,18.95%,TEP1;DCP2;DHX36;GAR1;TENT4B;WRAP53;EXOSC10
prerank,snRNA binding (GO:0017069),-0.2932991870243504,-0.961301882259687,0.5157116451016636,0.7303257915988093,1.0,20/42,42.10%,SNRNP35;COIL;SF3B3;PRPF8;SNRPA;SART3;SNRNP70;SNU13;RBM22;DDX39B;LARP7;ISG20;TUT1;SNRPA1;SNRPD3;LSM8;DDX21;MEPCE;RBM41;NCBP2
prerank,protein phosphatase 2A binding (GO:0051721),0.3300764581505612,0.9602012357055453,0.48661800486618007,0.8025728142670726,1.0,4/23,8.49%,ADCY8;GRIN3A;BOD1;SMG5
prerank,tau protein binding (GO:0048156),-0.2952966839650419,-0.9565469456732445,0.5346869712351946,0.7388662884122077,1.0,10/40,13.94%,APOE;ROCK1;ACTB;PICALM;TAOK1;PIN1;DCTN1;DYRK1A;HSP90AB1;MARK2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3316570411617568,0.9535488513051716,0.5404761904761904,0.8148095283123367,1.0,4/21,15.88%,GRIK2;CHRNA5;CHRNA7;P2RX6
prerank,dynactin binding (GO:0034452),0.38176132573599014,0.9500444981137135,0.5150812064965197,0.8191023472363186,1.0,3/12,7.08%,BICD1;BICDL1;HOOK3
prerank,FAD binding (GO:0071949),-0.3323067073409389,-0.948339752874404,0.5470383275261324,0.7555130998368041,1.0,9/24,24.96%,CYB5R1;CYB5R3;KMO;MICAL1;MICAL2;MTHFR;NQO2;QSOX1;CYB5R2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.26316698126133903,-0.9462170662698814,0.5669421487603306,0.7581347166305358,1.0,25/69,30.71%,CREBBP;ZDHHC7;ZDHHC8;ZDHHC2;DGAT1;ZDHHC12;PLA2G4A;PLAAT3;MCAT;PLAAT1;ZDHHC1;ZDHHC5;NAA16;LPCAT3;ESCO2;HHAT;ZDHHC13;NMT1;ZDHHC6;CERS3;PLA2G15;EP300;SCP2;LPCAT4;AWAT2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.3949259850360652,0.941348376810246,0.5255474452554745,0.8371740180446552,1.0,4/10,13.04%,IDE;ANKRD13A;FAAP20;DNAJB2
prerank,protein kinase inhibitor activity (GO:0004860),-0.28825460014706705,-0.9410527339521031,0.5827814569536424,0.7677164173200618,1.0,11/42,18.28%,TAOK3;IBTK;TRIB1;SPRED1;SPRY2;SPRED2;CIB1;GMFG;GMFB;DNAJC3;SOCS3
prerank,aminopeptidase activity (GO:0004177),0.31682244404668497,0.9403464841412261,0.541860465116279,0.8346634061468932,1.0,4/26,5.66%,METAP2;MMP16;TRHDE;MMP15
prerank,gamma-tubulin binding (GO:0043015),0.3280002432060316,0.9400859465617047,0.530373831775701,0.8302402467475978,1.0,11/21,22.31%,ARHGEF7;BRSK1;CDK5RAP2;NDRG1;TUBGCP5;RAD51D;TUBGCP3;DIXDC1;B9D2;PAK1;BRCA2
prerank,calcium channel inhibitor activity (GO:0019855),-0.40178517554457027,-0.9392227738747163,0.5559380378657487,0.7695560689327503,1.0,2/11,5.41%,ITPR1;MCUB
prerank,ion gated channel activity (GO:0022839),0.31343626324251345,0.9390665898250691,0.5615763546798029,0.8277390169638974,1.0,4/24,7.83%,KCNT2;ANO4;ANO3;ANO5
prerank,chloride transmembrane transporter activity (GO:0015108),0.3513713224041705,0.9338285985935706,0.5327102803738317,0.8361322626604122,1.0,4/16,13.06%,SLC26A3;SLC1A1;SLC12A5;SLC26A8
prerank,chloride channel inhibitor activity (GO:0019869),-0.40372739400921787,-0.9336779786134131,0.5616197183098591,0.7800567879904159,1.0,2/10,5.15%,STX7;STX8
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.40877344310312275,-0.9329541536191004,0.5581787521079258,0.779274919804702,1.0,4/10,17.01%,OTUD5;ATXN3;OTUD4;STAMBPL1
prerank,CoA-ligase activity (GO:0016405),0.35294640687578555,0.9286835729292624,0.5803571428571429,0.8442605480643759,1.0,4/14,20.05%,SLC27A2;ACSS2;ACSM3;ACSS1
prerank,glutathione transferase activity (GO:0004364),0.3140733119733858,0.9277311803673794,0.5540838852097131,0.8417720284867874,1.0,8/23,22.42%,GSTZ1;GSTP1;GSTK1;GSTM5;LANCL1;GSTA4;GSTT1;GSTT2
prerank,phospholipase activity (GO:0004620),0.25230985859251376,0.9265269392981526,0.5980392156862745,0.8395982089399483,1.0,9/67,6.71%,PLCL1;ENPP2;PITPNM3;ABHD16A;ABHD3;GDPD1;PLCE1;PLA2G4E;FAM83B
prerank,poly(A) binding (GO:0008143),-0.33045424869350226,-0.9262990371636807,0.5757071547420965,0.7926192877051718,1.0,8/21,19.06%,RBMS1;RBPMS;HNRNPDL;LARP4;ZC3H14;RBMS2;DDX1;DDX3X
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.24785702087822165,-0.9256348080939033,0.594306049822064,0.7918305540091995,1.0,26/85,28.32%,LIPA;AOAH;ABHD12;PAFAH2;DAGLB;PNPLA7;LPL;ABHD5;PLA2G7;PLA2G4A;PLAAT3;TARS2;PON2;PGLS;PLAAT1;PLA2G6;AARS1;PLA2G12A;LYPLA1;PGAP1;LIPE;PON3;ESD;PLA2G15;LCAT;NOTUM
prerank,tau-protein kinase activity (GO:0050321),-0.331904157799217,-0.9230977535674177,0.5839285714285715,0.7952561562218541,1.0,10/20,27.63%,ROCK1;PHKG2;TAOK1;DYRK1A;MARK2;TAOK2;GSK3B;CDK5;SIK3;MARK4
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.3447892056795844,-0.9225303910726709,0.5451263537906137,0.7942071169054831,1.0,13/17,43.04%,ACOT9;ACOT13;ACAA2;PLA2G6;ACOT2;ACOT4;PPT1;ACOT11;ACOT6;BAAT;ACSBG2;THEM4;ACOT1
prerank,pre-mRNA binding (GO:0036002),-0.30717400746352885,-0.9208669937480974,0.584055459272097,0.7956408573141769,1.0,10/28,26.35%,TRA2B;HNRNPL;DDX5;PRPF8;CELF1;ZRSR2;HNRNPA1;SLU7;RBM22;U2AF2
prerank,kinase inhibitor activity (GO:0019210),-0.297534720177795,-0.9202318254611079,0.5986733001658375,0.7947131544619311,1.0,10/33,27.04%,TAOK3;LRP6;TRIB1;GMFG;GMFB;DNAJC3;SOCS3;ITPRIP;NCK1;SH3BP5
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.40456364102107784,-0.9166066072965663,0.6185567010309279,0.800741976742119,1.0,4/11,17.06%,SLC5A11;SLC5A3;SLC23A1;SLC23A2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3013518844088836,-0.9141946233006705,0.6021314387211367,0.8039407179663218,1.0,8/28,17.36%,MAPKAPK3;SGK1;MAPK14;MAP2K5;MAP2K1;TTK;AURKA;MAP2K3
prerank,UDP-glycosyltransferase activity (GO:0008194),0.24513296326710543,0.913424667909242,0.6401985111662531,0.8675530932594645,1.0,5/70,3.49%,MGAT4C;B3GALT1;CHSY3;B3GALT5;HEXB
prerank,MAP kinase kinase activity (GO:0004708),0.34830818781666706,0.9098062668206981,0.5995525727069351,0.8714962218153494,1.0,4/15,5.84%,MAPK10;PAK3;MAP2K6;MAP2K7
prerank,nuclear export signal receptor activity (GO:0005049),-0.38620261300313585,-0.9060769647492669,0.589605734767025,0.8195508385437156,1.0,3/11,10.33%,NUP42;XPO6;XPO5
prerank,BMP binding (GO:0036122),-0.38305616052092883,-0.9057291103496621,0.5905096660808435,0.8178380730023386,1.0,4/11,27.20%,GREM1;BMPR2;GREM2;ENG
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.31916853904763404,0.9048819317926126,0.6027713625866051,0.8782035114538365,1.0,1/20,0.06%,DLG2
prerank,potassium ion leak channel activity (GO:0022841),0.33942392322522175,0.9045100323283518,0.5951327433628318,0.8741971171873827,1.0,5/15,20.05%,KCNK10;KCNK2;TMEM175;KCNK12;KCNK1
prerank,carboxypeptidase activity (GO:0004180),-0.2862381513872645,-0.9041415887885886,0.596964586846543,0.8190219568000814,1.0,4/35,5.55%,CTSZ;PEPD;CTSA;MINDY2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.37631704776542035,-0.903599273417526,0.6094570928196147,0.8153538527421651,1.0,6/11,32.42%,SIL1;HSPH1;BAG3;GRPEL2;PFN1;HSPBP1
prerank,adenyl nucleotide binding (GO:0030554),-0.37631704776542035,-0.903599273417526,0.6094570928196147,0.8153538527421651,1.0,6/11,32.42%,SIL1;HSPH1;BAG3;GRPEL2;PFN1;HSPBP1
prerank,sodium:proton antiporter activity (GO:0015385),-0.3905891408408225,-0.9033749877200764,0.594306049822064,0.8134437430021203,1.0,3/11,8.82%,SLC9A9;SLC9A8;SLC9A1
prerank,NF-kappaB binding (GO:0051059),-0.31292148827626376,-0.9031087025448772,0.5964285714285714,0.8115933570308167,1.0,8/24,23.33%,ANXA4;RELA;RNF25;TAF4B;FAF1;GSK3B;MTDH;SETD6
prerank,death receptor activity (GO:0005035),-0.3695789901792718,-0.8987008957121391,0.5634782608695652,0.8185498916073086,1.0,6/11,39.50%,TNFRSF1B;TNFRSF25;NGFR;TNFRSF14;EDA2R;TNFRSF11A
prerank,symporter activity (GO:0015293),0.3722843690084354,0.8974574606183962,0.5515587529976019,0.8861101248990244,1.0,2/10,10.94%,SLC4A4;MFSD2A
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.27662777605209626,-0.8970758374537531,0.6192109777015438,0.8195470774841997,1.0,13/42,24.92%,CCNL1;CCND3;CCNY;INCA1;CCNL2;CCNE1;CDKN2C;CNPPD1;CCNK;CCNF;CCNB1;CKS2;CCNB2
prerank,sialyltransferase activity (GO:0008373),0.32072799347774755,0.8961721173654126,0.5889724310776943,0.8841326466052435,1.0,8/20,19.83%,ST8SIA2;ST8SIA3;ST6GAL2;ST6GALNAC3;ST3GAL6;ST8SIA1;ST8SIA5;ST6GALNAC5
prerank,serine-type endopeptidase activity (GO:0004252),-0.23829551733038826,-0.8949117657762571,0.6769983686786297,0.8218512421240982,1.0,34/80,36.86%,PLAU;DPP4;HGF;PCSK7;RHBDF1;RHBDF2;CTSH;KLK3;PRSS36;F7;FAP;CD5L;MMP8;GZMM;F10;RHBDD3;MMP2;HPR;HP;MASP1;FURIN;PRTN3;ACR;F11;PRSS53;KLK9;F12;RHBDD1;MMP9;GZMB;GZMA;PRSS56;PRSS38;TMPRSS3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3122633660260772,0.8945329708604808,0.5851318944844125,0.8830097094536313,1.0,3/18,5.08%,BMPR1B;ACVR1;LTBP1
prerank,lysophospholipase activity (GO:0004622),0.318211330277228,0.8943643346338221,0.6347438752783965,0.878414063760013,1.0,3/20,6.05%,ENPP2;ABHD16A;GDPD1
prerank,glucuronosyltransferase activity (GO:0015020),-0.32514454723476,-0.8939541059678455,0.6003521126760564,0.8215367763173933,1.0,8/19,31.88%,EXT1;LARGE1;UGT1A7;UGT1A4;UGT1A6;UGT1A8;UGT1A1;CHSY1
prerank,endopeptidase inhibitor activity (GO:0004866),-0.23919480982564986,-0.8914430892203518,0.6848184818481848,0.8248054189143446,1.0,15/82,13.71%,ROCK1;BIRC6;GAPDH;ANXA2;UCHL5;TFPI;PROS1;TIMP2;BST2;CAST;SERPINB9;AGT;APP;SERPINE1;CST7
prerank,actin monomer binding (GO:0003785),-0.3146799746592729,-0.8913885915445161,0.6187050359712231,0.8225289473566098,1.0,6/22,21.42%,MTSS1;ABL2;LIMA1;TMSB4X;TWF2;MYL4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2920555886630439,0.8908125127699056,0.5975609756097561,0.8817986348205803,1.0,7/27,13.51%,ZMYM2;RNF144A;UBE3D;SIAH3;RNF217;DCUN1D2;PRKN
prerank,muscle alpha-actinin binding (GO:0051371),0.32998969129625233,0.8901493355271008,0.6127450980392157,0.8784160649557778,1.0,5/15,17.40%,PRICKLE4;SYNPO2;TTN;PDLIM4;PDLIM7
prerank,U6 snRNA binding (GO:0017070),-0.34864034724709214,-0.8901178444307918,0.6061151079136691,0.8228988806284091,1.0,7/14,35.20%,PRPF8;SART3;RBM22;DDX39B;LARP7;TUT1;LSM8
prerank,filamin binding (GO:0031005),0.38515472090241093,0.8900031489638629,0.6055045871559633,0.8738788856072421,1.0,5/11,11.81%,NEBL;TMEM67;SYNPO2;DPYSL4;DPYSL3
prerank,NAD binding (GO:0051287),-0.3027718365056007,-0.8875145246593737,0.6280701754385964,0.8260880011209651,1.0,8/26,24.63%,ZC3HAV1;PARP9;SIRT3;SORD;QDPR;NNT;SIRT2;NUDT6
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.3282440779125706,0.8866665017820433,0.6218905472636815,0.8766612908622478,1.0,4/16,11.27%,SLC1A6;SLC1A1;SLC13A5;SLC25A11
prerank,protein phosphatase regulator activity (GO:0019888),0.245928111015221,0.8861746805042588,0.6790697674418604,0.8730024030405237,1.0,11/53,13.27%,PPP2R2B;RCAN2;PTN;BOD1;PPP2R1B;PPP2R2A;PPP1R16B;CALM1;CALM3;CALM2;PPP4R4
prerank,histone methyltransferase binding (GO:1990226),-0.3824382224870228,-0.8856478538472276,0.6269982238010657,0.827726316463942,1.0,3/11,19.61%,CTNNB1;HSP90AB1;LCORL
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3179402430603043,0.8833358312106244,0.6365853658536585,0.8745538135673356,1.0,5/20,14.84%,LPCAT2;MOGAT3;AGPAT3;GPAT3;AGPAT2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.338395480885906,0.8817991636830739,0.6258823529411764,0.873020702302999,1.0,6/14,21.45%,POP7;RPP25;RPP14;POP4;RPP21;RPP38
prerank,G protein-coupled receptor binding (GO:0001664),-0.2178697495683682,-0.8808394044159634,0.7475728155339806,0.8355397547831658,1.0,40/132,28.55%,SDCBP;ZNRF3;GNAI3;PDCD6IP;FLNA;GNA12;ARRB2;GRK3;GNA15;LRP6;ARRB1;GNA11;DNAJA1;GNA13;ARHGEF11;CCL5;CCRL2;CALCA;RNF43;GNA14;GPRC5B;HSPA1A;RYK;RSPO1;C1QBP;WNT3;SFRP1;S1PR2;NPB;DVL2;ADM;CCDC88C;WNT7B;FZD1;FZD7;HSPA8;PPY;WNT6;UTS2B;GHRL
prerank,water transmembrane transporter activity (GO:0005372),0.37195428519933127,0.88025123512027,0.6103286384976526,0.8718348229945698,1.0,3/11,19.87%,SLC4A11;AQP11;AQP4
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3765779148501809,-0.8796024963081734,0.6297520661157024,0.8357337486174402,1.0,5/10,24.88%,SIRPA;CXADR;JUP;CD47;DSP
prerank,gated channel activity (GO:0022836),-0.35550211758266614,-0.8780908934362806,0.648972602739726,0.8364850945711894,1.0,3/14,10.19%,PIEZO1;PACC1;TMC6
prerank,O-acyltransferase activity (GO:0008374),0.2821870777318055,0.876997011442257,0.6426799007444168,0.8744054913435974,1.0,7/30,15.41%,LPCAT2;MOGAT3;GPAM;MBOAT2;DGAT2L6;GPAT3;SOAT1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3681573251040561,-0.8763688007435307,0.6417112299465241,0.8375899377797799,1.0,2/12,14.15%,AGO2;NCBP1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3792147347557264,-0.875778399570269,0.6465661641541038,0.8363773837838216,1.0,2/10,7.77%,KDM7A;KDM2A
prerank,snoRNA binding (GO:0030515),-0.2918774531516397,-0.8740412931480791,0.6730103806228374,0.8374701023387976,1.0,17/30,40.61%,NOP14;DHX37;GAR1;NUFIP1;UTP6;SNU13;PRKDC;NHP2;NUDT16;IMP4;WDR3;ISG20;TBL3;NUDT1;NUDT5;BMS1;DDX21
prerank,disordered domain specific binding (GO:0097718),-0.3078644314645251,-0.8740389148364383,0.6627318718381113,0.8351110316279841,1.0,8/23,21.85%,RB1;GAPDH;FN1;HSP90AB1;HSPA1A;HSPA2;PPIL1;BCL2L2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.2511046763278879,-0.8739336227235585,0.664440734557596,0.8329897661988788,1.0,13/54,23.37%,ACER3;DARS1;SUDS3;TGM2;KLK3;HDAC10;HDAC5;MIER1;SIRT2;ASAH1;AMDHD2;HDAC8;UPB1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.36663584722602505,0.8737728302528608,0.605568445475638,0.8764602741247352,1.0,3/10,15.06%,SLCO4A1;SLCO2B1;SLCO3A1
prerank,fatty acid synthase activity (GO:0004312),0.37458785566287095,0.8712956626436621,0.6616161616161617,0.8770904672148692,1.0,4/10,22.83%,ELOVL7;ELOVL6;ELOVL2;OXSM
prerank,glucose transmembrane transporter activity (GO:0005355),0.32897074419131683,0.8704763407229144,0.6431924882629108,0.8743348183420708,1.0,3/17,10.00%,SLC2A5;MFSD4A;SLC5A10
prerank,intracellular chloride channel activity (GO:0061778),-0.32799639011015014,-0.8648350485470571,0.6728499156829679,0.8465334166102932,1.0,3/16,8.21%,ANO6;TTYH3;TTYH2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.32799639011015014,-0.8648350485470571,0.6728499156829679,0.8465334166102932,1.0,3/16,8.21%,ANO6;TTYH3;TTYH2
prerank,phospholipase A2 activity (GO:0004623),-0.29072675786083185,-0.8629852298714268,0.6654929577464789,0.8479608699365344,1.0,13/26,37.47%,PLA2G7;PLA2G4A;PLAAT3;PLAAT1;PLA2G6;PLA2G5;PLA2G12A;PNPLA8;PLA2G15;PLA2G3;PLA2G4B;PLB1;PLAAT5
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3582451124287881,-0.8621997794652422,0.666095890410959,0.8470837755066928,1.0,5/11,18.15%,ALKBH1;NEIL3;APLF;NEIL2;RPS3
prerank,calcium-release channel activity (GO:0015278),-0.3268393730803039,-0.861876020397811,0.6539735099337748,0.8453348729356276,1.0,4/17,6.51%,RASA3;ITPR1;MCOLN2;MCOLN3
prerank,cardiolipin binding (GO:1901612),0.381022451185636,0.8618470418779142,0.6210045662100456,0.8884791156637646,1.0,2/10,11.15%,MME;GSDMD
prerank,methyltransferase activity (GO:0008168),-0.25816586759577675,-0.861553864016716,0.7133220910623946,0.8436258835244821,1.0,15/46,27.44%,NSUN3;ARMT1;NSUN4;PRMT1;METTL4;MGMT;PRMT3;COMT;CARNMT1;BCDIN3D;RRP8;NDUFAF7;BUD23;MRM2;METTL3
prerank,hexose transmembrane transporter activity (GO:0015149),0.3502584099353129,0.8605428481324998,0.6347826086956522,0.8866676272292301,1.0,2/12,6.66%,SLC2A5;MFSD4A
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.34946443605808425,-0.8580564702997133,0.6519434628975265,0.8481136395629484,1.0,4/12,13.83%,ITGA5;VEGFA;CCDC88A;GREM1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.3041760166767626,-0.8575313440906969,0.681260945709282,0.8468697075609433,1.0,5/22,9.82%,OPTN;TAB2;RNF169;MINDY2;PRPF8
prerank,phosphatase activator activity (GO:0019211),-0.3376673172332547,-0.8541213087493984,0.6777003484320557,0.8512879834717055,1.0,7/14,27.18%,FRS2;PHACTR4;PPP2R5B;GTF2F1;PPP2R5A;BMP2;PPP2R5E
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.25006114386028677,-0.8523760077193057,0.7065972222222222,0.852334055951275,1.0,14/53,22.81%,SLC38A6;SLC43A2;SLC7A7;SLC38A7;SLC36A4;CTNS;SLC66A1;SLC7A5;SFXN1;SLC6A9;SLC38A2;SLC25A22;SLC15A4;SLC25A13
prerank,lipase activator activity (GO:0060229),0.3615580386048133,0.8519134513341349,0.6372093023255814,0.9001569954947748,1.0,2/10,7.51%,ARHGAP6;FYN
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.337302030743601,0.8507436390188104,0.6789838337182448,0.898103003098613,1.0,4/13,14.84%,LPCAT2;AGPAT3;GPAT3;AGPAT2
prerank,RNA stem-loop binding (GO:0035613),-0.3528367058612538,-0.8485963311370041,0.6723842195540308,0.8571877982486711,1.0,5/12,20.90%,DHX9;RC3H1;CSDE1;DDX3X;ZC3H12A
prerank,pseudouridine synthase activity (GO:0009982),-0.3366416634816841,-0.8462104596331949,0.6727941176470589,0.8593965018110331,1.0,2/13,10.10%,PUS7;PUS1
prerank,pyridoxal phosphate binding (GO:0030170),0.30192490126503446,0.8448844287529593,0.6952380952380952,0.9058455649613545,1.0,11/20,27.00%,GLDC;ABAT;CTH;PSAT1;THNSL2;CBS;ACCS;SHMT2;PLPBP;SDS;PYGM
prerank,CXCR chemokine receptor binding (GO:0045236),-0.3643864107497908,-0.8443243659966811,0.6876061120543294,0.8606495101556776,1.0,1/11,6.05%,PF4
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.29674981585333027,-0.8425553537453775,0.6947368421052632,0.8618898261531894,1.0,11/21,42.67%,FRS2;FGF18;FGF9;FGF22;FGF20;FGF16;FGF2;FGF23;KLB;FGF7;NPTN
prerank,protein phosphatase inhibitor activity (GO:0004864),0.2767865607270132,0.8346951448353089,0.7058823529411765,0.9214001296038206,1.0,3/26,5.29%,PPP1R14C;PTN;BOD1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3430450869192153,0.8343899706821605,0.683046683046683,0.9174310967249059,1.0,2/11,14.82%,CHRNA5;CHRNA7
prerank,Hsp90 protein binding (GO:0051879),-0.26658482430293046,-0.8327091500344154,0.7457627118644068,0.8775306400302515,1.0,14/33,33.24%,ERN1;CSNK2A1;AHR;HIF1A;NR3C1;RPS3;NOD2;KDR;HDAC8;AHSA1;TSC2;PPID;STUB1;PPEF2
prerank,chemoattractant activity (GO:0042056),0.27424249490395314,0.8312191429773206,0.7530864197530864,0.9186484242160623,1.0,5/26,12.03%,GDNF;VEGFD;PGF;FGF10;SCG2
prerank,protein kinase C binding (GO:0005080),-0.25683503910967415,-0.8307193952137851,0.755,0.87868358325258,1.0,12/43,21.61%,PRKCB;PLEK;TOP2A;ITGAV;ADAM9;GRK5;CCDC88A;HDAC5;TWF2;HSPB1;RACK1;PDLIM5
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3419034729832523,-0.8287973295384488,0.6907775768535263,0.8797716272686288,1.0,3/12,9.27%,SLC25A24;SLC25A42;SLC25A25
prerank,platelet-derived growth factor binding (GO:0048407),-0.3484032823408529,-0.825713840370598,0.7,0.8830205805343618,1.0,7/11,43.51%,PDGFRB;PDGFA;COL2A1;PDGFB;PDGFRA;COL1A2;COL4A1
prerank,phospholipase binding (GO:0043274),-0.3384514251718644,-0.8237332454138461,0.6878216123499142,0.8839919694435842,1.0,3/13,10.70%,SYK;BLNK;LCK
prerank,phospholipase activator activity (GO:0016004),0.35394864729826037,0.8208163833919229,0.7009345794392523,0.9340652632453263,1.0,2/10,7.51%,ARHGAP6;FYN
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.31264815475945673,0.8194198741289352,0.7327188940092166,0.9320246541974773,1.0,4/15,14.84%,LPCAT2;AGPAT3;GPAT3;AGPAT2
prerank,sequence-specific mRNA binding (GO:1990825),0.3444296898238237,0.8137926587414005,0.7105882352941176,0.9381861808833172,1.0,3/10,14.73%,FMR1;LARP6;DHFR
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3577291417644701,-0.8128401965873147,0.7356521739130435,0.9003533272273215,1.0,2/10,7.39%,PRKAG2;PKIB
prerank,cytokine activity (GO:0005125),-0.20413027618342977,-0.8127713943603728,0.8780864197530864,0.8980696916948773,1.0,47/131,38.63%,IL15;IL18;CKLF;PF4;VEGFA;CXCL16;CCL5;IL34;FAM3C;HMGB1;IL7;CSF1;GDF3;WNT3;INHA;IL6;KITLG;TGFB1;CCL7;WNT7B;BMP2;IL36G;WNT6;CCL24;IL2;IL16;CCL4;CCL25;CCL19;FGF2;TNF;FAM3D;WNT10B;BMP8B;IL12A;CNTF;CCL8;CXCL9;LEFTY1;GDF6;IL12B;WNT11;WNT2;INHBC;CTF1;IL17F;CXCL1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.34446013127175795,-0.8114715534293426,0.7290909090909091,0.8978492333859321,1.0,7/11,33.46%,SLC25A24;SLC25A42;SLC25A25;SLC35B3;SLC17A9;SLC19A1;SLC25A17
prerank,phosphatase inhibitor activity (GO:0019212),0.28714196537610803,0.8095779690133293,0.7591743119266054,0.9412969737165104,1.0,3/20,5.29%,TESC;PTN;BOD1
prerank,gap junction channel activity (GO:0005243),0.276636864295127,0.8082815325777374,0.7333333333333333,0.9390972386794858,1.0,6/22,19.00%,GJC3;GJC2;PANX2;GJD2;GJD3;GJC1
prerank,antiporter activity (GO:0015297),0.278558802001419,0.8080827577802345,0.7522522522522522,0.9348208684082593,1.0,10/20,26.89%,ATP1A3;SLC35E4;SLC25A11;CLCN3;SLC35C1;SLC25A30;SLC35C2;SLC35A1;CLCN4;SLC35E3
prerank,Hsp70 protein binding (GO:0030544),0.2578742043922507,0.8080736117404621,0.7748815165876777,0.9302818998716303,1.0,9/31,16.07%,SACS;GPR37;TSC1;PACRG;HIKESHI;CYP1A1;DNAJB2;PRKN;SNCA
prerank,phosphoric ester hydrolase activity (GO:0042578),0.23034788523202931,0.8068746512104759,0.8450363196125908,0.9278143557561963,1.0,14/49,17.07%,MPPED2;PXYLP1;GDPD1;ACP6;PLCXD3;ENPP6;DUSP4;DUSP10;DUSP18;APEX1;PLCXD2;DUSP8;PHOSPHO2;PRUNE1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.3440048613934726,-0.806055153410101,0.7446428571428572,0.904443101804148,1.0,3/12,8.82%,SLC9A9;SLC9A8;SLC9A1
prerank,hormone activity (GO:0005179),0.22674141894434574,0.8043668961454893,0.8313817330210773,0.9275975061620995,1.0,13/54,18.75%,PNOC;SPX;APLN;CORT;EDN1;GHRH;CALCB;INHBB;INHBA;PENK;GRP;INSL6;CRH
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.2768450028252502,0.8035844388306194,0.7701711491442543,0.9244375982868805,1.0,2/22,2.99%,RBMS3;ELAVL4
prerank,cAMP response element binding (GO:0035497),0.3364302729455825,0.8026584509193456,0.7235576923076923,0.9216561725401724,1.0,4/10,12.88%,ATF2;CREB5;HMGA2;CREB3L1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3235468481747079,0.8006147378139524,0.7132352941176471,0.9207620704654197,1.0,2/11,7.69%,WT1;HMGA2
prerank,transcription coregulator binding (GO:0001221),0.22884220634222785,0.7996365740140647,0.7972350230414746,0.9179997897293074,1.0,13/50,19.95%,RORA;PGR;THRB;MTF2;CHD6;NR1D1;PER2;WIZ;CTCF;CIT;TERT;PHF1;PER1
prerank,ankyrin binding (GO:0030506),-0.29496518208530703,-0.7986795637188843,0.7835951134380453,0.9143537741846098,1.0,2/19,9.28%,PTPRC;SLC8A1
prerank,metalloaminopeptidase activity (GO:0070006),0.2939248321965878,0.7968376643193276,0.7494199535962877,0.9185250683233891,1.0,3/16,5.66%,MMP16;TRHDE;MMP15
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.22588123151186865,-0.7955955663369527,0.8244406196213425,0.9168601803374764,1.0,19/57,29.36%,NDUFA9;COX4I1;NDUFB2;COX10;NDUFS5;UQCRC1;COX8A;NDUFA1;CYB561A3;NDUFA3;NDUFA4;CYB5A;COX5A;NDUFB8;NDUFC2;COX6A2;NDUFC1;UQCRQ;NDUFS6
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.24350739032741225,-0.7939669801430953,0.8093645484949833,0.9169913107489555,1.0,10/40,23.12%,DNMT3A;ARMT1;METTL4;METTL9;COMT;GNMT;CARNMT1;METTL2A;METTL2B;RRP8
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.277958328252472,-0.7924880153659957,0.7842465753424658,0.9169816553152849,1.0,7/24,24.44%,ZDHHC7;ZDHHC8;ZDHHC2;ZDHHC12;ZDHHC1;GOLGA7;ZDHHC6
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.32499834391189314,-0.7914115172779067,0.7676419965576592,0.9162990347888923,1.0,1/12,1.17%,XDH
prerank,ATPase activator activity (GO:0001671),-0.2918486697818438,-0.7896660947531652,0.784965034965035,0.9166240169245433,1.0,8/20,27.55%,DNAJC1;ATP1B3;DNAJA1;TOR1AIP1;MYBPC3;DNAJB6;AHSA1;FXYD2
prerank,ion channel inhibitor activity (GO:0008200),-0.24599393454896745,-0.7896525337948835,0.8121827411167513,0.9142720391786225,1.0,9/35,21.40%,ITPR1;STX7;STX8;MCUB;NEDD4L;RASA1;SCN3B;WNK1;RACK1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.32577660419601107,-0.7798625885966923,0.7857142857142857,0.9265643542092294,1.0,3/13,8.82%,SLC9A9;SLC9A8;SLC9A1
prerank,transcription corepressor binding (GO:0001222),0.25642712207605745,0.7793325382192521,0.8009367681498829,0.9414799085946737,1.0,4/27,11.87%,RORA;MTF2;NR1D1;PER2
prerank,O-methyltransferase activity (GO:0008171),-0.3363111131849982,-0.7766571241546564,0.75,0.9289517357197818,1.0,3/10,20.45%,CMTR2;COMT;BCDIN3D
prerank,NADPH binding (GO:0070402),0.3043100636175063,0.7741326495880829,0.7553444180522565,0.9450486965076242,1.0,6/13,25.15%,CRYZ;DHFR;DUS2;KCNAB1;GRHPR;DECR1
prerank,acetyltransferase activity (GO:0016407),-0.24673625937191013,-0.772145810828075,0.8283185840707965,0.9333283824848876,1.0,7/31,20.24%,CREBBP;SAT1;PAFAH2;NAA50;SAT2;NAA16;ESCO2
prerank,N-acyltransferase activity (GO:0016410),-0.2512392585152906,-0.7693458698697732,0.8076256499133448,0.9351021368844844,1.0,14/32,38.21%,SAT1;TGM2;NAA50;PLAAT3;PLAAT1;SAT2;NMT1;CERS3;EP300;GNPNAT1;CERS2;BAAT;PLAAT5;SATL1
prerank,mRNA methyltransferase activity (GO:0008174),-0.3248037821600125,-0.7671931179714359,0.7889908256880734,0.9357577389688556,1.0,9/12,44.90%,PCIF1;CMTR2;METTL14;METTL3;TRMT61A;TRMT61B;METTL8;METTL16;TRMT10C
prerank,solute:proton symporter activity (GO:0015295),-0.2946852926833534,-0.7639356374233757,0.7828371278458844,0.9379576288861783,1.0,5/16,22.76%,SLC33A1;CTNS;MFSD3;SLC11A2;SLC15A4
prerank,adenylyltransferase activity (GO:0070566),-0.2725444497877223,-0.7631541616436275,0.797962648556876,0.9366716170329796,1.0,8/21,20.04%,MTPAP;OASL;OAS3;KARS1;SELENOO;TENT4B;PAPOLA;OAS2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.2543554007236526,0.7629186211162508,0.8321678321678322,0.9575753583458937,1.0,5/27,10.07%,SLC8A3;SLC9B2;SLC9A2;SLC8A2;SLC4A11
prerank,vinculin binding (GO:0017166),0.32176074851959213,0.7624360745485108,0.7990654205607477,0.9538842491904692,1.0,2/11,7.42%,DMD;SYNM
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.31487799820353257,-0.761114408024398,0.7775831873905429,0.9372042891750365,1.0,3/12,20.94%,GTF2A1;RELA;STAT1
prerank,phosphatase activity (GO:0016791),0.19950633202145804,0.7600927407378609,0.9182692307692307,0.9530182106826651,1.0,22/73,23.83%,PLPP4;PLPPR1;PLPPR4;PXYLP1;ACP6;HDDC2;DUSP4;DUSP10;DUSP18;NOCT;PLPPR2;DUSP8;PHOSPHO2;PRUNE1;PGAM5;BPNT2;NT5M;FRA10AC1;SACM1L;DUSP28;DUSP26;PDXP
prerank,protein phosphatase 1 binding (GO:0008157),-0.2694426093912745,-0.759794643184885,0.8265993265993266,0.9365282946085907,1.0,4/21,15.90%,LILRB1;AKAP11;PPP1R3E;PPP1R9B
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.25451013854771204,0.7581445731607453,0.8204545454545454,0.9513731458831323,1.0,7/24,16.87%,NME2;IP6K2;ITPKA;AK4;PPIP5K2;AK5;AK3
prerank,AMP binding (GO:0016208),0.31196353918712255,0.7567349931536609,0.7795823665893271,0.9489478570194309,1.0,1/11,1.20%,MPPED2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3093552911917888,0.7532994006716395,0.7602739726027398,0.9491321918620744,1.0,3/11,19.52%,DHRS13;RDH11;RDH14
prerank,hydro-lyase activity (GO:0016836),-0.23039780527250409,-0.7532505399085545,0.8571428571428571,0.9426750502860753,1.0,2/41,1.64%,TBXAS1;IREB2
prerank,telomeric DNA binding (GO:0042162),-0.24291376893249353,-0.7514959285866226,0.8760195758564437,0.9425293229727758,1.0,8/32,23.07%,BLM;UPF2;XRCC6;WRN;TEN1;NCL;KDM1A;SMG1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.25249462011322665,-0.7472377657713969,0.839527027027027,0.9457658562244483,1.0,14/27,33.28%,ATP2B1;ITPR1;ATP2A3;MAGT1;CNNM4;SLC23A1;SLC11A2;ZDHHC13;ITPR2;AQP1;SLC12A3;SLC4A8;CNNM2;SLC11A1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.23355542702916018,-0.7427179409309657,0.8933566433566433,0.9491206492539804,1.0,13/37,30.00%,SLC16A7;COX4I1;COX10;UQCRC1;SLCO5A1;COX8A;NDUFA4;CYB5A;COX5A;SLC4A1;COX6A2;UQCRQ;SLCO1B1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.22769131162748274,0.74111609540826,0.8632075471698113,0.9612571588276626,1.0,7/33,13.51%,ZMYM2;RNF144A;UBE3D;SIAH3;RNF217;DCUN1D2;PRKN
prerank,sulfate transmembrane transporter activity (GO:0015116),0.28718142453468815,0.7394970590562276,0.7995226730310262,0.9589801441284695,1.0,3/14,13.06%,SLC26A3;SLC25A11;SLC26A8
prerank,diacylglycerol kinase activity (GO:0004143),0.30373576288675364,0.7359418915311862,0.8129496402877698,0.9590898128841355,1.0,1/11,0.91%,DGKB
prerank,nucleosomal DNA binding (GO:0031492),-0.2624011599006293,-0.7308520532667637,0.8430034129692833,0.9614109135955404,1.0,5/21,22.56%,ACTB;SMARCC2;RBBP4;RCC1;GATAD2B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3020240591310947,0.7303515840739077,0.8352941176470589,0.9614342881998384,1.0,2/11,8.10%,NUDT11;NUDT7
prerank,anion transmembrane transporter activity (GO:0008509),-0.30040004141079446,-0.7300563381281585,0.8114186851211073,0.9599227573679613,1.0,5/12,38.07%,SLC26A11;SLC22A3;SLC4A1;SLC19A1;SLC22A6
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.31632275447226965,-0.7278257904853559,0.8128161888701517,0.9601854092806331,1.0,2/11,10.63%,AMFR;UBE4B
prerank,5'-nucleotidase activity (GO:0008253),-0.2869035013752371,-0.725925946212203,0.8245315161839863,0.9599848150331173,1.0,3/13,30.83%,NT5C2;NT5DC1;ACP3
prerank,wide pore channel activity (GO:0022829),0.24454608566270292,0.7255619597619203,0.8486997635933806,0.9630262432941858,1.0,6/23,19.00%,GJC3;GJC2;PANX2;GJD2;GJD3;GJC1
prerank,lysine N-methyltransferase activity (GO:0016278),-0.2597042725837868,-0.7243317902421661,0.8547008547008547,0.9594030215037608,1.0,10/20,35.13%,SMYD2;KMT5A;EEF2KMT;SETD6;METTL21A;SETD7;SETD2;ETFBKMT;ANTKMT;SETD4
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.2758648171079094,-0.7184820122754897,0.8674911660777385,0.9634450508317753,1.0,5/18,21.87%,PIK3R5;WDR91;SOCS6;SOCS3;SOCS5
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.3149951158713745,-0.7144584688177973,0.8496503496503497,0.9653795117218191,1.0,2/10,17.90%,INCA1;CDKN2C
prerank,death receptor binding (GO:0005123),-0.2741954027379061,-0.7124750197407523,0.8617594254937163,0.9651143149117755,1.0,4/15,22.28%,RIPK1;MYD88;BID;FEM1B
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.2659096865727061,-0.7024591468375874,0.8646209386281588,0.973004438938784,1.0,8/18,36.82%,HSD17B7;SRD5A2;HSD17B10;HSD3B2;HSD17B14;DHRS11;AKR1C1;HSD17B3
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.22959782769582196,-0.6940914047882493,0.9026086956521739,0.9785908601828932,1.0,5/30,19.82%,SLC30A5;ATP7A;SLC31A1;SLC39A3;SLC11A2
prerank,N-methyltransferase activity (GO:0008170),0.24179068026612588,0.6939954205653637,0.9018691588785047,0.993358435949451,1.0,5/20,15.27%,TRMT1;METTL18;FDXACB1;TRMT11;SETD3
prerank,hormone receptor binding (GO:0051427),-0.27578785887209656,-0.6935990833983195,0.8729582577132486,0.9766554381406309,1.0,5/14,29.18%,JAK1;NCOA6;TYK2;VIP;CCK
prerank,hexosaminidase activity (GO:0015929),-0.2834537347682981,-0.6908493975891494,0.8779599271402551,0.9768849485238325,1.0,1/12,0.81%,HEXA
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.25833319082101647,0.6893655299141294,0.8707482993197279,0.9933605302439483,1.0,2/15,9.63%,PLA2G4E;PLA2G10
prerank,phosphate ion binding (GO:0042301),-0.29960300257626926,-0.6874564457687808,0.8578512396694215,0.9776449350094862,1.0,2/10,10.48%,ADSS1;RELA
prerank,MAP kinase activity (GO:0004707),0.2624822783186311,0.675561972435507,0.8832951945080092,1.0,1.0,5/14,21.27%,MAPK10;MAPK4;MAPK11;NLK;MAPK8
prerank,RNA methyltransferase activity (GO:0008173),-0.24839759837728428,-0.673597391091137,0.9003496503496503,0.9870213178541621,1.0,10/19,43.97%,METTL4;TGS1;BCDIN3D;MRM2;METTL3;FTSJ1;METTL8;MEPCE;TRDMT1;LCMT2
prerank,mechanosensitive ion channel activity (GO:0008381),-0.27710573784796605,-0.6714722065211124,0.8743801652892562,0.9863380146408679,1.0,2/12,10.19%,PIEZO1;TMC6
prerank,copper ion binding (GO:0005507),-0.2042679769205075,-0.6689114491211701,0.9513422818791947,0.9860538150122944,1.0,10/42,30.20%,P2RX4;ATP7A;AOC2;MOXD1;ANG;MT3;DCT;ACR;ATP13A2;ATOX1
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.23651014972853612,-0.6680241995806887,0.9215358931552587,0.9843837101269743,1.0,5/21,24.58%,POLE2;PRIMPOL;POLN;POLB;POLD4
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.28434206764913755,-0.6671443803438808,0.8624787775891342,0.9827321196619664,1.0,3/11,19.72%,NAA25;NAA50;NAA16
prerank,H4 histone acetyltransferase activity (GO:0010485),0.27764847417770244,0.6615213555147181,0.8631346578366446,1.0,1.0,2/10,12.71%,ATF2;NAA60
prerank,exoribonuclease activity (GO:0004532),-0.275017690939811,-0.6613643122025812,0.9036363636363637,0.9849500148919555,1.0,5/12,27.04%,EXOSC5;EXOSC10;ZC3H12A;EXOSC4;EXOSC8
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.28812356124988264,-0.6612528015892192,0.8842832469775475,0.9826855458919059,1.0,3/10,19.72%,NAA25;NAA50;NAA16
prerank,ribosome binding (GO:0043022),-0.19757932490348848,-0.657240980804678,0.976,0.9832060522939434,1.0,11/46,21.59%,YTHDF3;EFL1;EEF2;EIF2A;MAIP1;NAA16;C1QBP;ZC3H12A;CPEB4;RACK1;BAG6
prerank,fibroblast growth factor binding (GO:0017134),-0.23372179005920218,-0.6562819395003741,0.9221453287197232,0.9815469398834347,1.0,2/21,7.58%,ITGAV;CEP57
prerank,alkali metal ion binding (GO:0031420),-0.25697008103372254,-0.6446217633217803,0.9104991394148021,0.9871538119441846,1.0,4/13,33.62%,IMPA1;PDXK;ATP1A1;DRG1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.25694983048857595,-0.6443681004694083,0.9099099099099099,0.9849599119094319,1.0,7/14,36.71%,BLVRB;QDPR;MTHFR;PYCR3;PYCR2;MTHFD1;CRYM
prerank,MAP kinase phosphatase activity (GO:0033549),-0.26519160253479823,-0.6367384256831806,0.9166666666666666,0.9876370510176058,1.0,4/12,24.06%,DUSP3;DUSP6;DUSP5;DUSP2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.17517270055346645,0.6341756318712675,0.9775,1.0,1.0,19/51,26.89%,SLC4A4;SLCO4A1;SLC35E4;MFSD2A;SLCO2B1;SLC25A11;CLCN3;SLC16A2;SLCO3A1;SLC35C1;SLC25A30;SLC35C2;SLC35A1;SLC28A1;SLC22A8;CLCN4;MCU;SLCO4C1;SLC35E3
prerank,CoA hydrolase activity (GO:0016289),-0.2404102816008591,-0.6267812137940333,0.9427549194991055,0.9910874698048932,1.0,5/16,20.32%,ACOT9;ACOT13;ACAA2;ACOT2;ACOT4
prerank,glycerophospholipid flippase activity (GO:0140333),0.25175491805292904,0.6253095794487837,0.919661733615222,1.0,1.0,1/11,2.33%,ATP8A2
prerank,anion:anion antiporter activity (GO:0015301),0.2301652513070545,0.6245787015849558,0.919047619047619,1.0,1.0,3/17,13.06%,SLC26A3;SLC25A11;SLC26A8
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.23177299635519671,0.6219495336172896,0.9243119266055045,1.0,1.0,4/17,16.87%,NME2;AK4;AK5;AK3
prerank,protein phosphatase activator activity (GO:0072542),-0.24787686682096013,-0.6219108844730322,0.9267015706806283,0.9914369686686236,1.0,6/13,31.16%,IGFBP3;PHACTR4;PPP2R5B;PPP2R5A;PPP2R5E;PTPA
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.24333201170066077,0.6213717763396719,0.9496567505720824,1.0,1.0,3/14,14.90%,NME2;AK4;AK5
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.2151797503260312,0.6183826009729896,0.9667405764966741,1.0,1.0,6/22,16.43%,MTMR2;DUSP19;DUSP4;DUSP10;DUSP18;DUSP8
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.2672380837830794,-0.6182105154172456,0.9181184668989547,0.9911000875409691,1.0,2/10,13.97%,ASH1L;SETDB1
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2555373674504643,-0.6141834280162088,0.931899641577061,0.9907647806241914,1.0,7/12,36.14%,CBR1;NQO2;NQO1;DHRS4;AIFM2;CBR4;AKR1C1
prerank,DNA polymerase activity (GO:0034061),-0.21292265556379075,-0.6106755082879894,0.957983193277311,0.9902344848297155,1.0,5/22,24.58%,POLE2;PRIMPOL;POLN;POLB;POLD4
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.19975389653736475,-0.6060152496925949,0.9637931034482758,0.9901854328865586,1.0,8/27,29.41%,SLC26A11;XPR1;GET3;ANKH;SLC25A10;SLC4A1;SLC26A4;SLC5A5
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.18486401399088453,0.5978757261877906,0.9821826280623608,1.0,1.0,6/34,15.54%,NDUFB7;NDUFV2;NDUFA2;NDUFB9;NDUFA8;NDUFV3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.18486401399088453,0.5978757261877906,0.9821826280623608,1.0,1.0,6/34,15.54%,NDUFB7;NDUFV2;NDUFA2;NDUFB9;NDUFA8;NDUFV3
prerank,nucleotide diphosphatase activity (GO:0004551),0.2289851353291582,0.5968622135833641,0.9585253456221198,1.0,1.0,3/14,17.45%,NUDT11;ENPP5;NUDT3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.2221681933998059,0.5927640655373644,0.9487179487179487,1.0,1.0,3/16,14.98%,SLC5A7;SLC18A3;SLC22A5
prerank,solute:anion antiporter activity (GO:0140323),-0.2340919700912792,-0.5916635357258173,0.9516407599309153,0.9940824388032183,1.0,1/14,3.90%,SLC26A11
prerank,enoyl-CoA hydratase activity (GO:0004300),0.2432211900577454,0.589946706160744,0.9365079365079365,1.0,1.0,10/10,75.69%,EHHADH;HSD17B4;AUH;ECHDC1;HADHA;HADHB;ECI1;ECHS1;ECHDC2;ECHDC3
prerank,peptide hormone receptor binding (GO:0051428),-0.24842392823441967,-0.5878770192509607,0.9463327370304114,0.9933909821868943,1.0,3/11,29.18%,GNRH1;VIP;CCK
prerank,carboxy-lyase activity (GO:0016831),0.20232775403049452,0.5871392871119693,0.9563106796116505,1.0,1.0,8/23,24.51%,PISD;DDC;GGCX;MLYCD;ACOD1;ODC1;MVD;AMD1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.18707752637547484,0.5836423191328296,0.9830508474576272,0.9987998950316164,1.0,9/28,21.96%,POP7;RPP25;RNASEH1;RPP14;POP4;APEX1;RPP21;RPP38;MRPL44
prerank,tRNA methyltransferase activity (GO:0008175),-0.22499965767925717,-0.5834616308520204,0.955249569707401,0.9927912358912484,1.0,4/16,20.93%,TRMT44;BCDIN3D;METTL2A;METTL2B
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.23227352062077095,-0.5832271143310237,0.9610619469026549,0.990597057484519,1.0,4/15,21.87%,PIK3R5;SOCS6;SOCS3;SOCS5
prerank,pyrophosphatase activity (GO:0016462),-0.17181219375875265,-0.5812429621757454,0.9965986394557823,0.9891077740163675,1.0,24/50,40.69%,DHX9;DCP2;ENTPD6;NUDT14;BNIP2;ENTPD3;DDX3X;ENPP1;NUDT22;BNIPL;NUDT15;NUDT6;NUDT16;ALPL;DCTPP1;NUDT10;ENTPD7;LHPP;NUDT1;CILP;NUDT5;DOLPP1;PLPP1;DXO
prerank,Notch binding (GO:0005112),0.19934981413823716,0.5770837706535414,0.9814814814814815,0.9972961298256353,1.0,6/22,21.21%,CCN3;DNER;SNED1;ADAM17;SNW1;DLL4
prerank,leucine zipper domain binding (GO:0043522),-0.24496531911893887,-0.5543668102336815,0.9516994633273703,0.9955344825136876,1.0,2/10,15.46%,DAPK3;AATF
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.2036388244116421,-0.5512375468279099,0.9819168173598554,0.9941559876774624,1.0,1/20,1.91%,SLC30A5
prerank,nucleotidase activity (GO:0008252),-0.21026060294588078,-0.548768009097218,0.979557069846678,0.9925637720939375,1.0,3/15,30.83%,NT5C2;NT5DC1;ACP3
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.17582803001673208,-0.5479377988998251,0.9950819672131147,0.9905871772821899,1.0,7/35,21.70%,ALKBH1;FTO;QTRT1;TARS2;AARS1;BCDIN3D;ELAC2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.21949175317810812,0.5441037223015871,0.9729119638826185,1.0,1.0,4/11,28.80%,SLC22A5;SLC25A47;SLC25A29;SLC22A4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.22981110882517475,0.5397404600783342,0.9705882352941176,0.9967502307471966,1.0,4/10,21.28%,DUSP4;DUSP10;DUSP8;DUSP7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.22981110882517475,0.5397404600783342,0.9705882352941176,0.9967502307471966,1.0,4/10,21.28%,DUSP4;DUSP10;DUSP8;DUSP7
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.19882364668002106,0.5036035090909585,0.9908466819221968,1.0,1.0,2/13,13.86%,EBP;EHHADH
prerank,ribosomal large subunit binding (GO:0043023),0.20124285983302992,0.5013890581523409,0.9863325740318907,0.9964541946708949,1.0,11/11,79.89%,CPSF6;NPM1;MRRF;NMD3;LTN1;DHX33;CPEB2;MALSU1;NEMF;EIF6;RBM3
prerank,single-stranded telomeric DNA binding (GO:0043047),0.20406527740969785,0.4973042801065603,0.9737470167064439,0.9929986950848195,1.0,10/11,58.74%,NABP2;TERF1;RPA2;CTC1;TERF2IP;HNRNPA2B1;RPA1;RAD50;STN1;TERF2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.19762222753651354,-0.4847734794054476,0.9836065573770492,0.9993961091246938,1.0,1/13,5.12%,METTL1
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.18371147842315527,-0.4836631958981596,0.9911971830985915,0.9972788947105631,1.0,6/18,31.15%,TGFBR1;TGFBR2;SMAD7;TGFB1;ENG;SMAD2
prerank,N-acetyltransferase activity (GO:0008080),-0.16979819462748721,-0.4658424992117872,1.0,0.9965512542582843,1.0,7/19,38.21%,SAT1;NAA50;SAT2;EP300;GNPNAT1;ATAT1;SATL1
